Biosensor molecules and methods of their use

Engineered PYR/PYL receptor polypeptides with amino acid substitutions address the limitations of narrow ligand specificity in PYR1-based sensors, enabling high-throughput design of sensitive and specific biosensors for diverse small molecules.

WO2026241433A1PCT designated stage Publication Date: 2026-11-19RGT UNIV OF CALIFORNIA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/028055
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-07
Filing Date
2026-05-13
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing methods for designing small-molecule biosensors, particularly those based on the PYR1 CID system, suffer from narrow ligand specificity and lack scalability for high-throughput engineering of sensors against a broad panel of molecules, including drugs, pharmaceuticals, and environmental contaminants.

Method used

Development of engineered PYR/PYL receptor polypeptides with amino acid substitutions in the ligand-binding pocket, utilizing high-throughput yeast-based selection and data-driven library design to create sensors for diverse small molecules.

Benefits of technology

The engineered PYR/PYL receptors demonstrate broad chemical scope and high affinity for a variety of small molecules, including FDA-approved drugs, natural products, and environmental contaminants, with sensitivity and specificity enhanced through data-driven optimization.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026028055_19112026_PF_FP_ABST
    Figure US2026028055_19112026_PF_FP_ABST
Patent Text Reader

Abstract

Sensor design pipelines and small-molecule sensors with broad chemical scope and antibody-like simplicity for the detection of multiple plant natural products, 2,4,6-trinitrotoluene (TNT), and "forever" per- and polyfluoroalkyl substances (PFAS) are described.
Need to check novelty before this filing date? Find Prior Art

Description

Atty Docket No. 690104.0046BIOSENSOR MOLECULES AND METHODS OF THEIR USECross-Reference to Related ApplicationsThis application claims priority under 35 U. S. C. § 119(e) to US Provisional Application No.63 / 805,810, filed May 14, 2025, and to US Provisional Application No. 63 / 913,291 filed November 7, 2025, the disclosures of which are incorporated by reference in their entireties.Government License RightThis invention was made with government support under D24AC00011, and HR0011 - 18-C-0137 awarded by the Defense Advanced Research Projects Agency; R01-GM151616 and DA053496 awarded by the National Institutes of Health; 2128016, 2128287, and 1922642 awarded by the National Science Foundation; and P200A210136 and P200A240099 awarded by the United States Department of Education Graduate Assistance in Areas of National Need (GAANN) Program. The government has certain rights in the invention.Reference to Sequence Listing Submitted ElectronicallyThe Sequence Listing associated with this application is provided in XML format, and is hereby incorporated by reference into the specification. The name of the XML file containing the Sequence Listing is “690104.0046 Sequence Listing.” The XML file is 875.8 kilobytes, was created on May 13, 2026, and is being submitted electronically, concurrent with the filing of this application.Field of InventionThe invention pertains to the field of biochemical and molecular biology, and specifically to biosensors. The invention focuses on the novel creation and characterization of sensors for drugs, chemicals, and multiple plant natural products with broad chemical scope and antibody-like simplicity.Background of the InventionThe ability to create protein binders through antibodies and designed proteins transformed biotechnology by rendering proteins targetable entities (1). Antibodies achieve this versatility through the exploitation of a single protein domain and establish engineering pipelines for isolating binders with defined specificity and affinity. An analogous capability for smallAtty Docket No. 690104.0046molecules has long been sought, as protein scaffolds that can be programmed to recognize smallmolecule ligands with the same simplicity with which antibodies recognize protein antigens are highly desirable.Existing approaches to small-molecule sensing rely on various biological components, including ligand-induced transcription factors (lacI) (2,3), cell surface receptors such as GPCRs and DREADDs (4), and chemical-induced dimerization (CID) systems such as rapamycin / FKBP / FRB (5). Among these, CID systems are particularly attractive because they enable the facile control of diverse cellular outputs via induced proximity mechanisms (5-9). However, existing CID systems typically have narrow ligand specificity and are not readily programmable to respond to user-specified molecules.Small-molecule biosensors are critical tools for monitoring environments, controlling cellular behavior, and enabling new biotechnologies; yet they remain challenging to design.Phytohormone signaling in plants has yielded naturally occurring CID modules that can be harnessed to engineer new sense-response capacities (10-16). The plant abscisic acid (ABA) receptor PYR1 (Pyrabactin Resistance 1) was previously established by the inventors as an engineerable scaffold for sensor design, with demonstrated ability to reprogram binding for certain cannabinoid and pesticide ligands (17-20). PYR1 offers several advantageous properties. In particular, ligand recognition is separated from effector (HAB1) binding. This separation simplifies engineering efforts to a single molecular recognition surface. Moreover, PYR1 benefits from intrinsic sensitivity amplification. Thus, the native ligand, ABA, binds to the receptor with only µM affinity, whereas the activated receptor binds with nanomolar affinity to HAB1 in an orientation that blocks ligand dissociation. This binding causes up to a 100-fold increase in affinity to the ligand (21) and reduces the challenges of identifying activating ligands (22). Additionally, PYR1 components are soluble and function in diverse prokaryotic and eukaryotic hosts (13, 17, 19, 23).These features could ideally make the PYR1 CID module an effective sensor scaffold, with the ability to be reprogrammed to bind non-native ligands and a candidate for designing smallmolecule binders akin to antibodies for protein antigens.Atty Docket No. 690104.0046Despite these advantages, the full chemical scope of the PYR1 binding pocket has not been defined, and methods for high-throughput, data-driven engineering of PYR1 sensors for diverse small molecules have been lacking. There remains a need in the art for scalable platforms for generating PYR1 -based sensors against a broad panel of small molecules, and effective methods that use ligand-receptor interaction datasets to design targeted, high-affinity sensor libraries and produce sensors for molecules of practical importance including drugs, pharmaceuticals, and environmental contaminants.Summary of the InventionThe present invention answers to the need for broader scope PYR1 -based sensors by providing engineered PYR1 protein scaffolds for detecting small molecules, methods for generating and optimizing such sensors using high-throughput yeast-based selection and data-driven library design, and applications thereof.Thus, in embodiments, provided herein is a library comprising a plurality of polypeptides. Each polypeptide contained in the plurality of polypeptides comprises a mutated PYR / PYL receptor polypeptide having amino acid substitutions in the ligand-binding pocket relative to the corresponding position in the wild-type PYR1 of SEQ ID NO:853.In embodiments, at least one polypeptide of the library comprises an amino acid sequence selected from the group consisting of SEQ ID NOS: 1-852.In embodiments, the library is a display library or a yeast two-hybrid library.Also provided herein is an isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS: 1-852 and a sequence which is at least 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% to any one of SEQ ID NOS: 1-852.In embodiments, the mutated PYR / PYL receptors act as sensors for the detection of non-native small-molecules. Non-native small molecules include, but are not limited to, FDA-approved drugs and pharmaceuticals, natural products, agrochemicals, per- and polyfluoroalkyl substance (PFAS), explosives and explosive residues, such as trinitrotoluene (TNT), dinitrotoluene (DNT), and 2-amino-4,6-dinitrotoluene (2-ADNT), and coumarin derivatives.Atty Docket No. 690104.0046In additional embodiments, provided herein is a system for detecting a substance, including a drug, a natural product, a chemical compound and an agrochemical, comprising one or more of the mutated PYR / PYL receptor polypeptides disclosed herein and an HAB polypeptide.In yet other embodiments, provided herein is a method for detecting a substance of interest in a sample, wherein the disclosed method comprises contacting a sample containing, or suspected of containing the substance of interest with one or more of the engineered PYR1 polypeptides provided herein.Figure 1. Large-scale sensor isolation to enable data-driven sensor design. (A) The PYR1 sensor isolation pipeline. PYR1 binds to its effector protein HAB1 in response to ABA, its native ligand. This interaction can be measured in yeast growth assays by activating a genetic circuit that rescues uracil auxotrophy. Mutant PYR1 variants that recognize new ligands are identified from receptor library pools using selection experiments (responders grow without uracil). (B) A high-throughput version of the receptor isolation approach was developed. About 150,000 cells were plated onto media containing a test chemical and colonies from the wells were selected for retesting and subsequent sequencing. These efforts lead to the identification of 569 receptors that recognize 182 unique molecules. (C) Chemoinformatic analysis of the data is used to build maps of sequence-ligand interactions. (D) The sequence-ligand maps developed are harnessed for data-driven design of sensors. Libraries of receptors targeted to specific molecule classes are constructed using sequence profiles to design oligonucleotide pools that can be assembled using Golden Gate cloning; subsequent growth-based screens enable one-step isolation of high-affinity sensors.Figure 2. The PYR1 binding pocket can be mutated to sense small molecules of broad chemical scope. (A) Summary of ligands sensed by receptors isolated from a 2726-member small molecule library screen. The hits obtained include FDA-approved molecules, natural products, agrochemicals, and a collection of research ligands. (B) The molecules sensed by PYR1 -derived sensors are structurally diverse. The heatmap shows hierarchical clustering based on the pairwise chemical similarities of the 182 hit molecules. Pairwise ligand-similarity,, measured using Tanimoto scores calculated from atom-pair descriptors in ChemmineR (21), is shown by the heatmap (blue = identical). Selected clusters of similar ligands are highlighted. (C).Atty Docket No. 690104.0046Selected chemical ligands from each cluster identified in part B. (D) PYR1 -derived receptors sense drug-like molecules. Comparisons of the physicochemical properties of ligand hits (n=182) and the non-hits (n=2545). Molecular weight (MW), computationally calculated octanol-water partition coefficient (cLogP), topological polar surface area, and a quantitative estimate of druglikeness (24) values were extracted from ChEMBL (23). The median of each population is shown, along with the p-value from a two-sided Wilcoxon rank sum test.Figure 3. Mutant PYR1 receptor-ligand interactions can be mapped using large-scale sensor screens. (A) Screening outcomes: ligand hits per receptor sequence, number of receptors identified per hit ligand, and the minimum dose response of receptor hits during validation (each sensor strain was tested for ligand-dependent growth on 1, 10, 100 pM ligand). (B) Sensor mutations are broadly distributed throughout the PYR1 binding pocket; the top panel shows mutations per binding pocket residue, and the bottom panel maps the frequency of specific mutations per residue for the 553 receptors isolated. (C) Selected binding-pocket sequences for ligands that yielded > 4 receptor hits. WT residues are shown at the top; the boxes denote basic, hydrophobic, polar, and aromatic substitutions. (D) Sensor binding pocket mutations are tailored to their target ligands. Selection for mutational bias in each sensor-ligand set was quantified by calculating the Shannon diversity of mutation counts per position across receptors, with lower values indicating more positionally clustered mutational patterns (i.e., sensors for a ligand tend to have mutations in the same binding pocket locations). The analysis was performed for the 68 ligands with four or more sensors isolated (n=523 receptor-ligand interactions). The null model shows Shannon diversity values calculated from randomly permuted receptor-ligand assignments (p < 6.4 x 10-13; two-sided Wilcoxon rank-sum test).Figure 4. Ligand-receptor interaction maps and sequence profile-guided design enable the isolation of high-affinity sensors. (A) Selected chemical structures of coumarin hits used to generate the sequence profile of the coumarin-target library: imperatorin (1), osthole (2), and angelicin (3). Receptors for 4-methylumbelliferone (4) and 7-methoxycoumarin (5) were not identified in the initial screen; sensors for these compounds were isolated from the coumarin-target library. (B) Sequence profile of the coumarin targeted-library and binding pocket mutations of PYR1 receptors activated by compounds (1-5). (C) Yeast-hybrid P-galactosidase colony assays comparing PYR1 sensor response of the initial sensor and high-affinity sensorsAtty Docket No. 690104.0046isolated from the coumarin-targeted library. The targeted library yielded PYR1 receptors for (4) and (5), which were not identified in the initial data generation screen. The minimum dose responses are shown in comparison to the mock condition. Figure 7 shows additional growth and reporter dose response assays for the coumarin sensors. (D) Chemical structures of selected ligands used to design the sequence profile of a TNT target library: 2,4-dinitrophenol (6), chloroxylenol (7), 2,4,6-trihydroxybenzoic acid (8), 2,6-dihydroxybenzoic acid (9). Hits for trinitrotoluene (TNT; 10), dinitrotoluene (DNT; 11), and 2-amino-dinitrotoluene (2ADNT; 12) were not identified using the screening libraries. Sensors for these were isolated from the TNT target library. (E) Sequence profile of the TNT target library (TNTv2) and binding pocket mutations for TNT, DNT, and 2ADNT receptors isolated from the library. The sequence profile used for library construction additionally includes 117L / W and 160A / V. (F) Yeast-hybrid 0-galactosidase colony and cell-based titration assays for PYR1TNT, PYR1DNT, and pyRl2ADNTfor their on-target ligands. Triplicate data points are shown. The inset data indicates the EC50 and range.Figure 5. Data-driven engineering of PYR1 receptors for PFAS detection. (A) Chemical structures of selected PFAS molecules targeted for sensor design. PFNA (13), PFOS (14), PFOA (15), and PFHxS (16) are four of six PFAS molecules regulated by the U. S. Environmental Protection Agency in drinking water. (B) PFAS-library sequence profile and binding pocket mutations in PYR1PFAS, a pan-PFAS receptor strongly activated by any of compounds 13 - 16. The library was screened against 103 unique PFAS molecules. (C) Yeast-hybrid P-galactosidase colony assays show that PFNA, PFOS, PFOA, and PFHxS strongly activate PYR1PFAS. (D) Dose-dependent response of PYR1PFASto four on-target PFAS molecules in cell -based 0-galactosidase assays. Triplicate data points are shown. EC50 values and range are shown as insets.Figure 6. Sensor isolation and validation pipeline. (A) PYR1 mutant libraries were first transformed into MAV99. Approximately 150,000 cells were inoculated in each well (1.5% agar with SD -Trp, -Ura and 100 pM ligand). Each well was visually inspected after 3 days of growth. Cells in wells with at least one colony were pooled and subjected to a triage step on SD -Trp, -Ura media to remove wells primarily containing constitutive mutants; cells that grew in the absence of Ura were abandoned. Clones from wells that passed the constitutive test wereAtty Docket No. 690104.0046isolated, sequenced, and then validated on media containing the test ligand at differing concentrations. (B) Selected examples of validation. Single colonies for Mav99 (pBD-PYR1SENSOR; pACT-HABl) sensor strains were resuspended in media, and approximately 150,000 cells were spotted onto SD -Leu, -Trp, -Ura media supplemented with differing concentrations of test ligand, as described in the methods. Images were acquired after 72 hours of growth at 30 °C. Representative images for high-, medium-, and low-sensitivity strains are shown.Figure 7. Docking of the largest hit ligands into sensors. High molecular weight ligand predictions compared to known structures. (A) Structures of the ligands analyzed and their molecular weights. (B)-(D) show known crystal structures for PYR1 *1binding to ABA (PBD 3QN1), and two engineered receptors - PYRlMANUl(PBD 4WV0) binding to mandipropatnid, and PYL2WIN(PBD 7MWN) binding to WIN 55,212-2. (E)-(G) Predicted ligand binding modes for the three largest ligands identified to their cognate receptors using Boltz 2. (E) PYR1{tiRAhave the substitution mutations F159L and A160F. (F) PYRlLIOTt RON1 Ehas the substitutions V81I, LI 17A, and V164L. (G) PYRlMEZL0C’ILLINhas the substitutions Y120A, S122T (B)-(G) All structures were rendered using open-source PyMOL with custom theming. W385 of HAB1, which inserts into ABA’s binding pocket and contacts ABA in WT structures through a water- mediated H-bond, is notably in a similar position for all predicted structures, suggesting a functional tryptophan lock insertion into the activated PYR1 receptor conformers.Figure 8. Direct and sensitive binding of PYRl-derived sensors to their target ligands.Dose-response characteristics were quantified for five PYR1 mutants isolated from the primary screens. 17 PYR1 mutants were initially selected; 11 showed detectable binding in the yeast surface display assay, requiring a minimum apparent dissociation constant (Kd) of 1 pM. The five shown were selected for dose-response validation. Yeast surface displays (YSD) were conducted as previously described

[0017] , with the exception that they employed HAB1T+, a stabilized variant of HAB1 [6], Sensors were prepared for YSD by incorporating H70P and N90S mutations, which are required for proper display of PYR1. Assays were conducted using 200 nM biotinylated HAB1T+and varying target ligand concentrations (380 pM - 200 µM). Error bars are shown as two s.e.m. (n=4; two bio reps, two tech reps). Complex formation is indicated by fluorescence derived from a streptavidin-phycoerythrin conjugate recruited HAB1T+uponAtty Docket No. 690104.0046ligand binding. The limits of detection (LOD) were calculated using the 3σ method, which is equivalent to the drug concentration that yields a signal equal to 3 times the standard deviation of the blank after subtraction.Figure 9. Coumarin-related receptor screening and analysis. (A) Structures of the 11 coumarin-related compounds used for PYR1 receptor screening. (B) Comparison of sensor sensitivity across screens. Dendogram (left) shows the coumarin chemical similarity based on data in (C). Lack of response in the primary screen (‘-’) indicates that the compounds failed to activate any PYR1 mutant at a concentration of 100 pM. (C) Heat map showing pairwise structural similarity between the 11 compounds, based on a distance matrix of pairwise Tanimoto similarity scores, calculated in ChemmineR. (D) The cross-reactivity matrix for the most sensitive receptors identified for each ligand, as well as receptor names, is shown above each column. Sensor strains were tested at the on-target minimum activation concentration observed in yeast hybrid growth assays (see panel B). (E) Dose-response curves for selected receptors in yeast, quantified using the Beta-Gio assay system. Data points represent individual values (n=3); ECso values with associated standard deviation are shown.Figure 10. TNT and degradation product sensors. (A) Chemical structures of TNT and related compounds targeted for sensor development. p-Cresol was one of the phenyl aromatics used to generate the input sequence profile and was screened as a positive control. (B) Comparison of the chemical similarity of target molecules by Tanimoto score and (C) The most sensitive sensors isolated from each screen (PYR12ADNT, PYR14ADNT, PYR1DNT, PYR1TNT, PYRICRESOL) were tested for on- and off-target responses in yeast hybrid growth assays at lOx the minimum concentration required for a growth response. (D) Binding pocket mutations in the sensors.Figure 11. Comparison of the chemical similarity of hit PFAS molecules by Tanimoto score (left) and their on- and off-target responses of their cognate receptor in yeast hybrid growth assays (right). PYR1PFASwas isolated in a screen against PFOA. The strong on- and off-target effects of PFNA, PFOS, PFOA, and PFHxS show that it can be used as a sensor for any of these molecules. Sensor strains were tested at the on-target minimum activation concentration observed in yeast hybrid growth; sensor strains were tested by spotting 2 pL of a single colony suspended in 100 pL TE buffer onto selective media.Atty Docket No. 690104.0046Figure 12. Auto-activating double mutants excluded from the DSM-Hao library (n = 1,188). Each entry lists a double-mutant pair (single-letter amino acid + position + substitution, separated by "_"). These constitutive variants were identified by deep sequencing of constitutive isolates and depleted-mutant analysis, and were omitted from the oligonucleotide pools used to assemble the DSM-Hao library.Figure 13. Subset of validated sensor hits from the primary sensor screen. Each row represents one isolated sensor variant. Columns within the residue grid (positions 59, 81, 83, 87, 89, 92, 94, 108, 110, 117, 120, 122, 141, 159, 160, 163, 164, 167) show the mutated amino acid at each binding-pocket position; blank cells indicate wild-type residues. The wild-type PYR1 receptor sequence at each position is shown in the column header. The rightmost column gives the minimum activating ligand concentration (pM) determined in dose-response retests; "nd" indicates a sensor validated at 100 but not subjected to dose-response teste.Figure 14. Remaining validated sensor hits from the primary sensor screen. Each row represents one isolated sensor variant. Columns within the residue grid (positions 59, 81, 83, 87, 89, 92, 94, 108, 110, 117, 120, 122, 141, 159, 160, 163, 164, 167) show the mutated amino acid at each binding-pocket position; blank cells indicate wild-type residues. The wild-type PYR1 receptor sequence at each position is shown in the column header. The rightmost column gives the minimum activating ligand concentration (pM) determined in dose-response retests; "nd" indicates a sensor validated at 100 but not subjected to dose-response teste.Detailed DescriptionTerminologyThe term " PYR / PYL receptor polypeptide" refers to a protein characterized in part by the presence of one or more or all of a polyketide cyclase domain 2 (PF 10604), a polyketide cyclase domain 1 (PF03364), and a Bet V I domain (PF03364), which in wild-type form mediates abscisic acid (ABA) and ABA analog signaling. A wide variety of PYR / PYL receptor polypeptide sequences are known in the art. In some embodiments, a PYR / PYL receptor polypeptide comprises a polypeptide that is at least 60%, 65%, or 70% identical to PYR1 (SEQ ID NO:853); or at least 75%, 80% or 85% identical to SEQ ID NO:853; and has at least one mutation in the binding pocket as described herein. In some embodiments, a mutant PYR / PYL receptor polypeptide comprises a polypeptide that is at least 90% identical, or at least 95%Atty Docket No. 690104.0046identical, to PYR1 (SEQ ID NO:853) and has one or more mutations in the binding pocket as described herein.A "wild-type PYR / PYL polypeptide" refers to a naturally occurring PYR / PYL receptor polypeptide that mediates abscisic acid (ABA) and ABA analog signaling and comprises the amino acid sequence of SEQ ID NO: 853.A "mutated PYR / PYL polypeptide" or “variant PYR / PYL polypeptide refers to a PYR / PYL receptor polypeptide that is a variant from a naturally-occurring (i.e, wild-type) PYR / PYL receptor polypeptide of SEQ ID NO: 853. In embodiments, a mutated PYR / PYL receptor polypeptide comprises at least one mutation in the binding pocket as described herein. In some embodiments, the polypeptide comprises one, two, three, four, or more amino acid substitutions in the binding pocket relative to a corresponding wild-type PYR / PYL receptor polypeptide of SEQ ID NO: 853 as described herein. In this context, a "mutated" polypeptide can be generated by any method for generating non-wild type nucleotide sequences.In embodiments, a mutated PYR / PYL receptor polypeptide comprises at least one mutation, or at least two mutations, or at least three mutations, or at least four mutations, or at least five mutations, or at least six mutations, or at least seven mutations, or at least eight mutations, or at least nine mutations, or at least ten mutations, or at least eleven mutations, or at least twelve mutations, or at least thirteen mutations, or at least fourteen mutations, or at least fifteen mutations, or at least sixteen mutations, or at least seventeen mutations, or at least eighteen mutations, or at least nineteen mutations, or at least twenty mutations, or at least twenty one mutations, or at least twenty two mutations, or at least twenty three mutations, or at least twenty four mutations, or at least twenty five mutations, or at least twenty six mutations, relative to SEQ ID NO: 853.In embodiments, a polypeptide in the libraries provided herein may comprise one or more mutations in the binding pocket of the PYR / PYL receptor protein corresponding to one or more positions selected from the group consisting of position 59, 65, 71, 74, 81, 83, 87, 89, 92, 94, 108, 109, 110, 117, 120, 122, 124, 134, 141, 159, 160, 163, 164, 167, 178, and 184, relative to wild-type PYR / PYL polypeptide represented by SEQ ID NO: 853.Atty Docket No. 690104.0046The term “HAB1” or “Hypersensitive to ABAI” refers to a protein serine / threonine phosphatase 2C (PP2C) in Arabidopsis thaliana that acts as a key negative regulator of abscisic acid (ABA) signaling, particularly in drought stress responses. In embodiments, HAB1 inhibits kinases involved in activating ABA responses, such as SnRK2.6 / OSTl, and is regulated by oxidation and alternative splicing.An "amino acid substitution" refers to replacing the naturally occurring amino acid residue in a given position (e.g., the naturally occurring amino acid residue that occurs in a wild-type PYR / PYL receptor polypeptide) with an amino acid residue other than the naturally-occurring residue.An amino acid residue "corresponding to an amino acid residue [X] in [specified sequence]," or an amino acid substitution "corresponding to an amino acid substitution [X] in [specified sequence]" refers to an amino acid in a polypeptide of interest that aligns with the equivalent amino acid of a specified sequence. Generally, as described herein, the amino acid corresponding to a position of a specified PYR / PYL receptor polypeptide sequence can be determined using an alignment algorithm such as BLAST. In some embodiments of the present invention, "correspondence" of amino acid positions is determined by aligning to a region of the PYR1 polTwo nucleic acid sequences or polypeptides are said to be "identical" if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The terms "identical" or percent "identity," in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same, when compared and aligned for maximum correspondence over a comparison window, as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection. When percentage of sequence identity is used in reference to proteins or peptides, it is recognized that residue positions that are not identical often differ by conservative amino acid substitutions, where amino acids residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. Where sequences differ in conservative substitutions, the percent sequenceAtty Docket No. 690104.0046identity may be adjusted upwards to correct for the conservative nature of the substitution.Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated according to, e.g., the algorithm of Meyers & Miller, Computer Applic. Biol. Sci. 4:11-17 (1988) e.g., as implemented in the program PC / GENE (Intelligenetics, Mountain View, California, USA).For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters can be used, or alternative parameters can be designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters.A "comparison window," as used herein, includes reference to a segment of any one of the number of contiguous positions selected from the group consisting of from 20 to 600, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned. Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison can be conducted, e g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Nat'l. Acad. Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, WI), or by manual alignment and visual inspection.

[0001] Algorithms that are suitable for determining percent sequence identity and sequence similarity are the BLAST and BLAST 2.0 algorithms, which are described in Altschul et al.Atty Docket No. 690104.0046(1990) J. Mol. Biol. 215: 403-410 and Altschul et al. (1977) Nucleic Acids Res. 25 3389-3402, respectively. Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (NCBI) web site. The algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul el al, supra'). These initial neighborhood word hits acts as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequences, the parameters M (reward score for a pair of matching residues; always >0) and N (penalty score for mismatching residues; always <0). For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLASTN program (for nucleotide sequences) uses as defaults a word size (W) of 28, an expectation (E) of 10, M=l, N=-2, and a comparison of both strands. For amino acid sequences, the BLASTP program uses as defaults a word size (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989)). For purposes of this application, percent identity of protein and nucleic acid sequences are determined using BLAST algorithms.

[0002] The BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul, Proc. Natl. Acad. Sci. USA 90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.01, more preferably less than about 10'5, and most preferably less than about IO’20.Atty Docket No. 690104.0046An "expression cassette" refers to a nucleic acid construct that, when introduced into a host cell, results in transcription and / or translation of an RNA or polypeptide, respectively. Antisense or sense constructs that are not or cannot be translated are expressly included by this definition. In the case of both expression of transgenes and suppression of endogenous genes (e.g., by antisense, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical, but may be only substantially identical to a sequence of the gene from which it was derived. As explained herein, these substantially identical variants are specifically covered by reference to a specific nucleic acid sequence.The term "host cell" refers to any cell capable of replicating and / or transcribing and / or translating a heterologous polynucleotide. Thus, a "host cell" refers to any prokaryotic cell (including but not limited to E. coll) or eukaryotic cell (including but not limited to yeast cells, mammalian cells, avian cells, amphibian cells, plant cells, fish cells, and insect cells), whether located in vitro or in vivo. For example, host cells may be located in a transgenic animal or transgenic plant, prokaryotic cell (including but not limited to E. coli) or eukaryotic cells (including but not limited to yeast cells, mammalian cells, avian cells, amphibian cells, plant cells, fish cells, and insect cells). Host cells can be for example, transformed with the heterologous polynucleotide.As used herein, the term “biosensor” or “sensor” refers to an analytical device that detects and measures the presence or concentration of a biological or chemical substance (the analyte) by combining a biological recognition element with a signal-transducing component.As used herein, the term “library of polypeptides” refers to a large, diverse collection of polypeptide molecules — each with a different amino acid sequence — generated and screened simultaneously to identify candidates with desired properties, such as high binding affinity or selectivity toward a specific target. In embodiments, the library contain a plurality of unique polypeptide sequences, either synthesized chemically or expressed biologically. In embodiments, the library is exposed to a target of interest (such as a receptor or analyte), and polypeptides that bind with high specificity and affinity are selected and identified. In embodiments, selected sequences are further refined through iterative rounds of mutation and selection to improve performance.Atty Docket No. 690104.0046To facilitate an understanding of the principles and features of the various embodiments of the disclosure, various illustrative embodiments are explained herein. Although exemplary embodiments of the disclosure are explained in detail, it is to be understood that other embodiments are contemplated. Accordingly, it is not intended that the disclosure is limited in its scope to the details of construction and arrangement of components set forth in the description or examples. The disclosure is capable of other embodiments and of being practiced or carried out in various ways.PYR / PYL Receptor Polypeptide Libraries

[0003] PYR1 (pyrabactin resistance 1) is a plant receptor for the hormone abscisic acid (ABA). The PYR1 receptor binds to and inhibits HAB1 (Homology to ABH), a type 2C protein phosphatase. Together, they form a key chemical-induced dimerization (CID) system where ABA acts as a ligand to lock PYR1 onto HAB1, thereby regulating drought responses. The binding pocket of PYR1 and homologs comprises a conserved START-domain ligand-binding pocket flanked by two loops called the "gate" and the "latch" (Melcher, K. et al., Nature 462 (2009)). When a compound binds to PYR / PYL receptor protein at the ligand-binding pocket, the binding induces closure of the loops. This allows PYR1 to bind HAB1, blocking its phosphatase activity.Libraries to screen for biosensors for small molecule compounds as described herein comprise mutated PYR / PYL receptor polypeptides having substitutions, relative to a wild-type PYR / PYL polypeptide of SEQ ID NO: 853. In wild-type PYR / PYL receptor proteins, residues comprising the ligand-binding pocket are those residues with side chains that are within 4 angstroms of ABA or the water molecules that accompany ABA when ABA binds in the pocket of the PYR / PYL receptor protein.To profile the binding scope of PYR1, the inventors assembled a collection of diverse small molecules from a commercially available collection of FDA-approved drugs and natural products, and a curated set of agrochemicals and other research chemicals. Since commercial screening libraries often contain redundancy, for example, the same parent molecule present as different salts, we used ChemmineR (24, 25) to define the non-redundant set of molecules screened. We mapped them to the ChEMBL database (26) to identify redundancies and extractAtty Docket No. 690104.0046molecular properties and approval statuses. These analyses showed that the screening collection contains 2726 small molecules. This collection was screened in duplicate against previously and newly designed PYR1 variant libraries harboring double and triple mutations localized to 19 ligand-contacting residues (17). Candidate sensor strains for a given molecule were screened in duplicate at 100 LIM and retested at multiple concentrations of the molecule to eliminate false positives and profile the sensitivity of the strain. Together these screens yielded 553 distinct sensor sequences and strains that respond to 181 small molecules, including 81 FDA-approved ligands, 30 plant natural products, 17 agrochemicals, and 53 research molecules, representing an overall success rate of 6.6% of the ligands screened (Figure 2A).Chemical clustering of the hit ligands based on their pairwise Tanimoto distances, calculated using atom-pair fingerprints, reveals a broad distribution of structurally dissimilar hits, with several small clusters of similar molecules (Figure 2B, C). Thus, there is broad structural diversity amongst the collection of sensed ligands. Several important pharmacological agents and agrochemicals are sensed by the collection, including steroids, non-steroidal anti-inflammatory drugs (NSAIDs), dihydropyridine calcium channel antagonists, Transient Receptor Potential Vanilloid 1 (TRPV1) receptor agonists, and antifungal strobilurins (Figure 2C). The physicochemical properties of the 181 ligands sensed are drug-like by multiple measures; 173 (96%) comply with Lipinski’s rule of 5, compared to 76% for the library. Moreover, they score highly using the quantitative estimate of drug-likeness (QED) metric, a unitless measure of druglikeness (med. QEDhits = 0.69, QEDnon-hits = 0.55) (27). Compared to the non-hit members of the collection screened, the ligands sensed are enriched for higher cLogP (computed loglOoctanol / water partition coefficient) and lower tPSA (topological polar surface area; Figure 2D). These trends are likely driven partly by the cell-based nature of our sensor isolation methods, which enriches for molecules with good membrane permeability and bioavailability. The size of ligands sensed is relatively smaller than those of the non-hit collection (median MWhits= 276 Da; MWnon-hits= 324 Da), but includes molecules as small as 90 Da and as large as 748 Da (Figure 2D). We note that the two largest ligands sensed are poly-iodinated thyroxins tetrac (MW 748) and lyothyronine (MW 651). Blotz 2 (28) docking of these ligands suggests that they can adopt binding conformations in PYR1 TETRAC - and PYR1 LYOTHYRONINE -HAB1 that enable HABl’s Trp385 lock residue to insert into the PYRl’s' 4’ pore of closed-conformer receptors, a critical interaction for stabilizing the receptor complex (Figure 7).Atty Docket No. 690104.0046Collectively, these data demonstrate that the chemical space accessible with PYRl-derived sensors is structurally diverse and drug-like, which defines PYR1 as an unusually versatile and malleable scaffold for developing sensors for drugs and other bioactive ligands.Analyses of the PYRl-ligand binding pocket dataset show that 26 receptors (~5%) were isolated in three or more screens, suggesting that a small number of promiscuous binders did not dominate the screening outcomes (Figure 3A). Consistent with this observation, the mutations obtained are distributed broadly across the ligand-binding pocket (Figure 3B). However, Fl 59, which resides at the top of the pocket and contacts both the ligand and HAB1, was preferentially mutated and may be important for stabilizing PYR1-HAB1 interactions. The mutational patterns obtained also suggest strong selection for specific ligand-receptor interactions (Figure 3C). For example, six sensors for the anticonvulsant valproic acid were isolated, and all harbor the mutation II 10R, suggesting our screens selected for a stabilizing salt bridge between valproic acid’s carboxylate and the mutant receptor's basic arginine side chain. Similarly, 11 receptors were identified for the amine-containing ligand cinacalcet, used to treat hyperthyroidism, and 10 of these harbored K59D / E, suggesting selection for a stabilizing salt bridge. These PYR1 sensors suggest a strong selection bias toward distinct binding pocket mutations (Figure 3B).To quantify these patterns, the inventors employed Shannon diversity to measure the distribution of mutations across binding pocket positions using a shuffled dataset as a null comparator (Figure 3D). The lower Shannon diversity values observed in the sensor hits indicate significantly clustered, positionally biased mutational patterns for specific ligands (p < 6.4 x 10-13). Lastly, yeast surface display assays demonstrated nM to pM limits of detection for a subset of receptors that functioned well in the YSD assay (Figure 8). These experiments demonstrate direct physical interactions without a cell-based growth assay. Collectively, these analyses show strong global selection for ligand-specific mutational patterns, with mutations broadly distributed across the binding pocket.The obtained large dataset of ligand-receptor interactions provides maps of binding-pocket residues that, in principle, could be harnessed for receptor improvement. The inventors took two complementary approaches to test this possibility. First, the inventors mined the data for the coumarin scaffold — the largest cluster of plant-derived natural products in our screening library (selected examples shown in Figure 4A). Of the 14 coumarins present in the library, theAtty Docket No. 690104.0046inventors isolated sensors for eight, which harbored mutations at 11 of the 19 binding pocket sites mutagenized. The inventors derived a coumarin binder sequence profile from these data and encoded combinations of up to nine of the most frequent coumarin-associated mutations (Figure 4B). The library contained 77,327 members and was constructed by the combinatorial assembly of 218 oligonucleotides. It was then transformed into S. cerevisiae and screened against 12 coumarins. This yielded sensors for three ligands not identified in the original screens (5, 6, and 5,7-dihydroxy-4-methylcoumarin) and between 10 to 400-fold sensitivity gains for the eight positive coumarins, including (1), (2), and (3) (Figure 4C, Figure 9). As a second approach, the inventors asked whether profiles derived from receptors that recognize single-ring phenyl derivatives (sensors for 6-9) could guide the discovery of sensors for the chemically similar molecules, TNT (11) and three of its degradation products (12, 13, and 4-amino-2,6-dinitrotoluene)) (Figures 4D and 10); none of these were present in the screening collection and DSM / TSM library screens did not yield hits for TNT. A 506,229-member receptor library built using a sequence profile derived from receptors activated by (6)-(9) yielded initial sensors for the four targets. Sequence profiles derived from the first-round sensors were used to design a second-round library, which ultimately yielded sensors for TNT and three degradation products, DNT and 2ADNT, and 4ADNT with low pM EC50 ligand responsiveness, as measured using reporter and growth assays (Figure 4F, 10). Together, these data demonstrate that the obtained large dataset of ligand-PYRl interactions can be harnessed to yield receptors with improved affinity and target recognition.These data establish a simple approach for creating new sensors for small molecules: 1) screen receptor libraries with relatively few binding pocket mutations to identify initial sensors, 2) use the data generated to derive sequence profiles, and then 3) design and screen affinity maturation libraries to yield high-affinity sensors. To test this pipeline on a class of molecules dissimilar from members of the initial screening library, the inventors focused on ‘forever’ PFAS molecules, which are critical targets for biosensing due to their persistence, bioaccumulation, and associated health and environmental risks (29). To do this, the inventors constructed and screened an improved double site mutant library designed to enhance coverage in HTS assays by reducing auto-activating and wild-type receptors from the original DSM library (DSM-Hao; see Methods). The screening wass against a panel of 103 different PFAS, including six of major concern that have been targeted for regulation in drinking water by the EPA (30),Atty Docket No. 690104.0046perfluorononanoic acid (PFNA; 13), perfluorooctanesulfonic acid (PFOS; 14), perfluorooctanoic acid (PFOA; 15), perfluorohexanesulfonic acid (PFHxS; 16), hexafluoropropylene oxide dimer acid (HFPO-DA), and perfluorobutanesulfonic acid (PFBS) (Figure 5 A).The initial library screens yielded 86 sensors for 18 targets, providing a dataset to create a PFAS-targeted library for isolating high-affinity sensors (Figure 5B). Screens using this targeted library expanded the scope of PFAS sensing, increasing the total number of PFAS molecules sensed to 25, and yielded sensors with improved on-target sensitivity. PYR1PFAS, isolated in a screen against PFOA (13), shows a strong response to low pM concentrations of four of the six molecules targeted for regulation (Figures 5D and 11). PYR1APFAS, the pan-PFAS receptor described herein, comprises the amino acid sequence of SEQ ID NO: 336, which differs from wild-type PYR1 (SEQ ID NO: 853) by the substitutions K59M, E94G, Y120L, E141Q, A160V, and V164W. These experiments further validate the data-driven sensor approach and its power for developing new sensors.The ligand binding pocket of PYR1 is unusually malleable; it can be reshaped to recognize a surprising number of structurally unrelated ligands. The inventors isolated and validated sensors for 6.6% of the nearly 3000 molecules screened and isolated over a dozen more using data-driven targeted libraries. Most of the ligands sensed are represented by independently isolated sequence variants that recognize them. Sequence analyses of the receptors demonstrate binding pocket mutational patterns tailored to each ligand, mutations distributed broadly across the binding pocket, and a small frequency of promiscuous receptors. Collectively, these trends indicate a robust pipeline for sensor isolation.Without being bound to any theories, the inventors believe that PYR1 unusual malleability is related to the fact that PYR1 belongs to the ligand-binding START / SRPBCC START superfamily. These are characterized by a helix-grip motif, which consists of a seven-stranded antiparallel P-sheet that wraps around a C-terminal a-helix to create a central ligand binding pocket. START proteins are present in all domains of life and, like our PYR1 variants, bind structurally diverse molecules - from hydrophobic steroids to polar flavonoid-glucosides (32-34). This domain is frequently involved in transport and catalysis. However, PYR1 and its relatives link ligand recognition to effector binding to control signaling. PYR1, therefore, couples an evolutionarily malleable binding pocket with a biochemical mechanism well-suitedAtty Docket No. 690104.0046for engineering signaling systems. Given the success of computational design for CID sensors (9, 35) and new methods built for PYR1 (36), we anticipate that PYRl’s properties can be harnessed broadly to design sense-response systems controlled by user-specified molecules with antibody-like simplicity.Plant hormone signaling employs a suite of sensor modules that, like PYR1, involve hormone-mediated stabilization of protein-protein interactions (14, 16, 37-39). For example, the gibberellic acid receptor is a member of the large GDSL lipase family and, like the ABA system, its module employs induced dimerization with an effector that greatly stabilizes the activated receptor complex (40-42). GID 1 and other plant hormone sensors should provide a suite of scaffolds for building new sensor systems with the antibody-like simplicity and scope of the PYR1 system.It has been estimated that drug-like space encompasses approximately 1033 molecules (31).The present invention provides a privileged PYR1 scaffold for sensor design across biological kingdoms that is based on PYRl’s malleability, ease of sensor design, and induced dimerization mechanisms.In particular, the present invention discloses a system that provides access to a large chemical space and allows the building of new biochemical, cellular, and whole-organism control systems. Furthermore, the present invention provides sensors that recognize drugs and drug-like molecules, thereby opening many possibilities. In certain aspects, the isolated NSAID-controlled switches disclosed herein are valuable in clinical applications. Additionally, the sensors provided herein are orthogonalized for deployment in plants using the PYR1*-HAB1* module, which enables two-channel control systems and control of plant phenotypes without perturbing native ABA signaling (19).Thus, in embodiments, provided herein is a library comprising a plurality of polypeptides. In embodiments, each polypeptide contained in the plurality of polypeptides comprises a mutated PYR / PYL receptor polypeptide having amino acid substitutions, relative to the corresponding position of SEQ ID NO:853.Atty Docket No. 690104.0046In embodiments, a polypeptide comprises one, two, three, four, or more amino acid substitutions in the binding pocket relative to a corresponding wild-type PYR / PYL receptor polypeptide of SEQ IDNO: 853.In embodiments, a mutated PYR / PYL receptor polypeptide comprises at least one mutation, or at least two mutations, or at least three mutations, or at least four mutations, or at least five mutations, or at least six mutations, or at least seven mutations, or at least eight mutations, or at least nine mutations, or at least ten mutations, or at least eleven mutations, or at least twelve mutations, or at least thirteen mutations, or at least fourteen mutations, or at least fifteen mutations, or at least sixteen mutations, or at least seventeen mutations, or at least eighteen mutations, or at least nineteen mutations, or at least twenty mutations, or at least twenty one mutations, or at least twenty two mutations, or at least twenty three mutations, or at least twenty four mutations, or at least twenty five mutations, or at least twenty six mutations, relative to SEQ ID NO: 853.In embodiments, a polypeptide of the library comprises at least two mutations. In embodiments, a polypeptide of the library comprises at least three mutations. In embodiments, a polypeptide of the library comprises at least four mutations. In embodiments, a polypeptide of the library comprises at least five mutations. In embodiments, a polypeptide of the library comprises at least six mutations. In embodiments, a polypeptide of the library comprises at least seven mutations. In embodiments, a polypeptide of the library comprises eight or more mutations.In embodiments, a polypeptide in the libraries provided herein may comprise one or more mutations in the binding pocket of the PYR / PYL receptor protein corresponding to one or more positions selected from the group consisting of position 59, 65, 71, 74, 81, 83, 87, 89, 92, 94, 108, 109, 110, 117, 120, 122, 124, 134, 141, 159, 160, 163, 164, 167, 178, and 184, relative to wild-type PYR / PYL polypeptide represented by SEQ ID NO: 853.In embodiments, the mutated PYR / PYL receptor polypeptide is at least 80%, 85%, 90%, 91%, 92%, 93%, 94% 95%, 96%, 97%, 98%, or 99% identical to SEQ ID NO:853. In some embodiments, the PYR / PYL polypeptide has at least 90% identity to SEQ ID NO: 853.Atty Docket No. 690104.0046In embodiments, provided herein is an isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS: 1-852 and a sequence which is at least 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% to any one of SEQ ID NOS: 1-852.In embodiments, the isolated polypeptide comprises an amino acid sequence which is at least 95%, 96%, 97%, 98%, 99%, or 100% identical to SEQ ID NO: 336. In embodiments, the amino acid sequence comprises the substitutions K59M, E94G, Y120L, E141Q, A160V, and V164W relative to SEQ ID NO: 853. In embodiments, the polypeptide is a sensor for PFOA. In embodiments, the polypeptide is a sensor for PFNA. In embodiments, the polypeptide is a sensor for PFOS. In embodiments, the polypeptide is a sensor for PFHxS.In embodiments, the amino acid substitutions in the binding pocket of the PYR / PYL receptor protein comprise at least three of the following mutations relative to the corresponding positions in SEQ ID NO: 853:L, A, V, D, N, S, R, M, Q, T, or E at position 59;M, Y, R I, T, or L at position 81;Q, F, L, M, A, H, W, I, or Y at position 83;F, M, V, or I at position 87;G, F, I, W, L, M, or D at position 89;L at position 92;G, Q, M, od D at position 94;W, Q, K, Y, S, A, M, N, or L at position 108;R, W, T, or A at position 110;M, N, H, D, G, A, or W at position 117;W, H, A, V, T, M, S, G, F, or L at position 120;K, M, D, V, T, Q, I, E, G, or N at position 122;I, V, T, or F at position 141;S, G, H, M, L, Q, I, T, V, K, A, or N at position 159;I, V, M, L, S, G, or N at position 160;W, M, H, or Q at position 163;W, F, G, S, N, T, H, M, L, K, D, I, or E at position 164; andQ, H, F, T, S, V, Y, K, G, I, D, or N at position 167.Atty Docket No. 690104.0046In embodiments, the amino acid substitutions in the binding pocket of the PYR / PYL receptor protein do not comprise the mutations listed in Figure 12. In embodiments, the amino acid substitutions in the binding pocket of the PYR / PYL receptor protein comprise at least two of the following mutations relative to the corresponding positions in SEQ ID NO: 853:A, D, E, F, G, H, 1, L, M, N, Q, R, S, T, V, W, or Y at position 59;I, L, M, R, T, or Y at position 81;A, D, E, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 83;A, F, G, I, M, V, W, or Y at position 87;D, E, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 89;A, D, E, F, G, H, I, K, L, M, N, Q, R, T, V, W, or Y at position 92;A, D, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Yat position 94;A, D, E, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 108;A, F, K, L, M, R, T, V, or W at position 110;A, D, E, F, G, H, I, K, M, N, Q, R, S, T, V, W, or Y at position 117;A, D, E, F, G, H, I, K, L, M, N, Q, R, S, T, V, or W at position 120;A, D, E, F, G, H, I, K, L, M, N, Q, R, T, V, W or Y at position 122;A, D, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 141;A, D, E, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 159;D, E, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 160;A, D, E, F, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 163;A, D, E, F, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 164; andA, D, E, F, G, H, I, K, L, M, Q, R, S, T, V, W, or Y at position 167In some embodiments, the library comprises variant PYR1 polypeptides comprising I, Y, or M at position 81 relative to the corresponding positions in SEQ ID NO: 853.In some embodiments, the library comprises variant PYR1 polypeptides comprising; L or I at position 83 relative to the corresponding positions in SEQ ID NO: 853.In some embodiments, the library comprises variant PYR1 polypeptides comprising H, I, L, M, or V at position 159 relative to the corresponding positions in SEQ ID NO: 853.Atty Docket No. 690104.0046In some embodiments, the library comprises variant PYR1 polypeptides comprising G, M, W, or S at position 163 relative to the corresponding positions in SEQ ID NO: 853.In some embodiments, the library comprises variant PYR1 polypeptides comprising D, Q, V, or G at position 167 relative to the corresponding positions in SEQ ID NO: 853.In embodiments, at least one polypeptide of the library comprises an amino acid sequence selected from the group consisting of SEQ ID NOS: 2-852.In embodiments, the library is a display library or a yeast two-hybrid library. In some embodiments, the library is immobilized to a solid support.In embodiments, each of the PYR1 receptor polypeptides further comprises a detection reagent. In some embodiments, the detection reagent is a member of a binding complex or an enzymatic complementation reagent.In embodiments, each polypeptide in the library is a sensor for a different molecule and the library comprises variant PYR1 polypeptides comprising multiple mutations in the binding pocket, e.g., at least two or more mutations in the binding pocket, or at least three or more mutations in the binding pocket as described herein.In embodiments, a polypeptide of the library comprises D, M, or N at position 59; M or W at position 163; and one or more mutations selected from the group consisting of I at position 81; I at position 83; 1 at position 87; F at position 120; E at position 122; 1 or T at position 141; V at position 160; L or N at position 164; and V at position 167; and the polypeptide is a sensor for 2,4,6-Trinitrotoluene.In embodiments, a polypeptide of the library comprises D, M, or N at position 59; and one or more mutations selected from the group consisting of I at position 81; I at position 83; F or I at position 87; W at position 117; F at position 120; E at position 122; I or T at position 141; V at position 160; W at position 163; D, K or N at position 164; and Q or V at position 167; and the polypeptide is a sensor for 2,4 -Dinitrotoluene.In embodiments, a polypeptide of the library comprises Q or V at position 167; and three or more mutations selected from the group consisting of M, N, or T at position 59; I at position 81; I at position 83; I at position 87; G at position 92; W at position 117; F at position 120; E or G atAtty Docket No. 690104.0046position 122; I or T at position 141; V at position 160; M or W at position 163; and K, L or N at position 164; and the polypeptide is a sensor for 2-amino-4,6 -Dinitrotoluene.In embodiments, a polypeptide of the library comprises V at position 160; and three or more mutations selected from the group consisting of M, N, or R at position 59; I at position 81; I at position 83; M at position 87; V or W at position 117; F, S, or W at position 120; E at position 122; I, K, or T at position 141; M at position 159; G or W at position 163; D, K, L, or N at position 164; and Q at position 167; and the polypeptide is a sensor for 4-amino-2,6 -Dinitrotoluene.In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of A, D, Q, and E at position 59; M at position 81; M at position 89; W at position 108; A at position 120; N or V at position 122; T at position 141; V at position 159; G or I at position 160; W at position 163; M at position 164; and D at position 167; and the polypeptide is a sensor for Pentosalen.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of A or Q at position 59; I, R, or Y at position 81; L at position 83; W at position 108; A at position 120; N at position 122; V at position 159; I or V at position 160; W at position 163; and F, N, or S at position 164; and the polypeptide is a sensor for Angelicin.In embodiments, a polypeptide of the library comprises L at position 83 and one or more mutations selected from the group consisting of A or Q at position 59; I at position 81; L at position 83; W at position 108; A or M at position 120; G or N at position 122; G, I or V at position 160; W at position 163; F or S at position 164; and D at position 167; and the polypeptide is a sensor for Scopoletin.In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of A, L or Q at position 59; I at position 81; L at position 83; W at position 89; W at position 108; M at position 120; E, G, or N at position 122; H, I, or T at position 159; I at position 160; W at position 163; and E or S at position 164; and the polypeptide is a sensor for Bergapten.In embodiments, a polypeptide of the library comprises L at position 83 and one or more mutations selected from the group consisting of A or Q at position 59; I at position 81; W atAtty Docket No. 690104.0046position 108; M at position 120; E or N at position 122; H at position 159; I, M, or V at position 160; W at position 163; E or S at position 164; and D at position 167; and the polypeptide is a sensor for Psoralen.In embodiments, a polypeptide of the library comprises mutations selected from the group consisting of Y at position 81; L at position 83; H at position 159; I at position 160; W at position 163; and one or more mutation selected from the group consisting of W at position 108; M at position 120; E or G at position 122; M or S at position 164; and D at position 167; and the polypeptide is a sensor for Citropten.In embodiments, a polypeptide of the library comprises mutations selected from the group consisting of L at position 83; H at position 159; W at position 163; and three or more mutations selected from the group consisting of A at position 59; I at position 81; W at position 108; M at position 120; E, G, or N at position 122; I or V at position 160; and E or F at position 164; and the polypeptide is a sensor for 7-Methoxycoumarin.In embodiments, a polypeptide of the library comprises mutations selected from the group consisting of A at position 59; L at position 83; W at position 108; M at position 120; N at position 122; I or V at position 160; W at position 163; E at position 164; and I at position 81; and the polypeptide is a sensor for 5,7-Dihydroxy-4-methylcoumarin.In embodiments, a polypeptide of the library comprises mutations selected from the group consisting of E or N at position 122; W at position 163; and one or more mutations selected from the group consisting of A at position 59; I at position 81; W at position 108; A or M at position 120; I or M at position 160; F at position 164; and D at position 167; and the polypeptide is a sensor for Methoxsalen.In embodiments, a polypeptide of the library comprises W at position 163; and one or more mutations selected from the group consisting of Q at position 59; I at position 81; L at position 83; W at position 108; A or M at position 120; E, G or N at position 122; G, V, or M at position 160; F or S at position 164; and D at position 167; and the polypeptide is a sensor for Osthole.In embodiments, a polypeptide of the library comprises mutations selected from the group consisting of I or Y at position 81; L at position 83; I or V at position 160; W at position 163; and one or more mutations selected from the group consisting of Q at position 59; W at positionAtty Docket No. 690104.0046108; M at position 120; E, G, or N at position 122; E or F at position 164; and D at position 167; and the polypeptide is a sensor for 4-Methylumbelliferone.In embodiments, a polypeptide of the library comprises A, L, S, or T at position 120; and three or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; F at position 89; A or G at position 94; W at position 108; W at position 122; G or Q at position 141; I at position 159; I, L, M, or V at position 160; and L, M, or W at position 164; and the polypeptide is a sensor for Perfluorooctanoic acid.In embodiments, a polypeptide of the library comprises mutations selected from the group consisting of A, D, or S at position 94; A, M, or S at position 120; and one or more mutations selected from the group consisting of N at position 59; I at position 83; L at position 122; K or Q at position 141; M at position 160; and L, M, or W at position 164; and the polypeptide is a sensor for 2H,2H,3H,3H-Perfluorohexanoic acid.In embodiments, a polypeptide of the library comprises A, S, or T at position 94; W at position 163; and one or more mutations selected from the group consisting of N at position 59; A, L, M, or S at position 120; L or W at position 122; K at position 141; I, M, or V at position 160; and G, K, M, or W at position 164; and the polypeptide is a sensor for 2H,2H,3H,3H-Perfluoroheptanoic acid.In embodiments, a polypeptide of the library comprises A or S at position 94; and one or more mutations selected from the group consisting of M or N at position 59; G, L, or M at position 120; L at position 122; G at position 141; L at position 159; I, M, or V at position 160; and K, or W at position 164; and the polypeptide is a sensor for 2H,2H,3H,3H-Perfluorooctanoic acid.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of M or N at position 59; A at position 92; A, L, or S at position 94; I, L, M, or T at position 120; Q at position 122; G, K, or Q at position 141; I or L at position 159; M, or N at position 160; and L, M, or W at position 164; and the polypeptide is a sensor for 2H,2H,3H,3H-Perfluorononanoic acid.In embodiments, a polypeptide of the library comprises A, D, or G at position 94; and one or more mutations selected from the group consisting of M at position 59; I at position 83; M at position 87; A, I, or L at position 120 W at position 122; G or Q at position 141; I at positionAtty Docket No. 690104.0046159; I, L, or V at position 160; and K, L, M, or W at position 164; and the polypeptide is a sensor for Perfluorooctanesulfonic acid.In embodiments, a polypeptide of the library comprises L, M, S, or T at position 120; and one or more mutations selected from the group consisting of N at position 59; I at position 83; W at position 122; H, K, or Q at position 141; L at position 159; L or V at position 160; and M, S, or W at position 164; and the polypeptide is a sensor for Perfluorobutylsulfonamide.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of M or N at position 59; A or G at position 94; L, N, S, or T at position 120; L or W at position 122; G, K, L, or Q at position 141; L at position 159; L or N at position 160; and K, L, M, or S at position 164; and the polypeptide is a sensor for Perfluorohexanesulfonamide.In embodiments, a polypeptide of the library comprises A or G at position 94; and one or more mutations selected from the group consisting of M or N at position 59; I at position 83; L at position 120; G or Q at position 141; L at position 159; I, L, or V at position 160; and N or W at position 164; and the polypeptide is a sensor for Perfluorooctanesulfonamide.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of L or M at position 59; I at position 83; M at position 87; F at position 89; A, D, L, M, S or T at position 120; L or W at position 122; A, D, K, or Q at position 141; I at position 159; I, M, V, or W at position 160; and G, L, M, S, or W at position 164; and the polypeptide is a sensor for N-Methylperfluorobutanesulfonamide.In embodiments, a polypeptide of the library comprises M at position 59; D at position 94; H at position 159; L or M at position160; and one or more mutations selected from the group consisting of A, L, or M at position 120; W at position 122; and G or Q at position 141; and the polypeptide is a sensor for 1H,1H,8H-Perfluorooctan-1-ol.In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; L or M at position 120; L, R, or W at position 122; G, K, or Q at position 141; H at position 159; L, M, or V at position 160; and K or W at position 164; and the polypeptide is a sensor for 1H,1H,9H-Hexadecafluorononan- 1 -ol.Atty Docket No. 690104.0046In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of M or N at position 59; D or N at position 94; Q at position 108; L at position 120; L at position 122; Q at position 141; H at position 159; I or L at position 160; and W at position 164; and the polypeptide is a sensor for 1H,1H,6H,6H-Perfluoro-1,6-hexandiol.In embodiments, a polypeptide of the library comprises H at position 159; and one or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; L, M, N, or T at position 120; G, L or W at position 122; G or Q at position 141; I, L, M, N, or V at position 160; and G or W at position 164; and the polypeptide is a sensor for 1 H, 1 H, 8H, 8H-D odecafluoro- 1, 8 -octanedi ol.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of L, M, N, or R at position 59; I at position 83; T at position 89; D at position 94; M at position 110; G at position 117; A, I, L, M, S, or T at position 120; L or W at position 122; G or Q at position 141; H at position 159; and L, M, or V at position 160; and the polypeptide is a sensor for 1H,1H,9H,9H-Perfluoro-1,9-nonanediol.In embodiments, a polypeptide of the library comprises G or H at position 159; and one or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; A, L, M, or S at position 120; L or W at position 122; G or Q at position 141; I, M, or V at position 160; and K or M at position 164; and the polypeptide is a sensor for1 H, 1 H, 1 OH, 1 OH-Perfluoro- 1, 10-decanediol.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; A, G, L, M, S, T, or V at position 120; R or W at position 122; G or Q at position 141; I, L, or M at position 159; I or W at position 160; and L, M, S, or W at position 164; and the polypeptide is a sensor for 1 H, 1 H,2H, 3 H, 3 H-Perfluorononane- 1, 2 - di ol.In embodiments, a polypeptide of the library comprises A, E, G, or S at position 94; and one or more mutations selected from the group consisting of L or M at position 59; I at position 83; L at position 108; A, G, or L at position 120; L at position 122; G at position 141; H at position 159;A, I, L, or V at position 160; and H, K, L, or M at position 164; and the polypeptide is a sensor for Perfluoro-3, 6, 9-trioxatri decanoic acid.Atty Docket No. 690104.0046In embodiments, a polypeptide of the library comprises A or T at position 94; L or M at position 120; and two or more mutations selected from the group consisting of M at position 59; M at position 87; G at position 141; I at position 159; and V at position 160; and the polypeptide is a sensor for 9-Chlorohexadecafluorononanoic Acid.In embodiments, a polypeptide of the library comprises G at position 94; and one or more mutations selected from the group consisting of M at position 59; I at position 83; L at position 120; G, K, or Q at position 141; L or V at position 160; I at position 163; and K or W at position 164; and thee polypeptide is a sensor for 3, 5, 6-tri chlorooctafluorohexanoic acid.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of M or N at position 59; D at position 94; H at position 108; G, K, M, S, T, or V at position 120; L or W at position 122; G, K, or Q at position 141; L or T at position 159; L, M, or V at position 160; and G, L, M, S, or W at position 164; and the polypeptide is a sensor for Perfluoroheptanal hydrate (diol).In embodiments, a polypeptide of the library comprises A, G, S, or T at position 94; and one or more mutations selected from the group consisting of M or N at position 59; I at position 83; L at position 120; G, K, or Q at position 141; L at position 159; L or V at position 160; and G, M, or W at position 164; and the polypeptide is a sensor for 2H-Perfluoro-2-octenoic acid.In embodiments, a polypeptide of the library comprises M or N at position 59; A or G at position 94; A or L at position 120G or Q at position 141; I, M, or V at position 160; and W at position 164; and the polypeptide is a sensor for Perfluorohexanesulfonic Acid.In embodiments, a polypeptide of the library comprises T or V at position 159; and one or more mutations selected from the group consisting of W at position 120; W at position 163; and G at position 164; and the polypeptide is a sensor for ALFATRADIOL.In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of S at position 59; T at position 81; A at position 117; S at position 120; T at position 122; I or L at position 159; V at position 160; and D at position 167; and the polypeptide is a sensor for BOLDENONE.In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of N or S at position 59; Y at position 81; G at position 89; Q at positionAtty Docket No. 690104.0046122; I or L at position 160; M at position 163; and D at position 167; and the polypeptide is a sensor for METHANDROSTENOLONE.In embodiments, a polypeptide of the library comprises N, R, S, or T at position 59; T at position 81; and one or more mutations selected from the group consisting of I or L at position 159; L at position 160; and T at position 167; and the polypeptide is a sensor for NORETHINDRONE.In embodiments, a polypeptide of the library comprises R at position 81; L or M at position 83; I or V at position 159; and optionally Q at position 122; and the polypeptide is a sensor for KETOPROFEN.In embodiments, a polypeptide of the library comprises T or V at position 159; and one or more mutations selected from the group consisting of L at position 59; 1 at position 83; N or Q at position 108; W at position 120; V at position 160; W at position 163; and E or G at position 164; and the polypeptide is a sensor for PRANOPROFEN.In embodiments, a polypeptide of the library comprises D at position 59; and one or more mutations selected from the group consisting of L at position 81; I at position 87; I at position 89; I or V at position 160; and L at position 164; and the polypeptide is a sensor for DEXMEDETOMIDINE.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of A, M, or S at position 59; L, M, or Y at position 81; A at position 83; F at position 87; D at position 94; Y at position 108; A at position 110; T at position 120; Q or V at position 122; I, L, or V at position 159; L at position 160; and W at position 163; and the polypeptide is a sensor for ETOMIDATE.In embodiments, a polypeptide of the library comprises D or E at position 59; and one or more mutations selected from the group consisting of L at position 81; F at position 89; and V at position 160; and the polypeptide is a sensor for MEDETOMIDINE.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of M at position 59; L or Y at position 81; D at position 89; A at position 110;A, F, G, M, or S at position 120; I or V at position 122; A, I, T, or V at position 159; and F, M, or N at position 164; and the polypeptide is a sensor for CAPSAICIN.Atty Docket No. 690104.0046In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of A, M, Q, or R at position 59; I, L, T, or Y at position 81; L at position 89; D at position 94; L or M at position 108; A, G, S, or T at position 120; I or N at position 122; A, H, S, T, or V at position 159; I, M at position 160; and H, I, or M at position 164; and the polypeptide is a sensor for DIHYDROCAPSAICIN.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of R at position 59; I or Y at position 81; I at position 87; A, F, or T at position 120; V at position 122; A, S, T, or V at position 159; V at position 160; H at position 167; and S at position 167; and the polypeptide is a sensor for NONIVAMIDE.In embodiments, a polypeptide of the library comprises D or E at position 167; and one or more mutations selected from the group consisting of L at position 159; and H or I at position 164; and the polypeptide is a sensor for OLANEXIDINE.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of A, M, or T at position 59; Y at position 81; A, G, S, or T at position 120; D, G, I, M, or Q at position 122; A, H, or T at position 159; I or V at position 160; and L or T at position 164; and the polypeptide is a sensor for ZUCAPSAICIN.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of D at position 94; I or L at position 159; M at position 160; and H at position 164; and the polypeptide is a sensor for CROTAMITON.In embodiments, a polypeptide of the library comprises I or M at position 159; and one or more mutations selected from the group consisting of E or Q at position 122; and H or L at position 164; and the polypeptide is a sensor for AMIPROPHOS METHYL.In embodiments, a polypeptide of the library comprises K at position 159; and one or more mutations selected from the group consisting of D at position 94; M at position 117; and M or T at position 164; and the polypeptide is a sensor for CARBIMAZOLE.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of R at position 59; L or Y at position 81; L, M, W, or Y at position 83; F or M at position 87; A at position 117; W at position 120; M at position 122; A, G, H, or V at positionAtty Docket No. 690104.0046159; and I, L, M, or V at position 160; and the polypeptide is a sensor for DIETHYLTOLUAMIDE.In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of A, L, N, R, or S at position 59; L or Y at position 81; F, L, or Y at position 83; M at position 87; Y at position 108; D, G, H, or N at position 117; F at position 120; N or Q at position 122; I at position 159; L at position 160; and D, Q, or S at position 167; and the polypeptide is a sensor for CYCLOATE.In embodiments, a polypeptide of the library comprises R at position 110; and one or more mutations selected from the group consisting of L or M at position 81; I at position 159; S at position 160; S at position 164; and H at position 167; and the polypeptide is a sensor for VALPROIC ACID.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of E at position 59; L or R at position 81; K at position 83; I at position 89; Q at position 122; and F at position 167; and the polypeptide is a sensor for AMITRAZ.In embodiments, a polypeptide of the library comprises A, I, S, T, or V at position 159; and one or more mutations selected from the group consisting of T at position 59; A at position 83; Y at position 108; A at position 117; E at position 122; I, L, or M at position 160; I at position 164; and G, I, T, or V at position 167; and the polypeptide is a sensor for PICOXYSTROBIN.In embodiments, a polypeptide of the library comprises A, G, I, S, T, or V at position 159; and one or more mutations selected from the group consisting of A at position 59; L at position 83; M at position 87; G at position 89; D at position 94; A or F at position 120; G at position 160; F or S at position 164; and Q or S at position 167; and the polypeptide is a sensor for PYRACLOSTROBIN.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of A or S at position 108; K or Q at position 122; K at position 159; and L at position 160; and the polypeptide is a sensor for VOXELOTOR.In embodiments, a polypeptide of the library comprises Q at position 94; and two or more mutations selected from the group consisting of T at position 81; Y at position 83; M at position 87; and G at position 89; and the polypeptide is a sensor for DICLOFENAC.Atty Docket No. 690104.0046In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of M at position 59; R at position 81; W at position 83; D at position 94; I, R at position 108; K or M at position 117; T or V at position 159; W at position 163; and G at position 164; and the polypeptide is a sensor for FLAMPROP -METHYL.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of R at position 81; H, L, or M at position 83; M at position 87; G or I at position 89; G, M, or Q at position 94; L at position 108; T at position 120; T at position 122; S at position 160; M at position 164; and the polypeptide is a sensor for LONIDAMINE.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of I or L at position 83; A, G or T at position 120; D or E at position 122; A, M, or V at position 159; G, N, or V at position 160; W at position 163; F at position 164; and I at position 167; and the polypeptide is a sensor for DIMOXYSTROBIN.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of Q at position 59; Y at position 81; A, F, H, L, or M at position 83; F at position 89; H or N at position 117; A, G, S, or T at position 120; D or E at position 122; H, I, or L at position 159; I at position 160; and E or L at position 164; and the polypeptide is a sensor for CARPROPAMID.In embodiments, a polypeptide of the library comprises A, G, or S at position 120; and one or more mutations selected from the group consisting of L at position 81; A or Y at position 83; D at position 94; Y at position 108; H at position 117; A at position 159; and L or V at position 160; and the polypeptide is a sensor for FLUFENACET.In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of Y at position 83; H or Q at position 94; R at position 108; and H at position 164; and the polypeptide is a sensor for TRINEXAPAC-ETHYL.In embodiments, a polypeptide of the library comprises F, Y, or L at position 89; and one or more mutations selected from the group consisting of A, T, or W at position 110; G, H, or N at position 117; N or S at position 164; and H or S at position 167; and the polypeptide is a sensor for CHLORMADINONE ACETATE.Atty Docket No. 690104.0046In embodiments, a polypeptide of the library comprises two or more mutations selected from the group consisting of Q at position 59; A at position 83; F, 1, L, or M at position 89; A, T, or W at position 110; A, D, or N at position 117; L at position 159; and E at position 164; and the polypeptide is a sensor for CYPROTERONE ACETATE.In embodiments, a polypeptide of the library comprises D at position 59; L or M at position 160; and one or more mutations selected from the group consisting of A at position 110; and L at position 120; and the polypeptide is a sensor for DIFLUCORTOLONE 21-VALERATE.In embodiments, a polypeptide of the library comprises A at position 108; D, H, or N at position 117; and I or V at position 159; and the polypeptide is a sensor for GEDUNIN.In embodiments, a polypeptide of the library comprises three or more mutations selected from the group consisting of L at position 83; M at position 87; A at position 110; H or W at position 117; N at position 159; I at position 160; H at position 163; and N at position 164; and the polypeptide is a sensor for FORMESTANE.In embodiments, a polypeptide of the library comprises I or L at position 160; and one or more mutations selected from the group consisting of Q or S at position 108; A at position 120; and W at position 164; and the polypeptide is a sensor for MESTEROLONE.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of D, Q, or T at position 59; L or Y at position 81; L or M at position 83; M or V at position 87; D at position 94; D or Q at position 122; T at position 141; L or V at position 160; H or W at position 163; H or N at position 164; and Y at position 167; and the polypeptide is a sensor for RAC-3 -N-BUTYLPHTHALIDE.In embodiments, a polypeptide of the library comprises A, I, T, or V at position 159; and one or more mutations selected from the group consisting of V at position 59; T at position 110; W at position 120; and M or W at position 163; and the polypeptide is a sensor for BUTYLPARABEN.In embodiments, a polypeptide of the library comprises H or L at position 159; and one or more mutations selected from the group consisting of R at position 59; M at position 160; and H at position 167; and the polypeptide is a sensor for ORSELLINIC ACID, ETHYL ESTER.Atty Docket No. 690104.0046In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of I at position 83; M or V at position 87; W at position 117; W at position 120;G, H, or T at position 159; M, S, or V at position 160; W at position 163; E or K at position 164; and H or Q at position 167; and the polypeptide is a sensor for PROPYLPARABEN.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of D or N at position 59; I at position 81; I or L at position 83; M at position 87; I at position 141; V at position 160; and Q at position 167; and the polypeptide is a sensor for TIOXOLONE.In embodiments, a polypeptide of the library comprises Y at position 81; and one or more mutations selected from the group consisting of A at position 83; G at position 89; and V at position 160; and the polypeptide is a sensor for FLUNIXIN.In embodiments, a polypeptide of the library comprises A or G at position 120; and one or more mutations selected from the group consisting of T or Y at position 81; V at position 87; A or W at position 108; M at position 117; T at position 122; L or V at position 160; T at position 164; and D, H, or S at position 167; and the polypeptide is a sensor for CYCLANDELATE.In embodiments, a polypeptide of the library comprises I, T, or V at position 159; and one or more mutations selected from the group consisting of Y at position 81; M at position 160; Y at position 164; and T at position 167; and the polypeptide is a sensor for DANTHRON.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of L at position 81; L at position 83; G, I, or M at position 159; I at position 160; I, D or L at position 164; and K, Q, or V at position 167; and the polypeptide is a sensor for 2-HYDROXY-9-FLUORENONE.In embodiments, a polypeptide of the library comprises L, M, or V at position 159; and one or more mutations selected from the group consisting of F at position 120; S at position 160; W at position 163; and G at position 164; and the polypeptide is a sensor for 2-HYDROXYBENZOPHENONE.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of D, F, or L at position 89; M at position 159; and H at position 167; and the polypeptide is a sensor for BETANAPHTHOL.Atty Docket No. 690104.0046In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of M at position 87; W at position 120; 1 or T at position 159; N at position 160; W at position 163; and G or H at position 167; and the polypeptide is a sensor for 4-HYDROXYBENZOPHENONE.In embodiments, a polypeptide of the library comprises one or more mutations selected from the group consisting of T at position 81; W at position 83; N or Y at position 108; E at position 122; A, I, L, S, T, or V at position 159; L or N at position 160; Q or W at position 163; D or F at position 164; and Q at position 167; and the polypeptide is a sensor for 6-BENZOYL-2-NAPHTHOL.SensorsReal-time biosensors have seen rapidly growing demand across a wide range of applications, including precise drug dosage monitoring, early disease diagnosis, toxin detection, and monitoring the accumulation of hazardous substances. These devices typically consist of two core components: a receptor that captures the target analyte, and a transducer that generates a recordable signal in response to analyte binding. However, detecting small molecules remains a significant challenge. Because small molecules are low in both abundance and mass, techniques whose signal strength scales with analyte mass often struggle to achieve the sensitivity required for reliable detection under biologically relevant conditions.The present invention provides highly sensitive sensors for small molecules, thereby providing a solution to the aforementioned challenges.In embodiments, at least one polypeptide in the library provided herein is a sensor for a small molecule.Thus, in embodiments, provided herein are sensors for ANTHRACENE-9-CARBOXYLIC ACID, harboring a mutation selected from F159: I, L, M, V and 1 or more mutations selected from the following: V81: R, Y; V164: L relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for ANTHRONE, harboring a mutation selected from F159: I, M, V and 1 or more mutations selected from the following: V81: R, Y; F108: M, Y relative to the corresponding positions in SEQ ID NO:853.Atty Docket No. 690104.0046In embodiments, provided herein are sensors for CINCHOPHEN, harboring a mutation selected from Y120: A, G and 1 or more mutations selected from the following: V81: L, Y; L87: 1; E94: D; A160: L relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for FLAVONE, harboring 2 or more mutations selected from the following: K59: D, N; L87: I; F108: Q; E141: 1; F159: I, T, V; A160: V; V163: M, W; V164: F, G; N167: G, S, V relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for KHELLIN, harboring 1 or more mutations selected from the following: V81: L; V83: L; S122: Q; E141: I, T; F159: G, M, T; V164: F, G, S, T; N167: K relative to the corresponding positions in SEQ ID NO: 853.In embodiments, provided herein are sensors for ACETOMENAPHTHONE, harboring 1 or more mutations selected from the following: V81: L, M, Y; L87: I, M; A89: F, M; F108: N, W, Y; 1110: T; S122: T; F159: A, I, L, S, T, V; A160: L, V relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for HEXYLRESORCINOL, harboring 2 or more mutations selected from the following: K59: A; L117: W; S122: I; F159: T; A160: G, S; V163: W; V164: G, S relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for WHILE OLIVETOL, harboring 1 or more mutations selected from the following: V81: M; V83: L; L87: I; Y120: G; S122: E; F159: I, M, T; V164: H, L, N relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for DEHYDRO ACETIC ACID, harboring 2 or more mutations selected from the following: V81: R; V83: I, W; L87: M; E94: D, Q; F108: Y; L117: H, M; A160: G relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for LISURIDE, harboring 1 or more mutations selected from the following: V81: Y; Y120: A, G, S, T; S122: E, Q, V; F159: A, T, V relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for WIN-552122, harboring a mutation selected from F159: G, S, T and 1 or more mutations selected from the following: Y120: M; A160: I, L, M, V; V164: N; N167: T relative to the corresponding positions in SEQ ID NO:853.Atty Docket No. 690104.0046In embodiments, provided herein are sensors for BICALUTAMIDE, harboring a mutation selected from A160: I, V and 1 or more mutations selected from the following: K59: D; E141: I; V164: F, W relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for EFAVIRENZ, harboring 2 or more mutations selected from the following: K59: S, T; V81: T; V83: I; L87: M; F108: L; F159: N, Q; A160: G; V163: M, W; V164: H, L, S, T; N167: V, Y relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for FLUTAMIDE, harboring 1 or more mutations selected from the following: K59: A, D; V81: I; V83: I; Y120: H, L, M; S122: M; E141: F, I, T, V; A160: M, V; V164: M, S; N167: G, S relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for RILUZOLE, harboring 2 or more mutations selected from the following: K59: E, Q, S; V81: L; V83: M; L87: 1; Y120: A; S122: G; E141: 1; F159: 1, L; A160: M; V164: E relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for CINACALCET, harboring a mutation selected from K59: D, E, M and 1 or more mutations selected from the following: I110: T; L117: A, M; Y120: A, F, G, S; S122: M, N, V; F159: I; V164: F, I relative to the corresponding positions in SEQ ID NO:853In embodiments, provided herein are sensors for MONOBENZONE, harboring a mutation selected from F159: A, I, T, V and 1 or more mutations selected from the following: K59: N; F108: M; L117: H; Y120: H, M, V; S122: I, M; E141: T; A160: G, L; V164: E, F, K; N167: F, H relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for PRAZIQUANTEL, harboring a mutation selected from Y120: H, L, M and 2 or more mutations selected from the following: V81: L; V83: F, Y; F108: W; I110: W; F159: I; A160: G relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for DICLAZURIL, harboring 3 or more mutations selected from the following: V81: I; E94: G; Y120: M; S122: V; A160: I, M, N; V164: T; N167: H, I, Y relative to the corresponding positions in SEQ ID NO:853.Atty Docket No. 690104.0046In embodiments, provided herein are sensors for TRICLABENDAZOLE, harboring a mutation selected from F159: G, H, Q, T, V and 2 or more mutations selected from the following: K59: A, S; V83: L; Y120: F; S122: D; A160: I, L; V163: W; V164: T, W relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for TOLBUTAMIDE, harboring 2 or more mutations selected from the following: V81: R; V83: F; S92: L; E94: G; Y120: S; V164: N; N167: D relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for MELITRACEN, harboring a mutation selected from F159: I, T, V and 1 or more mutations selected from the following: K59: L; V81: Y; S122: E; A160: M; V164: E, F, H relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for LATANOPROST, harboring a mutation selected from Y120: A, H and 2 or more mutations selected from the following: V83: Q; F159: I, V; A160: G; V164: E; N167: H relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for GUANABENZ, harboring a mutation selected from K59: A, E, Q and 1 or more mutations selected from the following: A89: D; Fl 59: A, V; A160: I; V163: M; V164: F relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for MEZLOCILLIN, harboring a mutation selected from Y120: A and 1 or more mutations selected from the following: V81: Y; F108: Y; S122: T; A160: V relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for LIOTHYRONINE, harboring a mutation selected from L117: A, M and 1 or more mutations selected from the following: V81: I; V83: L; Y120: F; V164: I, L relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for PHENAZOPYRIDINE, harboring mutations selected from K59: D, S; Fl 59: T, V and 1 or more mutations selected from the following: V83: L; A89: 1; S122: Q; N167: Q relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for CHLOROXYLENOL, harboring 1 or more mutations selected from the following: K59: D, M, N; V81: I; V83: I; L87: M; L117: W; Y120: F; E141: I; F159: T; A160: V; V163: M; V164: K, L, S; N167: Q, V relative to the corresponding positions in SEQ ID NO:853.Atty Docket No. 690104.0046In embodiments, provided herein are sensors for METYRAPONE, harboring mutations selected from V81: Y; F159: I, V and 1 or more mutations selected from the following: S122: Q relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for BENZBROMARONE, harboring a mutation selected from E94: G, M, Q and 1 or more mutations selected from the following: K59: L; V81: T; V83: L; L87: F; A89: G; S92: L; F159: H; A160: L relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for IBUDILAST, harboring 2 or more mutations selected from the following: K59: R; V81: 1; F159: M, S; V163: H; V164: L; N167: Y relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for IBUPROFEN PICONOL, harboring a mutation selected from F159: G, I, T and 1 or more mutations selected from the following: V81: M; V83: Y; Y120: L; S122: E; N167: Y relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for COMBRETASTATIN A4, harboring a mutation selected from F159: H, I, L, T and 1 or more mutations selected from the following: K59: N; V81: Y; L87: F; E94: D; A160: M; N167: G, T relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for 2-AMINOPYRIMIDINE, harboring a mutation selected from F159: L, Q and 1 or more mutations selected from the following: L87: 1; F108: M; L117: W relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for MAGNOLOL, harboring a mutation selected from Y120: G, H, M, T, V and 1 or more mutations selected from the following: V81: L; S122: D, T; F159: L; N167: G, Y relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for BENZYL CINNAMATE, harboring 1 or more mutations selected from the following: V81: L; F108: Y; F159: H; A160: G; V164: F; N167: N, T, V relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for per and poly-fluorinated substances, harboring a mutation selected from E94: A, D, G, Q and one or more mutations selected from the following:Atty Docket No. 690104.0046F159: 1, L; A160: 1, L, M, N, V; V163: S; V164: K, L, M, S, W relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for non-steroidal anti-inflammatory drugs (NSAIDs) harboring a mutation selected from F159: G, I, T, V and one or more mutations selected from the following: K59: L; V81: M, R; V83: H, I, L, M, Y; F108: K, N, Q; Y120: L, W; S122: E, Q; A160: V; V163: W; V164: E, G; N167: Y relative to the corresponding positions in SEQ ID NO:853.In embodiments, provided herein are sensors for strobilurin class fungicides, harboring a mutation selected from F159: A, G, I, S, T, V and one or more mutations selected from the following: K59: A, T; V83: A, L; L87: M; A89: G; E94: D; F108: Y; L117: A; Y120: A, F; S122: E; A160: G, I, L, M; V164: F, I, S; N167: G, I, Q, S, T, V relative to the corresponding positions in SEQ ID NO:853.Systems and Methods for Detecting Small MoleculesEmbodiments of the present invention also provide for methods and systems for screening and detecting small molecules by determining the binding of such small molecules to a mutated PYR / PYL receptor polypeptide having mutations in the binding pocket as described herein.Examples of small molecules that can be detected by the disclosed systems and methods include, but are not limited to, drugs, natural products, chemical compounds and agrochemicals.The systems and methods provided herein employ the disclosed mutated PYR / PYL receptor polypeptides and an HAB 1 polypeptide.In embodiments, the HAB1 polypeptide is an N-terminus deleted HAB1 polypeptide. In certain aspects, the N-terminus deleted HAB1 polypeptide is thermostable.In some embodiments, the engineered PYR1 polypeptides are labeled with a first detection reagent, and the HAB1 polypeptide is labeled with a second detection reagent. In embodiments, the first detection reagent and the second detection reagent are capable of binding to each other.In embodiments, a signal is generated when the engineered PYR1 polypeptides bind the substance and the first detection reagent binds to the second detection reagent.Atty Docket No. 690104.0046In some embodiments, the first detection reagent and / or the second detection reagent are an antibody, a ligand or an aptamer. In certain aspects, the first detection reagent and the second detection reagent are first and second components of a split complement system.In embodiments, the split complement system is selected from: a split GFP system; a split Vex-GFP system, a NanoBiT split ubiquitin system; a split beta-gal system; a split luciferase system; a split mCherry system; a split FRET system; and a split biotin system.In embodiments, the first detection reagent and the second detection reagent are fluorescent moieties. In other embodiments, one of the first detection reagents is a fluorescent moiety and the second is a quenching moiety that quenches the fluorescent moiety.In embodiments, the first detection reagent and the second detection reagent are oligonucleotides. In certain aspects, the oligonucleotides are proximity assay components. In embodiments, the proximity assay is a proximity extension assay. In embodiments, the proximity assay is a proximity ligation assay.In embodiments, the substance is present in a sample selected from: a biological sample, a food sample, and an environmental sample. In embodiments, the biological sample is urine. In embodiments, the biological sample is blood. In embodiments, the biological sample is plasma. In embodiments, the biological sample is hair. In embodiments, the biological sample is sweat. In embodiments, the biological sample is saliva.Binding assays can involve contacting a PYR / PYL receptor polypeptide library as described herein and a PP2C polypeptide, such as HAB1, with one or more small molecules or chemical agents and allowing sufficient time for the proteins and chemical agents to form a binding complex.Methods for detecting a substance of interest in a sample, as provided herein, comprise contacting a sample containing, or suspected of containing the substance of interest with one or more of the disclosed engineered PYR1 polypeptides and a HAB1 polypeptide.In embodiments, the engineered PYR1 polypeptides are labeled with a first detection reagent, and the HAB1 polypeptide is labeled with a second detection reagent. In embodiments, the detection reagent of the engineered PYR1 polypeptides and the detection reagent of the HAB1 polypeptide interact to generate a signal when the engineered PYR1 polypeptides bind theAtty Docket No. 690104.0046substance of interest and the HAB1 polypeptide and the first detection reagent binds to the second detection reagent.In embodiments, the HAB1 polypeptide is an N- terminus deleted HAB1 polypeptide. In embodiments, the N-terminus deleted HAB1 polypeptide is thermostable.In embodiments, the sample is a biological sample. In embodiments, the sample is a food sample. In embodiments, the sample is an environmental sample.In embodiments, the biological sample is urine. In embodiments, the biological sample is blood. In embodiments, the biological sample is plasma. In embodiments, the biological sample is hair. In embodiments, the biological sample is sweat. In embodiments, the biological sample is saliva.In embodiments, binding complexes formed can be detected using assays that include, but are not limited to, immunoassay analogous to ELISA assays, NMR techniques, displacement of labeled substrates (e.g., labeled agrochemical) or other assays. The PYR / PYL polypeptide protein utilized in such assays can be naturally expressed, cloned or synthesized.Agents and mutated PYR / PYL receptor polypeptides that are initially identified by any of the disclosed screening methods can be further tested to validate the binding activity of the mutated PYR / PYL receptor polypeptide.Atty Docket No. 690104.0046EXAMPLESExample 1: Chemicals and LibrariesThe ligands screened included a commercially available collection of FDA-approved molecules, natural products, and other medicinal compounds (SelleckUSA, L1300), which we supplemented with 480 agrochemicals and other ligands purchased from Sigma-Aldrich (USA) and Microsource Discovery Systems (USA). Ligands were purchased as 10 mM stocks in DMSO. Screens focused on identifying optimized sensors for specific compound subsets (coumarins, TNT, PFAS) were purchased from various sources as analytic grade standards;Example 2: Chemical informaticsCompounds were mapped to ChEMBL(23) using CAS IDs and compound names, respectively, obtained from the compound library providers to retrieve community identifiers, annotations, and physicochemical and structural descriptors. Due to inconsistent or ambiguous use of CAS IDs and compound names, a multi-step mapping strategy had to be employed. First, Selleck compounds were mapped to DrugBank (35) via CAS IDs, followed by ChEBI (36) and PubChem. Ambiguous mappings were then resolved using fingerprint / atompair similarities from ChemmineR. CAS IDs obtained from DrugBank, ChEBI, and PubChem were subsequently mapped to ChEMBL. Functional annotations and physicochemical properties were then gathered from various databases, including ChEMBL, ChemmineR (21), CDK (37), and PubChem. Finally, parent molecule hierarchies (representing the core structure of a compound) from ChEMBL were incorporated into a comprehensive master table. LATCA, an internal UCR collection of curated bioactives from which we selected agrochemicals and other molecules, lacked CAS IDs; these compounds were associated with ChEMBL using their given names and then annotated using a comparable method. The code employed for these annotations can be found in the GitHub repository.Example 3: Receptor Screening LibrariesThree screens against the collection of compounds were conducted using the same general procedure but with different PYR1 variant libraries. The previously described -37,797-member library of PYR1 single and double site mutant library (DSM) (14) was used in an initial screen and led to the identification of 285 sensors for 113 ligands; a second “shuffle” library containing 1.1 xAtty Docket No. 690104.0046106clones was created using nucleotide excision and exchange technology (NexT)(38) to shuffle plasmid DNA for the initial 285 hit sensors; creating a combinatorial library that we screened to yield an additional 23 sensors for 10 ligands. The binding pocket sequences of the hits from the DSM and shuffle sensors were analyzed and used to inform the design of a profile-based library that made all possible -324,000 triple mutant combinations of the input mutations; The libraries used were transformed into the S. cerevisiae reverse two-hybrid strain MaV99 (47) harboring pACT-HABl, which expresses a HAB1 -activation domain fusion that enables ligand-mediated activation of a UASGAL:: URA3 expression construct and rescue of MaV99’s uracil auxotrophy. Transformations were conducted using the LiAc / SS carrier DNA / PEG method(48) to generate >1 lx library coverage. The yeast libraries were then subjected to two rounds of negative selection using 0.1% 5-Fluoroorotic acid to eliminate constitutive mutants from the libraries; -0.001% of cells showed ligand-independent growth after negative selections. The PYR1-TSM library has been deposited at Addgene.Example 4: High-throughput sensor screensSensor screens were conducted in duplicate (DSM, shuffle) or quadruplicate (TSM) using 96-well microtiter plates with wells containing 200 pL of solid SD-Trp, -Leu, -Ura, 1.5% agar media (Sigma- Aldrich, USA), and 100 pM test compound. Each well was seeded with approximately 150,000 yeast cells harboring PYR1 variants in S. cerevisiae MaV99 (pACT-HABl), incubated at 30 °C for three days. Colonies were collected and used in retests with and without the test chemical. Up to 8 validated colonies from each positive well were propagated, and receptor amplicons sequenced. In the DSM and shuffle screens, individual colonies were selected from wells, retested, and Sanger sequenced. To expedite TSM screening, hit validation, and eliminate wells dominated by constitutive mutants, wells with colonies were washed to collect all cells, then retested on control wells lacking test compound; wells that exhibited robust growth without ligand (as evident by a lawn of growth) were eliminated from further consideration. Individual colonies from the remaining wells were subsequently isolated and retested in both the presence and absence of the ligand to confirm ligand-dependent responsiveness. Amplicons for 12 validated clones were sequenced using a modified version of evSeq (49) with barcoded primers designed for pBD-PYRl receptor amplicons. Individual yeast colonies were amplified using GoTaq DNA polymerase (Promega Corporation, USA) and pooled PCR products purified using a MONARCH® PCR &Atty Docket No. 690104.0046DNA Cleanup Kit (NEB, USA) and sequenced by Novogene (USA) using paired-end 250 bp reads. Receptor sequences were derived from fastq files after filtering low-quality reads using PYR1_evSEQ (50). Validated, non-redundant (i.e., unique binding pocket) mutant sensor strains were subsequently tested in dose-response experiments using newly stocked chemicals (DSM and shuffle screens) or compounds from source wells (TSM screen). -95% of the candidate sensor strains retested showed robust ligand-dependent growth relative to a mock control at least one of three concentrations tested: The DSM screen identified validated sensors for 108 compounds, the shuffled library for an additional 6, and the TSM screen an additional 63 for a total of 181 sensed ligands. Screens of targeted receptor variants (TNT, PFAS, coumarins) were conducted similarly but used -106 cells plated onto media in 25 cm or 6-well plates. Although this work used MaV99, we have determined that the commercially available strain MaV203 also works well. The sequences of the previously described (51). pACT-HABl and pBD-PYRl are provided here for reference and available from Addgene.Example 5: Receptor library assembly from oligonucleotide poolsLibraries were constructed using the Golden Gate Assembly (GGA) to assemble the PYR1 coding sequence from three -200-nucleotide blocks PCR amplified from oligonucleotide pools and cloned into pBD-PYRl-156, a domesticated pBD-PYRl vector with Bsal sites inserted adjacent to codon 50 and with (pBD-PYR1-156-F1) or without (pBD-PYRl-156) an in-frame stop codon adjacent to the 3’ Bsal site. Oligonucleotides encoding each of the desired mutations were generated using sequence profiles designed in the Targeted-PYRl -Library-Design Shiny App, which designs the encoded mutation according to user-set parameters, adds flanking indexset barcode primers (52) to each of the oligonucleotides, and outputs them to a fasta file. Most assemblies were conducted using oligonucleotides barcoded with block- and libraryspecific 18-mer primers, allowing PCR amplification of the target blocks from pools designed to harbor multiple libraries. The TSM library did not use barcoded oligonucleotides. It was constructed from three separate Twist oligonucleotide pools, each harboring all designs of single, double, or triple mutations at the target sites for each block. The TSM library was assembled from ten GGA reactions to generate all desired triple-mutant combinations systematically. The final library contained 4.3 x 106clones; deep sequencing determined that 95.3% of the 324,352 designed mutations were present. Targeted libraries were assembled combinatorially fromAtty Docket No. 690104.0046oligonucleotide blocks that harbored all desired mutations per block (i.e., all single, double, triple, etc). These were assembled into final screening libraries by running seven GGA reactions that combinatorially swapped the three blocks, each carrying either no mutations (wild type, WT), or all possible single, double, or triple mutations. The seven assemblies were transformed into E. coir and their plasmid was pooled before transformation into MaV99 harboring pACT-HAB1 at ratios relative to the number of potential unique PYRls per assembly. For TSM library quality control and coverage analysis, library plasmid DNA was diluted to 1 ng / pL, and PYR1-amplicons were amplified using Q5 High-Fidelity 2X master mix (NEB, USA). 1.5 pg of column-purified PCR product was sequenced by Novogene (USA) using 2x250 bp paired-end reads on an Illumina NovaSeq. FastQ files were processed to remove reads with a Q-score lower than 20, and coverage was determined using previously described code (17). The theoretical library sizes for the targeted libraries range from 77,327 to 516,647 mutants and were constructed with >10x coverage in both E. coli and subsequent S. cerevisiae strains for libraries with <100,000 members and >2.5x coverage for libraries with >100,000 members. pBD-PYRl-156 and pBD-PYRl-156-FL have been deposited at Addgene.To assemble the libraries, we PCR-amplified six oligonucleotide blocks — the three oligonucleotide pool blocks that harbor mutants, and the other three wild-type blocks from a plasmid template. One ng of the oligonucleotide pool templates or WT plasmid DNA was amplified using Q5 High-Fidelity 2X master mix. Each reaction included 0.5 pM of each primer and was run for 22 cycles (98 °C 10s, 60 °C 30 s., 72 °C 30 s.; initial denaturation 98 °C, 30 s.). Amplicons were purified using a Monarch PCR & DNA Cleanup Kit (NEB, USA). ~16 ng of each purified block was then combined with either -300 ng of the pBD-PYR1-156 or pBD-PYR1-156 bp-F1 (2: 1 molar insert-to-vector ratio) to assemble the seven block permutations. BsaI-HFv2 and T4 DNA ligase (NEB, USA) were then added using the manufacturer's recommendations and cycled (1 minute each 37°C / 16°C; 30 cycles). The reaction was transformed into chemically competent Top10; plasmid DNA was used to transform S. cerevisiae MaV99 (pACT-HABl) as described above.Example 6: Design and construction of an improved double-site mutant receptor library (DSM-Hao)Atty Docket No. 690104.0046Our initial screens used the previously designed PYR1 DSM library (77). This library was built using nicking site saturation mutagenesis(53) and harbors many wild-type sequences. We therefore created a new DSM library using GGA from oligonucleotide pools, based on the previous DSM sequence profile with slight modifications; in designing this new library, we sought to reduce the number of constitutive mutants. We, therefore, excluded two strong constitutive single mutants (V83F and Fl 59V) (54) from all designs. In addition, evSeq sequencing of a set of constitutive receptors and a separate deep sequencing experiment, conducted to identify mutants depleted from the DSM library after negative selections, together identified 1,188 constitutive double mutants co-located in the same assembly blocks. These double mutants were removed from the designed oligonucleotides, which were synthesized by Twist Bioscience (USA) and used to assemble the library as described above; see Figure S7 for the auto-activating double mutants excluded from the library. The library, created at 99.95% of coverage, harbors 34,657 of the 34,675 designed mutations, as determined by deep sequencing. The PYRl-DSM-Hao library has been deposited at Addgene.Example 7: Targeted library design using sequence profilesTo create targeted PYR1 libraries with focused small-molecule biosensor targets, sequence profiles were generated using binding pocket mutations from target sensors. Similar molecules in the ligand-receptor dataset were identified using similarity searches and clustering based on atompair fingerprints in ChemineR (24). The Targeted-PYRl -Library -Design- App (55) was used to generate a sequence profile for the selected sensors, which were manually curated to eliminate rare mutations and limit the final library sizes to less than 600,000. The final sequence profiles were used to create oligonucleotide pools for assembly using the methods described above. The coumarin library sequence profile was constructed from osthole, imperatorin, and isopsoralen sensors. The TNTvl sequence profile was built from sensors for 2,4-dinitrophenol, chloroxylenol, 2,4,6-trihydroxybenzoic acid, 2,6-dihydroxybenzoic acid, which we selected based on their similarity to TNT; the TNTv2 sequence profile was constructed from the TNT / ADNT / DNT screening hits from TNTvl, to which we added amiprofos-m ethyl sensor data to increase sequence diversity and the mutations V163W and T162D, which arose fortuitously in some of the TNTvl sensors. The PF AS library’s sequence profile was built from PFAS sensors identified from screening DSM-Hao.Atty Docket No. 690104.0046Example 8: Yeast display titrationsDesigns were ordered as eBlocks (IDT, USA) encoding the H60P and N90S mutations for compatibility with yeast display(56). Plasmids were assembled using Golden Gate cloning with the yeast display destination vector pND003 (57). Designs were confirmed by whole plasmid sequencing (Plasmidsaurus, USA). Plasmids were transformed into S. cerevisiae EBY100, and strains were stored at -80 °C using standard methods (58). Yeast display was performed essentially as described (56) using ligand stocks of 10 mM in DMSO. The final concentration of DMSO for all samples tested, including negative controls, was 2 (v / v)%. Plasmid pJS624 (17) encoding a yeast displayed PYR1mandi / N90Swas included as a positive control.Example 9: β-galactosidase assaysSensor strain responses to ligands were investigated using X-gal overlay assays of colonies cultured on test ligand or mock for 3 days. For the quantitative measurements of betagalactosidase expression in the biosensors, 50 mL cultures of yeast sensor strains were grown overnight then diluted to OD600 = 0.02 in SD, -Leu, -Trp liquid media in 1 mL aliquots and varying concentrations of test ligand from lOOOX-stocks in DMSO, incubated for approximately 7 - 16 hours then diluted OD600 0.1 in SD-Leu-Trp media and 50 pL of the suspension transferred to opaque flat-bottom Optifine 96-well plates along with 50 µL of Beta-Glo assay mixture (Promega, USA). Luminescence was measured using a Tecan Infinite F200 pro plate reader with shaking (450 rpm for 30 seconds) over 2 hours, using a 200 ms integration time. Relative luminescence (RLU) measurements are plotted using a time point at which the RLU has stabilized (~90 minutes).Atty Docket No. 690104.0046Description of the SequencesSEQ ID NO: 1 -Sensor for Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 2- Sensor for BICALUTAMIDESEQ ID NO: 3 -Sensor for PENTOSALENSEQ ID NO: 4- Sensor for BICALUTAMIDESEQ ID NO: 5-Sensor for YANGONINSEQ ID NO: 6-Sensor for NONIVAMIDESEQ ID NO: 7-Sensor for N-MethylperfluorobutanesulfonamideSEQ ID NO: 8-Sensor for BETANAPHTHOLSEQ ID NO: 9-Sensor for CAPSAICINSEQ ID NO: 10-Sensor for BETANAPHTHOLSEQ ID NO: 11 -Sensor for ACETOMENAPHTHONESEQ ID NO: 12-Sensor for CHLOROBENZILATESEQ ID NO: 13-Sensor for CHLORMADINONE ACETATESEQ ID NO: 14-Sensor for ACETOMENAPHTHONESEQ ID NO: 15-Sensor for CYPROTERONE ACETATESEQ ID NO: 16-Sensor for CYPROTERONE ACETATESEQ ID NO: 17-Sensor for CHLORMADINONE ACETATESEQ ID NO: 18-Sensor for CHLORMADINONE ACETATESEQ ID NO: 19-Sensor for Perfluorooctanoic acidSEQ ID NO: 20-Sensor for PYRACLOSTROBINSEQ ID NO: 21 -Sensor for RAMELTEONSEQ ID NO: 22-Sensor for PYRACLOSTROBINSEQ ID NO: 23 -Sensor for ETHISTERONESEQ ID NO: 24-Sensor for CYPROTERONE ACETATESEQ ID NO: 25-Sensor for MEDROXYPROGESTERONE ACETATESEQ ID NO: 26-Sensor for MEGESTROL ACETATESEQ ID NO: 27-Sensor for CHLORMADINONE ACETATESEQ ID NO: 28-Sensor for CYPROTERONE ACETATEAtty Docket No. 690104.0046SEQ ID NO: 29-Sensor for > A89I_I110W V164G MEDROXYPROGESTERONESEQ ID NO: 30-Sensor for CHLORMADINONE ACETATESEQ ID NO: 31 -Sensor for CHLORMADINONE ACETATESEQ ID NO: 32-Sensor for BETANAPHTHOLSEQ ID NO: 33 -Sensor for DIHYDROCAPSAICINSEQ ID NO: 34-Sensor for CHLORMADINONE ACETATESEQ ID NO: 35-Sensor for CHLORMADINONE ACETATESEQ ID NO: 36-Sensor for CYPROTERONE ACETATESEQ ID NO: 37-Sensor for PHENYLPHENOL ACETOMENAPHTHONESEQ ID NO: 38-Sensor for CYPROTERONE ACETATESEQ ID NO: 39-Sensor for DIHYDROXYACETONESEQ ID NO: 40-Sensor for Perfluoroheptanal hydrate (diol)SEQ ID NO: 41 -Sensor for FLUTAMIDESEQ ID NO: 42-Sensor for KHELLINSEQ ID NO: 43 -Sensor for FLUTAMIDESEQ ID NO: 44-Sensor for MONOBENZONESEQ ID NO: 45-Sensor for Perfluoroheptanoic acidSEQ ID NO: 46-Sensor for 2H,2H,3H,3H-Perfluoroheptanoic acid 2H,2H,3H,3H- Perfluorooctanoic acid 2H,2H,3H,3H-Perfluorononanoic acidSEQ ID NO: 47-Sensor for 2H,2H,3H,3H-Perfluorooctanoic acid Perfluorohexanesulfonamide 2H-Perfluoro-2-octenoic acidSEQ ID NO: 48-Sensor for 2H,2H,3H,3H-Perfluorononanoic acidSEQ ID NO: 49-Sensor for 2H,2H,3H,3H-Perfluoroheptanoic acid 2H-Perfluoro-2-octenoic acidSEQ ID NO: 50-Sensor for > 2H,2H,3H,3H-Perfluorohexanoic acidSEQ ID NO: 51 -Sensor for PerfluorooctanesulfonamideSEQ ID NO: 52-Sensor for PYRACLOSTROBINSEQ ID NO: 53-Sensor for 1H,1H,10H,10H-Perfluoro-1,10-decanediolSEQ ID NO: 54-Sensor for CARBIMAZOLESEQ ID NO: 55-Sensor for E94D F159N 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID NO: 56-Sensor for E94D S122D V163W RAC-3-N-BUTYLPHTHALIDEAtty Docket No. 690104.0046SEQ ID NO: 57-Sensor for E94D V164H CROTAMITON DIBUTYL PHTHALATE ETOFIBRATESEQ ID NO: 58-Sensor for E94D_Y120N_S122W_F159H_A160L 1H,1H,8H,8H-Dodecafluoro- 1, 8-octanediolSEQ ID NO: 59-Sensor for E94D_Y120S_F159L_V164M Perfluoroheptanal hydrate (diol)SEQ ID NO: 60-Sensor for E94G Perfluorooctanesulfonamide 2H-Perfluoro-2-octenoic acidSEQ ID NO: 61-Sensor for E94G A160I Perfluorooctanesulfonamide Perfluoro-3, 6, 9-trioxatridecanoic acidSEQ ID NO: 62-Sensor for E94G A160L Perfluorooctanesulfonic acidPerfluorooctanesulfonamide Perfluoro-3,6,9-trioxatridecanoic acid 2H-Perfluoro-2-octenoic acidSEQ ID NO: 63 -Sensor for E94G A160N PerfluorohexanesulfonamidePerfluorooctanesulfonamideSEQ ID NO: 64-Sensor for E94G_A160N_N167Y DICLAZURILSEQ ID NO: 65-Sensor for E94G A160V Perfluorooctanesulfonic acidSEQ ID NO: 66-Sensor for E94G A160V V164M Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 67-Sensor for E94G E141K Perfluorooctanesulfonic acid 3,5,6-trichlorooctafluorohexanoic acidSEQ ID NO: 68-Sensor for E94G F108L Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 69-Sensor for E94G F159L Perfluorooctanesulfonic acidSEQ ID NO: 70-Sensor for E94G V163I 3,5,6-trichlorooctafluorohexanoic acidSEQ ID NO: 71 -Sensor for E94G V163S Perfluorooctanesulfonic acidSEQ ID NO: 72-Sensor for E94G V164H Perfluoro-3, 6, 9-tri oxatri decanoic acidSEQ ID NO: 73-Sensor for E94G V164K Perfluorooctanesulfonic acid 3,5,6-trichlorooctafluorohexanoic acidSEQ ID NO: 74-Sensor for E94G V164L Perfluorooctanesulfonic acidSEQ ID NO: 75-Sensor for E94G V164M Perfluorooctanesulfonic acid Perfluoro-3, 6, 9-trioxatridecanoic acidSEQ ID NO: 76-Sensor for E94G V164N Perfluorooctanesulfonamide TOLBUTAMIDESEQ ID NO: 77-Sensor for E94G V164T N167H DICLAZURILSEQ ID NO: 78-Sensor for E94G_Y120L_A160L_V164W Perfluorooctanesulfonic acidSEQ ID NO: 79-Sensor for E94G Y120N PerfluorohexanesulfonamideSEQ ID NO: 80-Sensor for E94N F108Q 1H,1H,6H,6H-Perfluoro-1,6-hexandiolAtty Docket No. 690104.0046SEQ ID NO: 81-Sensor for E94Q E141T V164N 2,4-DINITROPHENOLSEQ ID NO: 82- Sensor for E94Q F159H A160L BENZBROMARONESEQ ID NO: 83- Sensor for E94Q S122E 2,4-DINITROPHENOLSEQ ID NO: 84- Sensor for > E94S_A160M 2H,2H,3H,3H-Perfluorooctanoic acidSEQ ID NO: 85- Sensor for > E94S_F108W 2H-Perfluoro-2-octenoic acidSEQ ID NO: 86- Sensor for > E94S_V164G 2H-Perfluoro-2-octenoic acidSEQ ID NO: 87- Sensor for > E94S_Y120A 2H,2H,3H,3H-Perfluorohexanoic acidSEQ ID NO: 88- Sensor for > E94T_A160L Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 89- Sensor for > E94T_F159L 2H-Perfluoro-2-octenoic acidSEQ ID NO: 90- Sensor for > F1O8A_L117D F159I GEDUNINSEQ ID NO: 91- Sensor for > F1O8A_L117H F159V GEDUNINSEQ ID NO: 92- Sensor for > F1O8A_L117N F159V GEDUNINSEQ ID NO: 93- Sensor for > F108A_S122K VOXELOTORSEQ ID NO: 94- Sensor for > F108A_S122Q VOXELOTORSEQ ID NO: 95- Sensor for > F108A_Y120A_A160L CYCLANDELATESEQ ID NO: 96- Sensor for > F108H_Y120K_F159L Perfluoroheptanal hydrate (diol)SEQ ID NO: 97- Sensor for > F108L_Y120A_S122N DIHYDROCAPSAICINSEQ ID NO: 98- Sensor for > F108M_F159M ANTHRONESEQ ID NO: 99- Sensor for > F108M_F159T_A160G MONOBENZONESEQ ID NO: 100- Sensor for > F108M_L117W_F159L 2- AMINOPYRIMIDINESEQ ID NO: 101- Sensor for > F108N_F159V 6-BENZOYL-2-NAPHTHOLSEQ ID NO: 102- Sensor for > F108N_F159V_A160L ACETOMENAPHTHONESEQ ID NO: 103- Sensor for > F108N_F159V_A160V PRANOPROFENSEQ ID NO: 104- Sensor for > F108Q_A160L MESTEROLONESEQ ID NO: 105- Sensor for > F108Q_F159V PRANOPROFENSEQ ID NO: 106- Sensor for > F108Q_V163M_N167G FLAVONESEQ ID NO: 107- Sensor for > F108R_V164H TRINEXAPAC-ETHYLSEQ ID NO: 108- Sensor for > F108S_A160L MESTEROLONESEQ ID NO: 109- Sensor for > F108S_S122K VOXELOTORAtty Docket No. 690104.0046SEQ ID NO: 110- Sensor for > F108W_S122N_A160G_V163W_N167D OstholeSEQ ID NO: 111 - Sensor for > F108W S122N V163W N167D Imperatorin MethoxsalenSEQ ID NO: 112- Sensor for > F108W_Y120A CYCLANDELATESEQ ID NO: 113- Sensor for > F108W_Y120H_A160G PRAZIQUANTELSEQ ID NO: 114- Sensor for > F108W_Y120M_V163W OSTHOLESEQ ID NO: 115- Sensor for > F108Y_A160G_V164F BENZYL CINNAMATESEQ ID NO: 116- Sensor for > F108Y_F159I_N167V PICOXYSTROBINSEQ ID NO: 117- Sensor for > F108Y_V163W_N167D PENTOSALENSEQ ID NO: 118- Sensor for > F108Y_V163W_V164F 6-BENZOYL-2-NAPHTHOLSEQ ID NO: 119- Sensor for > F108Y_Y120A_A160V FLUFENACETSEQ ID NO: 120- Sensor for > F108Y_Y120G_A160V FLUFENACETSEQ ID NO: 121- Sensor for > F159A_A160G_N167Q PYRACLOSTROBINSEQ ID NO: 122- Sensor for > F159A_A160G_V164S_N167S PYRACLOSTROBINSEQ ID NO: 123- Sensor for > F159A_V163M BUTYLPARABENSEQ ID NO: 124- Sensor for > F159A_V164D 6-BENZOYL-2-NAPHTHOLSEQ ID NO: 125- Sensor for > F159A_V164I_N167T PICOXYSTROBINSEQ ID NO: 126- Sensor for > F159G_A160I 1H,1H,10H,10H-Perfluoro-1,10-decanediolSEQ ID NO: 127- Sensor for > F159G_A160V MESTRANOL MALOTILATEPROPYLPARABEN WIN-552122SEQ ID NO: 128- Sensor for > F159G_N167M ESTRADIOL METHYL ETHERSEQ ID NO: 129- Sensor for > F159G_V164G ETHINYL ESTRADIOLSEQ ID NO: 130- Sensor for > F159G_V164S LYNESTRENOLSEQ ID NO: 131- Sensor for > F159H 1H,1H,6H,6H-Perfluoro-1,6-hexandiol 1H,1H,8H,8H- Dodecafluoro-1,8-octanediolSEQ ID NO: 132- Sensor for > F159H_A160I 1H,1H,6H,6H-Perfluoro-1,6-hexandiol ETHINYL ESTRADIOLSEQ ID NO: 133- Sensor for > F159H_N167G COMBRETASTATIN A4SEQ ID NO: 134- Sensor for > F159H_N167T VANILLYL BUTYL ETHER BENZYLCINNAMATESEQ ID NO: 135- Sensor for > F159H_V164G 1H,1H,8H,8H-Dodecafluoro-1,8-octanediolSEQ ID NO: 136- Sensor for > F159H_V164K PROPYLPARABENAtty Docket No. 690104.0046SEQ ID NO: 137- Sensor for > F159I ALACHLOR CROTAMITON DANTHRONANTHRACENE-9-CARBOXYLIC ACID ACETOMENAPHTHONE OSTHOLE IBUPROFEN PICONOL COMBRETASTATIN A4SEQ ID NO: 138- Sensor for > F159I_A160I_N167G PICOXYSTROBINSEQ ID NO: 139- Sensor for > F159I_A160L TRANS-ASARONE ACETOMENAPHTHONESEQ ID NO: 140- Sensor for > F159I_A160M_N167I PICOXYSTROBINSEQ ID NO: 141- Sensor for > F159I_A160N_V163W 4-HYDROXYBENZOPHENONE 6- BENZOYL-2-NAPHTHOLSEQ ID NO: 142- Sensor for > F159I N167S FLAVONESEQ ID NO: 143- Sensor for > F159I_N167T PICOXYSTROBIN DANTHRONSEQ ID NO: 144- Sensor for > F159I V163W BUTYLPARABENSEQ ID NO: 145- Sensor for > F159I_V163W_V164S DIETHYLSTILBESTROLSEQ ID NO: 146- Sensor for > F159I_V164D 2-HYDROXY-9-FLUORENONESEQ ID NO: 147- Sensor for > F159I_V164F FLAVONE OSTHOLE MONOBENZONE MELITRACENSEQ ID NO: 148- Sensor for > F159I_V164S OSTHOLESEQ ID NO: 149- Sensor for > F159K CARBIMAZOLESEQ ID NO: 150- Sensor for > F159K_A160L VOXELOTORSEQ ID NO: 151- Sensor for > F159K V164M CARBIMAZOLESEQ ID NO: 152- Sensor for > F159L 2 -HYDROXYBENZOPHENONE ANTHRACENE-9- CARBOXYLIC ACID 2-AMINOPYRIMIDINESEQ ID NO: 153- Sensor for > F159L_A160F TETRACSEQ ID NO: 154- Sensor for > F159L_A160M CROTAMITON ORSELLINIC ACID, ETHYLESTER TRANS-ASARONE RILUZOLE COMBRETASTATIN A4SEQ ID NO: 155- Sensor for > F159L_A160S 2-HYDROXYBENZOPHENONESEQ ID NO: 156- Sensor for > F159L_N167D OLANEXIDINESEQ ID NO: 157- Sensor for > F159L_N167H ORSELLINIC ACID, ETHYL ESTERSEQ ID NO: 158- Sensor for > F159L_V163Q 6-BENZOYL -2 -NAPHTHOLSEQ ID NO: 159- Sensor for > F159L_V164N ALACHLORSEQ ID NO: 160- Sensor for > F159L_V164S Perfluoroheptanal hydrate (diol)SEQ ID NO: 161- Sensor for > F159M_A160I_N167Q 2-HYDROXY-9-FLUORENONESEQ ID NO: 162- Sensor for > F159M_A160M ESTRADIOLAtty Docket No. 690104.0046SEQ ID NO: 163- Sensor for > F159M_N167H BETANAPHTHOLSEQ ID NO: 164- Sensor for > F159M V164D 2-HYDROXY-9-FLUORENONESEQ ID NO: 165- Sensor for > F159M_V164L AMIPROPHOS METHYL 2-HYDROXY-9- FLUORENONE ANTHRACENE-9-CARBOXYLIC ACID IBUDILASTSEQ ID NO: 166- Sensor for > F159N_V163M_N167Y EFAVIRENZSEQ ID NO: 167- Sensor for > F159Q_N167Y EFAVIRENZSEQ ID NO: 168- Sensor for > F159S 6-BENZOYL-2 -NAPHTHOLSEQ ID NO: 169- Sensor for > F159S_A160G PYRACLOSTROBINSEQ ID NO: 170- Sensor for > F159S_A160I 2 -METHOXYESTRADIOL ETOFIBRATESEQ ID NO: 171 - Sensor for > F159S_A160L WIN-552122SEQ ID NO: 172- Sensor for > F159S_A160L_N167T WIN-552122SEQ ID NO: 173- Sensor for > F159S_A160L_N167V PICOXYSTROBINSEQ ID NO: 174- Sensor for > F159S_A160M WIN-552122SEQ ID NO: 175- Sensor for > F159S N167D DEHYDRO ANDROGRAPHOLIDESEQ ID NO: 176- Sensor for > F159S_V163Q 7-NITROINDAZOLESEQ ID NO: 178- Sensor for > F159T ALFATRADIOL PRANOPROFEN DANTHRON IBUPROFEN PICONOLSEQ ID NO: 179- Sensor for > F159T_A160G PYRACLOSTROBINSEQ ID NO: 180- Sensor for > F159T_A160I_N167V PICOXYSTROBINSEQ ID NO: 181- Sensor for > F159T_A160L_V164W TRICLABENDAZOLESEQ ID NO: 182- Sensor for > F159T_A160M DANTHRONSEQ ID NO: 183- Sensor for > F159T_A160M_N167T COMBRETASTATIN A4SEQ ID NO: 184- Sensor for > F159T_N167G ISTRADEFYLLINE 4- HYDROXYBENZOPHENONESEQ ID NO: 185- Sensor for > F159T_N167H PROPYLPARABEN 4- HYDROXYBENZOPHENONE MONOBENZONESEQ ID NO: 186- Sensor for > F159T_N167Q 6-BENZOYL -2 -NAPHTHOLSEQ ID NO: 187- Sensor for > F159T_V163W ALFATRADIOL 4- HYDROXYBENZOPHENONESEQ ID NO: 188- Sensor for > F159T_V164H MELITRACENSEQ ID NO: 189- Sensor for > F159T V164N WHILE OLIVETOL WIN-552122Atty Docket No. 690104.0046SEQ ID NO: 190- Sensor for > F159V_A160N_N167I DIMOXYSTROBINSEQ ID NO: 191- Sensor for > F159V_N167F MONOBENZONESEQ ID NO: 192- Sensor for > F159V_N167I PICOXYSTROBINSEQ ID NO: 193- Sensor for > F159V_N167V PICOXYSTROBIN FLAVONESEQ ID NO: 194- Sensor for > F159V_V163W_V164G ALFATRADIOL PRANOPROFENTOLMETIN FLAMPROP -METHYL 2 -HYDROXYBENZOPHENONE FLAVONE AUS-131SEQ ID NO: 195- Sensor for > F159V_V164Y DANTHRONSEQ ID NO: 196- Sensor for >I110A_L117M_F159V AMSACRINESEQ ID NO: 197- Sensor for >1110M F159H 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID NO: 198- Sensor for >I110R VALPROIC ACIDSEQ ID NO: 199- Sensor for >I110R A160S N167H VALPROIC ACIDSEQ ID NO: 200- Sensor for >I110T F159I DESOGESTRELSEQ ID NO: 201- Sensor for >I110T F159V V163W BUTYLPARABENSEQ ID NO: 202- Sensor for >I110W_F159V_N167Y BREXANOLONESEQ ID NO: 203- Sensor for > K59A FLUTAMIDESEQ ID NO: 204- Sensor for > K59A_A160G_V163W PENTOSALEN HEXYLRESORCINOLSEQ ID NO: 205- Sensor for > K59A_A89D_A160I GUANABENZSEQ ID NO: 206- Sensor for > K59A_E141F_V164S METHOXSALEN FLUTAMIDESEQ ID NO: 207- Sensor for > K59A_F159H_A160M DIHYDROCAPSAICINSEQ ID NO: 208- Sensor for > K59A_L87M_F159I PYRACLOSTROBIN MEBENDAZOLESEQ ID NO: 209- Sensor for > K59A_S122Q_F159H ZUCAPSAICINSEQ ID NO: 210- Sensor for > K59A_V163W_V164M PENTOSALENSEQ ID NO: 211- Sensor for > K59A_V81I_N167S FLUTAMIDESEQ ID NO: 212- Sensor for > K59A_V81I_V83L_F108W_A160I_V163W_V164S_N167DScopoletinSEQ ID NO: 213- Sensor for > K59A_V81I_V83L_F108W_S122N_A160V_V163W_V164FIsopsoralenSEQ ID NO: 214- Sensor for > K59A_V81I_V83L_F108W_Y120M_F159H_A160I_V163WBergapten 7-MethoxycoumarinSEQ ID NO: 215- Sensor for > K59A_V81I_V83L_F108W_Y120M_S122N_A160V_V163W_V164E 5,7-Dihydroxy-4-methylcoumarinAtty Docket No. 690104.0046SEQ ID NO: 216- Sensor for > K59A_V81I_V83L_S122E_A160I_V163W_V164S BergaptenSEQ ID NO: 217- Sensor for > K59A_V81I_V83L_S122E_F159I_A160I_V163W BergaptenSEQ ID NO: 218- Sensor for > K59A_V81I_V83L_Y120M_A160V_V163W_N167D PsoralenSEQ ID NO: 219- Sensor for > K59A_V81I_V83L_Y120M_S122E_F159H_A160V_V163W 7-MethoxycoumarinSEQ ID NO: 220- Sensor for > K59A_V81I_Y120M_S122E_A160M_V163W_V164FMethoxsalenSEQ ID NO: 221- Sensor for > K59A_V81M_L87F_E94D_A160L ETOMIDATESEQ ID NO: 222- Sensor for > K59A_V83F_L117G S122N CYCLOATESEQ ID NO: 223- Sensor for > K59A_V83L_A160I_V163W_V164F IsopsoralenSEQ ID NO: 224- Sensor for > K59A_V83L_F108W_S122N_A160V_V164F ScopoletinSEQ ID NO: 225- Sensor for > K59A_V83L_F108W_Y120M_F159H_A160V_V163W 7- MethoxycoumarinSEQ ID NO: 226- Sensor for > K59A_V83L_F108W_Y120M_S122N_A160I_V163W_V164E5,7-Dihydroxy-4-methylcoumarinSEQ ID NO: 227- Sensor for > K59A_V83L_F108W_Y120M_S122N_A160V_V163W_V164E5,7-Dihydroxy-4-methylcoumarinSEQ ID NO: 228- Sensor for > K59A_V83L_F108W_Y120M_S122N_F159H_A160I_V163W BergaptenSEQ ID NO: 229- Sensor for > K59A_V83L_S122N_A160I_V163W_V164S IsopsoralenSEQ ID NO: 230- Sensor for > K59A_Y120F_F159V TRICLABENDAZOLESEQ ID NO: 231- Sensor for > K59D_A160V DEXMEDETOMIDINE MEDETOMIDINESEQ ID NO: 232- Sensor for > K59D_A89I DEXMEDETOMIDINE MEDETOMIDINESEQ ID NO: 233- Sensor for > K59D_A89I_F159T PHENAZOPYRIDINESEQ ID NO: 234- Sensor for > K59D_A89I_F159V PHENAZOPYRIDINESEQ ID NO: 235- Sensor for > K59D_A89I_S122Q_F159V PHENAZOPYRIDINESEQ ID NO: 236- Sensor for > K59D_E141I_A160V TIOXOLONE FLAVONEBICALUTAMIDE FLUTAMIDE CHLOROXYLENOLSEQ ID NO: 237- Sensor for > K59D_E141T_A160I PENTOSALENSEQ ID NO: 238- Sensor for > K59D_E141T_V163W RAC-3 -N-BUTYLPHTHALIDESEQ ID NO: 239- Sensor for > K59D_I110A A160L DIFLUCORTOLONE 21-VALERATESEQ ID NO: 240- Sensor for > K59D_I110A A160M DIFLUCORTOLONE 21-VALERATEAtty Docket No. 690104.0046SEQ ID NO: 241- Sensor for > K59D_I110T_S122V CINACALCETSEQ ID NO: 242- Sensor for > K59D_L117A_F159I CINACALCETSEQ ID NO: 243- Sensor for > K59D_L117M_V164I CINACALCETSEQ ID NO: 244- Sensor for > K59D_L87I_A160I DEXMEDETOMIDINESEQ ID NO: 245- Sensor for > K59D_L87M_E94D_F108W ATIPAMEZOLESEQ ID NO: 246- Sensor for > K59D_V163W_V164H OXCARBAZEPINESEQ ID NO: 247- Sensor for > K59D_V81L_V164L DEXMEDETOMIDINESEQ ID NO: 248- Sensor for > K59D_V83I_L87I_E141T_A160V_V163W_V164N_N167V 2,4,6-TrinitrotolueneSEQ ID NO: 249- Sensor for > K59D_Y120F_V164I CINACALCETSEQ ID NO: 250- Sensor for > K59D_Y120G_S122M CINACALCETSEQ ID NO: 251- Sensor for > K59D_Y120G_V164F CINACALCETSEQ ID NO: 252- Sensor for > K59D_Y120L_A160L DIFLUCORTOLONE 21-VALERATESEQ ID NO: 253- Sensor for > K59E_A89D GUANABENZSEQ ID NO: 254- Sensor for > K59E_A89I AMITRAZSEQ ID NO: 255- Sensor for > K59E_A89M_Y120A_S122V PENTOSALENSEQ ID NO: 256- Sensor for > K59E_V81L_A89F MEDETOMIDINESEQ ID NO: 257- Sensor for > K59E_V83M_Y120A RILUZOLESEQ ID NO: 258- Sensor for > K59E_Y120A CINACALCETSEQ ID NO: 259- Sensor for > K59E_Y120A_F159I CINACALCETSEQ ID NO: 260- Sensor for > K59E_Y120S CINACALCETSEQ ID NO: 261- Sensor for > K59L FLUTAMIDESEQ ID NO: 262- Sensor for > K59L_A89F_Y120L_S122L_A160I N- MethylperfluorobutanesulfonamideSEQ ID NO: 263- Sensor for > K59L_A89F_Y120T_S122L_A160V_V164L N- MethylperfluorobutanesulfonamideSEQ ID NO: 264- Sensor for > K59L_A89W_F159T BERGAPTENSEQ ID NO: 265- Sensor for > K59L_A89W_Y120H ACETAMIPRIDSEQ ID NO: 266- Sensor for > K59L_E94A_Y120S_S122W_A160M Perfluorooctanoic acidSEQ ID NO: 267- Sensor for > K59L_E94D_E141K_F159H_A160M 1H,1H,9H- Hexadecafluorononan- 1 -olAtty Docket No. 690104.0046SEQ ID NO: 268- Sensor for > K59L_E94D_E141Q_F159H_A160M 1H,1H,9H- Hexadecafluorononan- 1 -olSEQ ID NO: 269- Sensor for > K59L_E94D_F159H_V164M 1H,1H,10H,10H-Perfluoro-I,10-decanediolSEQ ID NO: 270- Sensor for > K59L_E94D_Y120L_E141G_F159H_V164K 1H,1H,1OH,1OH-Perfluoro- 1, 10-decanediolSEQ ID NO: 271- Sensor for > K59L E94D Y120M E141G F159H A160V 1H,1H,8H,8H- Dodecafluoro-l,8-octanediol 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID NO: 272- Sensor for > K59L_E94D_Y120M_S122L_F159H_A160I 1H,1H,8H,8H-Dodecafluoro- 1, 8-octanediolSEQ ID NO: 273- Sensor for > K59L_E94S_Y120G_S122L_F159H_V164K Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 274- Sensor for > K59L_F159V_A160M MELITRACENSEQ ID NO: 275- Sensor for > K59L_L87F_S92L_E94G BENZBROMARONESEQ ID NO: 276- Sensor for > K59L_L87M NITRENDIPINESEQ ID NO: 277- Sensor for > K59L_L87M_F159V NIMODIPINESEQ ID NO: 278- Sensor for > K59L_V83I_F159V PRANOPROFENSEQ ID NO: 279- Sensor for > K59L_V83I_S122R_E141Q_A160W_V164L 1H,1H,2H,3H,3H-Perfluorononane- 1,2-diolSEQ ID NO: 280- Sensor for > K59L_V83I_Y120M_E141Q_A160I_V164W N- MethylperfluorobutanesulfonamideSEQ ID NO: 281- Sensor for > K59L_V83L_L117D CYCLOATESEQ ID NO: 282- Sensor for > K59L_Y120L_S122R_A160V_V164K 1H,1H,9H- Hexadecafluorononan- 1 -olSEQ ID NO: 283- Sensor for > K59M_A89M_Y120L DIOXYBENZONESEQ ID NO: 284- Sensor for > K59M_E141KN-MethylperfluorobutanesulfonamideSEQ ID NO: 285- Sensor for > K59M_E94A_E141G_V164K PerfluorohexanesulfonamideSEQ ID NO: 286- Sensor for > K59M_E94A_E141K PerfluorohexanesulfonamideSEQ ID NO: 287- Sensor for > K59M_E94A_E141Q_F159L_V164M 2H-Perfluoro-2-octenoic acidSEQ ID NO: 288- Sensor for > K59M_E94A_S122L_E141Q_A160L_V164SPerfluorohexanesulfonamideSEQ ID NO: 289- Sensor for > K59M_E94A_S122W_E141G_A160L_V164SPerfluorohexanesulfonamideAtty Docket No. 690104.0046SEQ ID NO: 290- Sensor for > K59M_E94A_Y120A_E141G_A160M_V164WPerfluorooctanoic acidSEQ ID NO: 291- Sensor for > K59M_E94A_Y120A_E141Q_A160M_V164WPerfluorohexanesulfonic AcidSEQ ID NO: 292- Sensor for > K59M_E94A_Y120A_S122L_A160V Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 293- Sensor for > K59M E94A Y120L A160L V164W Perfluorooctanoic acidSEQ ID NO: 294- Sensor for > K59M_E94A_Y120L_A160V_V164WPerfluorooctanesulfonamideSEQ ID NO: 295- Sensor for > K59M_E94A_Y120L_E141G_A160V_V164WPerfluorohexanesulfonic AcidSEQ ID NO: 296- Sensor for > K59M_E94A_Y120L_E141G_F159I_V164WPerfluorooctanesulfonic acidSEQ ID NO: 297- Sensor for > K59M_E94A_Y120L_E141G_F159L_V164WPerfluorooctanesulfonamideSEQ ID NO: 298- Sensor for > K59M_E94A_Y120L_E141Q_A160I_V164W Perfluorooctanoic acidSEQ ID NO: 299- Sensor for > K59M_E94A_Y120L_S122L_A160V_V164L Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 300- Sensor for > K59M_E94A_Y120M_E141G_F159I_V164W 9- Chlorohexadecafluorononanoic AcidSEQ ID NO: 301- Sensor for > K59M E94A Y120M E141G F159L V164W 9-Chlorohexadecafluorononanoic AcidSEQ ID NO: 302- Sensor for > K59M_E94D_A160L ETOMIDATESEQ ID NO: 303- Sensor for > K59M_E94D_E141Q_F159H 1H,1H,10H,10H-Perfluoro-I,10-decanediolSEQ ID NO: 304- Sensor for > K59M_E94D_F108RFLAMPROP-METHYLSEQ ID NO: 305- Sensor for > K59M_E94D_F159H_A160L 1H,1H,8H-Perfluorooctan-1-olSEQ ID NO: 306- Sensor for > K59M_E94D_F159H_A160V 1H,1H,9H-Hexadecafluorononan-l-olSEQ ID NO: 307- Sensor for > K59M_E94D_S122L_E141Q_F159H_A160N 1H,1H,8H,8H- Dodecafluoro-1,8-octanediolSEQ ID NO: 308- Sensor for > K59M_E94D_S122L_F159H_A160L 1H,1H,6H,6H-Perfluoro- 1,6-hexandiolAtty Docket No. 690104.0046SEQ ID NO: 309- Sensor for > K59M_E94D_S122W_E141G_F159H_A160M 1H,1H,9H-Hexadecafluorononan- 1 -olSEQ ID NO: 310- Sensor for > K59M_E94D_Y120A_E141G_F159H_A160L 1H,1H,8H- Perfluorooctan- 1 -olSEQ ID NO: 311- Sensor for > K59M_E94D_Y120A_E141G_F159L_V164L 1H,1H,2H,3H,3H- Perfluorononane- 1,2-diolSEQ ID NO: 312- Sensor for > K59M E94D Y120A S122W F159H A160I 1H,1H,1OH,1OH- Perfluoro- 1, 10-decanediolSEQ ID NO: 313- Sensor for > K59M_E94D_Y120I_S122W_A160I_V164LPerfluorooctanesulfonic acidSEQ ID NO: 314- Sensor for > K59M_E94D_Y120L_E141Q_F159H_A160M 1H,1H,8H- Perfluorooctan- 1 -olSEQ ID NO: 315- Sensor for > K59M_E94D_Y120L_S122L_F159H_A160N 1H,1H,8H,8H- Dodecafluoro- 1, 8-octanediolSEQ ID NO: 316- Sensor for > K59M_E94D_Y120L_S122W_F159H_A160V 1H,1H,9H,9H- Perfluoro-l,9-nonanediolSEQ ID NO: 317- Sensor for > K59M_E94D_Y120M_E141Q_F159H_A160M 1H,1H,9H- Hexadecafluorononan- 1 -olSEQ ID NO: 318- Sensor for > K59M_E94D_Y120M_F159H_A160V 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID NO: 319- Sensor for > K59M_E94D_Y120M_S122W_F159H_A160L 1H,1H,8H- Perfluorooctan- 1 -olSEQ ID NO: 320- Sensor for > K59M_E94D_Y120M_S122W_V164L Perfluoroheptanal hydrate (diol)SEQ ID NO: 321- Sensor for > K59M_E94D_Y120T_E141Q_F159H_A160I 1H,1H,8H,8H- Dodecafluoro- 1, 8-octanediolSEQ ID NO: 322- Sensor for > K59M_E94D_Y120T_E141Q_F159I_V164S 1H,1H,2H,3H,3H-Perfluorononane-1,2-diolSEQ ID NO: 323- Sensor for > K59M_E94G_V164K Perfluorooctanesulfonic acidSEQ ID NO: 324- Sensor for > K59M_E94G_Y120A_E141Q_A160L_V164WPerfluorooctanesulfonic acidSEQ ID NO: 325- Sensor for > K59M_E94G_Y120A_E141Q_A160V_V164WPerfluorooctanesulfonic acidSEQ ID NO: 326- Sensor for > K59M_E94G_Y120L_A160V_V164W Perfluorooctanesulfonic acidAtty Docket No. 690104.0046SEQ ID NO: 327- Sensor for > K59M_E94G_Y120L_E141G_A160I_V164W Perfluorooctanesulfonic acidSEQ ID NO: 328- Sensor for > K59M_E94G_Y120L_E141G_A160L_V164WPerfluorooctanesulfonic acid 3,5,6-trichlorooctafluorohexanoic acidSEQ ID NO: 329- Sensor for > K59M_E94G_Y120L_E141G_A160V_V164L Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 330- Sensor for > K59M E94G Y120L E141G A160V V164WPerfluorooctanoic acid Perfluorononanoic acid Perfluorodecanoic acid Perfluorooctanesulfonic acid Perfluorohexanesulfonic AcidSEQ ID NO: 331- Sensor for > K59M_E94G_Y120L_E141G_F159L_V164WPerfluorooctanesulfonamideSEQ ID NO: 332- Sensor for > K59M_E94G_Y120L_E141Q_A160I_V164WPerfluorooctanesulfonic acid Perfluorohexanesulfonic AcidSEQ ID NO: 333- Sensor for > K59M_E94G_Y120L_E141Q_A160L_V164WPerfluorooctanesulfonic acidSEQ ID NO: 334- Sensor for > K59M_E94G_Y120L_E141Q_A160V_V164K 3,5,6-trichlorooctafluorohexanoic acidSEQ ID NO: 335- Sensor for > K59M_E94G_Y120L_E141Q_A160V_V164L Perfluorooctanoic acidSEQ ID NO: 336- Sensor for > K59M E94G Y120L E141Q A160V V164WPerfluorooctanesulfonamideSEQ ID NO: 337- Sensor for > K59M_E94G_Y120L_E141Q_F159I_V164W Perfluorodecanoic acidSEQ ID NO: 338- Sensor for > K59M_E94G_Y120L_S122L_A160V Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 339- Sensor for > K59M_E94S_E141Q_F159L_A160N 2H,2H,3H,3H- Perfluorononanoic acidSEQ ID NO: 340- Sensor for > K59M_E94S_Y120G_E141G_A160V_V164K 2H,2H,3H,3H- Perfluorooctanoic acidSEQ ID NO: 341- Sensor for > K59M_E94S_Y120L_E141G_F159L_V164L 2H,2H,3H,3H- Perfluorononanoic acidSEQ ID NO: 342- Sensor for > K59M_E94S_Y120L_S122L_A160V_V164M Perfluoro-3,6,9-trioxatridecanoic acidSEQ ID NO: 343- Sensor for > K59M_E94S_Y120M_S122L_A160V 2H,2H,3H,3H- Perfluorooctanoic acidAtty Docket No. 690104.0046SEQ ID NO: 344- Sensor for > K59M_E94S_Y120T_E141K_F159L_V164M 2H,2H,3H,3H-Perfluorononanoic acidSEQ ID NO: 345- Sensor for > K59M_F108Y_F159I ETOMIDATESEQ ID NO: 346- Sensor for > K59M_F159H 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID NO: 347- Sensor for > K59M_L87M_Y120S_S122L_A160W_V164S N- MethylperfluorobutanesulfonamideSEQ ID NO: 348- Sensor for > K59M_L87M_Y120S_S122W_A160M_V164M N- MethylperfluorobutanesulfonamideSEQ ID NO: 349- Sensor for > K59M V81L F159A CAPSAICINSEQ ID NO: 350- Sensor for > K59M_V81T_F159A DIHYDROCAPSAICINSEQ ID NO: 351- Sensor for > K59M V83I E141T V163W V164N N167Q 2,4- Di nitrotolueneSEQ ID NO: 352- Sensor for > K59M_V83I_Y120L_E141Q_F159I_V164W N- MethylperfluorobutanesulfonamideSEQ ID NO: 353- Sensor for > K59M_V83I_Y120M_S122W_A160V_V164M N- MethylperfluorobutanesulfonamideSEQ ID NO: 354- Sensor for > K59M_Y120A_S122N CINACALCETSEQ ID NO: 355- Sensor for > K59M_Y120F_F159T CAPSAICINSEQ ID NO: 356- Sensor for > K59M_Y120F_V164S CHLOROXYLENOLSEQ ID NO: 357- Sensor for > K59M_Y120G ZUCAPSAICINSEQ ID NO: 358- Sensor for > K59M_Y120L PHENMEDIPHAMSEQ ID NO: 359- Sensor for > K59M_Y120L_S122L_A160M_V164W N- MethylperfluorobutanesulfonamideSEQ ID NO: 360- Sensor for > K59M_Y120S_S122M ZUCAPSAICINSEQ ID NO: 361- Sensor for > K59N TIOXOLONE 2'-HYDROXYCHALCONESEQ ID NO: 362- Sensor for > K59N_E141Q_F159H_A160L 1H,1H,6H,6H-Perfluoro-1,6-hexandiolSEQ ID NO: 363- Sensor for > K59N_E94A PerfluorohexanesulfonamideSEQ ID NO: 364- Sensor for > K59N_E94A_Y120L_A160L_V164W Perfluorooctanoic acidSEQ ID NO: 365- Sensor for > K59N_E94A_Y120L_E141Q_A160L_V164MPerfluorohexanesulfonamideSEQ ID NO: 366- Sensor for > K59N_E94A_Y120L_E141Q_F159I_V164W Perfluorooctanoic acidAtty Docket No. 690104.0046SEQ ID NO: 367- Sensor for > K59N_E94A_Y120L_S122L_A160M_V164W 2H,2H,3H,3H-Perfluoroheptanoic acidSEQ ID NO: 368- Sensor for > K59N_E94A_Y120M_S122L_A160V_V164M 2H,2H,3H,3H- Perfluoroheptanoic acidSEQ ID NO: 369- Sensor for > K59N_E94A_Y120M_S122L_F159L_V164W 2H,2H,3H,3H- Perfluorooctanoic acidSEQ ID NO: 370- Sensor for > K59N E94A Y120S E141K A160I V164G 2H,2H,3H,3H- Perfluoroheptanoic acidSEQ ID NO: 371- Sensor for > K59N_E94A_Y120T_E141Q_F159L_V164LPerfluorohexanesulfonamideSEQ ID NO: 372- Sensor for > K59N_E94D_E141G_F159H_V164W 1H,1H,8H,8H- Dodecafluoro- 1, 8-octanediolSEQ ID NO: 373- Sensor for > K59N_E94D_Y120A_E141G_F159I_V164S 1H,1H,2H,3H,3H- Perfluorononane-l,2-diolSEQ ID NO: 374- Sensor for > K59N_E94D_Y12OG_F159L V164M 1H,1H,2H,3H,3H- Perfluorononane-l,2-diolSEQ ID NO: 375- Sensor for > K59N_E94D_Y120G_S122W_A160L Perfluoroheptanal hydrate (diol)SEQ ID NO: 376- Sensor for > K59N_E94D_Y120L_S122W_A160I_V164S 1H,1H,2H,3H,3H-Perfluorononane- 1,2-diolSEQ ID NO: 377- Sensor for > K59N_E94D_Y120M_E141Q_F159I_V164W 1H,1H,2H,3H,3H- Perfluorononane- 1,2-diolSEQ ID NO: 378- Sensor for > K59N_E94D_Y120M_S122L_F159H_A160L 1H,1H,9H- Hexadecafluorononan- 1 -olSEQ ID NO: 379- Sensor for > K59N_E94D_Y120M_S122W_A160V_V164LPerfluoroheptanal hydrate (diol)SEQ ID NO: 380- Sensor for > K59N_E94D_Y120S_E141K_A160M_V164WPerfluoroheptanal hydrate (diol)SEQ ID NO: 381- Sensor for > K59N_E94D_Y120S_E141K_V164L 2H,2H,3H,3H- Perfluorohexanoic acidSEQ ID NO: 382- Sensor for > K59N_E94D_Y120S_E141Q_F159H_A160I 1H,1H,1OH,1OH- Perfluoro- 1, 10-decanediolSEQ ID NO: 383- Sensor for > K59N_E94D_Y120S_E141Q_F159L_V164L 1H,1H,2H,3H,3H-Perfluorononane- 1,2-diolSEQ ID NO: 384- Sensor for > K59N E94D Y120T E141K A160V V164W Perfluoroheptanal hydrate (diol)Atty Docket No. 690104.0046SEQ ID NO: 385- Sensor for > K59N_E94D_Y120T_E141Q_F159H_A160M 1H,1H,9H,9H-Perfluoro- 1,9-nonanediolSEQ ID NO: 386- Sensor for > K59N_E94D_Y120T_E141Q_V164L Perfluoroheptanal hydrate (diol)SEQ ID NO: 387- Sensor for > K59N_E94D_Y120T_F159H_A160V 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID NO: 388- Sensor for > K59N E94D Y120V S122L Perfluoroheptanal hydrate (diol)SEQ ID NO: 389- Sensor for > K59N_E94G_Y120L_E141Q_A160V_V164WPerfluorooctanesulfonamide 2H-Perfluoro-2-octenoic acid Perfluorohexanesulfonic AcidSEQ ID NO: 390- Sensor for > K59N_E94G_Y120T_E141K_F159L_V164MPerfluorohexanesulfonamideSEQ ID NO: 391- Sensor for > K59N_E94G_Y120T_E141Q PerfluorohexanesulfonamideSEQ ID NO: 392- Sensor for > K59N_E94S_A160V_V164G 2H-Perfluoro-2-octenoic acidSEQ ID NO: 393- Sensor for > K59N_E94S_F159L 2H,2H,3H,3H-Perfluorononanoic acidSEQ ID NO: 394- Sensor for > K59N_E94S_Y120L_A160I_V164W 2H,2H,3H,3H- Perfluorooctanoic acidSEQ ID NO: 395- Sensor for > K59N_E94S_Y120L_E141G_F159L_V164W 2H-Perfluoro-2-octenoic acidSEQ ID NO: 396- Sensor for > K59N_E94S_Y120L_E141K_A160I_V164K 2H,2H,3H,3H- Perfluoroheptanoic acidSEQ ID NO: 397- Sensor for > K59N_E94S_Y120L_E141K_A160V_V164W 2H-Perfluoro-2-octenoic acidSEQ ID NO: 398- Sensor for > K59N_E94S_Y120M_E141Q_F159L_V164W 2H,2H,3H,3H- Perfluorononanoic acidSEQ ID NO: 399- Sensor for > K59N_E94S_Y120M_S122L_A160M_V164W 2H,2H,3H,3H- Perfluorohexanoic acidSEQ ID NO: 400- Sensor for > K59N_E94T_Y120A_S122W_V164M 2H,2H,3H,3H-Perfluoroheptanoic acidSEQ ID NO: 401- Sensor for > K59N_L117W V164K CHLOROXYLENOLSEQ ID NO: 402- Sensor for > K59N_L117W_Y120F_F159M_A160V_N167Q 4-amino-2,6- DinitrotolueneSEQ ID NO: 403- Sensor for > K59N_L87F_F159T COMBRETASTATIN A4SEQ ID NO: 404- Sensor for > K59N_L87I_F159T FLAVONESEQ ID NO: 405- Sensor for > K59N_L87M_L117H CYCLOATEAtty Docket No. 690104.0046SEQ ID NO: 406- Sensor for > K59N_S122M_F159T MONOBENZONESEQ ID NO: 407- Sensor for > K59N_V81I_F159T_V163M CHLOROXYLENOLSEQ ID NO: 408- Sensor for > K59N_V81I_V83I_Y120F_E141T_V163W_V164N_N167Q 2,4-DinitrotolueneSEQ ID NO: 409- Sensor for > K59N_V81T_F159I NORETHINDRONE PRASTERONESEQ ID NO: 410- Sensor for > K59N_V81 Y V163M METHANDROSTENOLONESEQ ID NO: 411- Sensor for > K59N_V83I_A89M_S122E_A160V_V164L_N167V P-CresolSEQ ID NO: 412- Sensor for > K59N_V83I_L87I_Y120F_E141I_V163W_V164N_N167V 2-amino-4,6-DinitrotolueneSEQ ID NO: 413- Sensor for > K59N_V83L_E94M_F159L_V164D LATHYROLSEQ ID NO: 414- Sensor for > K59N_V83L_E94Q_V164M LESINURADSEQ ID NO: 415- Sensor for > K59N_Y120F_E141I_V163W_V164N_N167V 2,4,6- Trinitrotoluene 2,4-DinitrotolueneSEQ ID NO: 416- Sensor for > K59N_Y120L_E141Q_F159H_V164W 1H,1H,6H,6H-Perfluoro-1,6-hexandiolSEQ ID NO: 417- Sensor for > K59N_Y120L_F159H_V164W 1H,1H,6H,6H-Perfluoro-1,6-hexandiolSEQ ID NO: 418- Sensor for > K59N_Y120L_S122W_A160V_V164MPerfluorobutylsulfonamideSEQ ID NO: 419- Sensor for > K59N_Y120M_A160L_V164M PerfluorobutylsulfonamideSEQ ID NO: 420- Sensor for > K59N_Y120M_A160L_V164W PerfluorobutylsulfonamideSEQ ID NO: 421- Sensor for > K59N_Y120S_E141K_A160V PerfluorobutylsulfonamideSEQ ID NO: 422- Sensor for > K59Q_F159A_V163M GUANABENZSEQ ID NO: 423- Sensor for > K59Q_F159L_V164E RILUZOLESEQ ID NO: 424- Sensor for > K59Q_F159T_V164H DIHYDROCAPSAICINSEQ ID NO: 425- Sensor for > K59Q_F159V GUANABENZSEQ ID NO: 426- Sensor for > K59Q_L117H F159L CARPROPAMIDSEQ ID NO: 427- Sensor for > K59Q_L87M_V163W RAC-3 -N-BUTYLPHTHALIDESEQ ID NO: 428- Sensor for > K59Q_V164F GUANABENZSEQ ID NO: 429- Sensor for > K59Q_V81I_F108W_Y120A_S122E_A160M_V163W_V164F MethoxsalenSEQ ID NO: 430- Sensor for > K59Q_V81I_F108W_Y120M_A160M_V163W_V164S OstholeAtty Docket No. 690104.0046SEQ ID NO: 431- Sensor for > K59Q_V81I_F108W_Y120M_S122E_V163W_V164FMethoxsalenSEQ ID NO: 432- Sensor for > K59Q_V81I_S122N_A160G_V163W_V164S OstholeSEQ ID NO: 433- Sensor for > K59Q_V81I_V83L_A160I_V163W PsoralenSEQ ID NO: 434- Sensor for > K59Q_V81I_V83L_A160I_V163W_V164S IsopsoralenSEQ ID NO: 435- Sensor for > K59Q_V81I_V83L_F108W_A160I_V163W_V164S Scopoletin PsoralenSEQ ID NO: 436- Sensor for > K59Q_V81I_V83L_F108W_S122G_A160I_V163W_V164S ScopoletinSEQ ID NO: 437- Sensor for > K59Q_V81I_V83L_F108W_V164F ScopoletinSEQ ID NO: 438- Sensor for > K59Q V81I V83L F108W Y120A A160G V164F ScopoletinSEQ ID NO: 439- Sensor for > K59Q_V81I_V83L_F108W_Y120M_A160I_V163W_V164FScopoletin 4-MethylumbelliferoneSEQ ID NO: 440- Sensor for> K59Q V81 I V83L F 108W_Y 120M_S 122E_F 159H_A 160I_V 163 W_V 164E B ergaptenSEQ ID NO: 441- Sensor for > K59Q_V81I_V83L_S122G_A160I_V163W_V164S ScopoletinSEQ ID NO: 442- Sensor for > K59Q_V81I_V83L_S122N_A160I_V163W_V164E 4- MethylumbelliferoneSEQ ID NO: 443- Sensor for > K59Q_V81I_V83L_Y120M_S122E_A160M_V163W_V164E PsoralenSEQ ID NO: 444- Sensor for > K59Q_V81I_Y120A_S122E_A160M_V163W_V164FMethoxsalen OstholeSEQ ID NO: 445- Sensor for > K59Q_V81I_Y120M_S122E_A160I_V163W_V164FMethoxsalenSEQ ID NO: 446- Sensor for > K59Q_V81L_F159L RILUZOLESEQ ID NO: 447- Sensor for > K59Q_V81L_V163W RAC-3-N-BUTYLPHTHALIDESEQ ID NO: 448- Sensor for > K59Q_V81M_F159V_V163W PENTOSALENSEQ ID NO: 449- Sensor for > K59Q_V83A_F159L CYPROTERONE ACETATECLOMIPRAMINESEQ ID NO: 450- Sensor for > K59Q_V83L_F108W_A160I_Vl 63 W_V164S IsopsoralenScopoletinSEQ ID No: 451: - Sensor for> K59Q V83L F108W F159H A160I V163WBergaptenSEQ ID No: 452: - Sensor for> K59Q_V83L_F108W_S122E_F159H_A160I_Vl 63 W Bergapten SEQ ID No: 453: - Sensor for> K59Q_V83L_F108W_Y120M_F159H_A1601_V163W Psoralen SEQ ID No: 454: - Sensor for> K59Q V83L Y120M S122N F159H A160I V163W PsoralenAtty Docket No. 690104.0046SEQ ID No: 455: - Sensor for>K59Q_V83Y_L117H PENTOSALENSEQ ID No: 456: - Sensor for> K59Q_Y120A_S122N_A160M_V163W_V164F OstholeSEQ ID No: 457: - Sensor for> K59R_A89T 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID No: 458: - Sensor for> K59R_F159H DIETHYLTOLUAMIDE ORSELLINIC ACID, ETHYL ESTER VANILLYL BUTYL ETHERSEQ ID No: 459: - Sensor for> K59R_F159I_V164M OXYTETRACYCLINESEQ ID No: 460: - Sensor for>K59R_L117A_Y120W 2,6-DIHYDROXYBENZOIC ACIDSEQ ID No: 461: - Sensor for> K59R V164I N167H METHOXSALENSEQ ID No: 462: - Sensor for> K59R_V81I_F159S NONIVAMIDE IBUDILASTSEQ ID No: 463: - Sensor for> K59R_V81I_L87M_Ll 17W_Y120F_S122E_F159M_A160V_V163 G_V 164N 4-amino-2,6-DinitrotolueneSEQ ID No 464 - Sensor for> K59R_V81L_A160L CYCLOATESEQ ID No 465 - Sensor for> K59R_V81L_A89L_F159Q ARTEMETHERSEQ ID No 466 - Sensor for> K59R_V81T_N167T NORETHINDRONESEQ ID No 467 - Sensor for> K59R V83I A89G CLOMAZONESEQ ID No 468 - Sensor for> K59R_V83M DIETHYLTOLUAMIDESEQ ID No 469 - Sensor for>K59R_V83M_S122M DIETHYLTOLUAMIDESEQ ID No 470 - Sensor for> K59R_V83M_S92L_F159H DIETHYLTOLUAMIDESEQ ID No 471 - Sensor for> K59R_Y120A DIMOXYSTROBINSEQ ID No 472 - Sensor for> K59R_Y120S_S122I DIHYDROCAPSAICINSEQ ID No 473 - Sensor for> K59R_Y120W_F159H DIETHYLTOLUAMIDESEQ ID No 474 - Sensor for> K59S NICLOSAMIDESEQ ID No 475 - Sensor for> K59S_A160I_V164W VILDAGLIPTINSEQ ID No 476 - Sensor for>K59S_E141I_F159L RILUZOLESEQ ID No 477 - Sensor for>K59S_E141V NICLOSAMIDESEQ ID No 478 - Sensor for> K59S_E141V_V164H LINAGLIPTINSEQ ID No 479 - Sensor for> K59S_F108K_S122Q_N167D CHLOROBENZILATESEQ ID No 480 - Sensor for>K59S_F159I RILUZOLESEQ ID No 481 - Sensor for> K59S_F159Q_A160I TRICLABEND AZOLESEQ ID No 482 - Sensor for> K59S_L87F_A160L ETOMIDATESEQ ID No 483 - Sensor for>K59S_L87I_F159I RILUZOLESEQ ID No 484 - Sensor for> K59S_S122G_F159I RILUZOLESEQ ID No 485 - Sensor for> K59S_S122Q_N167D METHANDROSTENOLONESEQ ID No 486 - Sensor for> K59S V163W V164S EFAVIRENZSEQ ID No 487 - Sensor for> K59S_V81I_F108L METHOXSALENSEQ ID No 488 - Sensor for> K59S_V81T NORETHINDRONESEQ ID No 489 - Sensor for> K59S_V81T_A160L NORETHINDRONESEQ ID No 490 - Sensor for> K59S_V81T_F159L NORETHINDRONESEQ ID No 491 - Sensor for> K59S_V81T_N167D BOLDENONESEQ ID No 492 - Sensor for> K59S_V81T_V163W EFAVIRENZSEQ ID No 493 - Sensor for> K59S_V83L_F159T_N167Q PHENAZOPYRIDINESEQ ID No 494 - Sensor for> K59S_V83L_Ll 17N CYCLOATESEQ ID No 495 - Sensor for> K59T_F159T_A160L PICOXYSTROBINSEQ ID No 496 - Sensor for> K59T_L87M_A160G EFAVIRENZAtty Docket No. 690104.0046SEQ ID No: 497: - Sensor for> K59T_L87V_V163W RAC-3-N-BUTYLPHTHALIDESEQ ID No: 498: - Sensor for> K59T_V81I_V83I_Y120F_E141T_A160V_V163W_V164N_Nl67Q 2-amino-4,6-DinitrotolueneSEQ ID No 499 - Sensor for> K59T_V81T_F159L NORETHINDRONESEQ ID No 500 - Sensor for> K59T_Y120A_V164L ZUCAPSAICINSEQ ID No 501 - Sensor for> K59V FLUTAMIDESEQ ID No 502 - Sensor for> K59V_F159V BUTYLPARABENSEQ ID No 503 - Sensor for> Ll 17A lH,lH,8H,8H-Dodecafluoro-l,8-octanediolSEQ ID No 504 - Sensor for> Ll 17A F159L V164G MEDROXYPROGESTERONESEQ ID No 505 - Sensor for> Ll 17A F159V N167G PICOXYSTROBINSEQ ID No 506 - Sensor for> Ll 17A S122T F159I BOLDENONESEQ ID No 507 - Sensor for> Ll 17G Y120I 1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID No 508 - Sensor for> Ll 17G Y120W A160G CLOPIDOGRELSEQ ID No 509 - Sensor for> Ll 17H S122M F159V MONOBENZONESEQ ID No 510 - Sensor for> Ll 17M F159I V163W HEXESTROLSEQ ID No 511 - Sensor for> L 117M_F 159K V164T CARBIMAZOLESEQ ID No 512 - Sensor for> Ll 17M Y120F VI 641 LIOTHYRONINESEQ ID No 513 - Sensor for> L 117M_Y120G_S122T CYCLANDELATESEQ ID No 514 - Sensor for> L 117W_F159N_V164N FORMESTANESEQ ID No 515 - Sensor for> Ll 17W F159T V164G HEXYLRESORCINOLSEQ ID No 516 - Sensor for> L87F_F159Q NEVIRAPINESEQ ID No 517 - Sensor for> L87F_Y120T_F159V ETOMIDATESEQ ID No 518 - Sensor for> L87G_F159E lH,lH,2H,3H,3H-Perfluorononane-l,2-diolSEQ ID No 519 - Sensor for> L87I_A89M_Y120V DIOXYBENZONESEQ ID No 520 - Sensor for> L87I_F159A_A160L ACETOMENAPHTHONESEQ ID No 521 - Sensor for> L87I_F159M_V164H WHILE OLIVETOLSEQ ID No 522 - Sensor for> L87I_Ll 17W F159Q 2-AMINOPYRIMIDINESEQ ID No 523 - Sensor for> L87I_V164HNONIVAMIDESEQ ID No 524 - Sensor for> L87M ETHYLPARABEN METHYLPARABENPROPYLPARABEN 4-HYDROXYBENZOPHENONESEQ ID No: 525: - Sensor for> L87M_A160I_V163H FORMESTANESEQ ID No: 526: - Sensor for> L87M_E94G Perfluorooctanesulfonic acidSEQ ID No: 527: - Sensor for> L87M_E94T_Y120L_A160V_V164W 9- Chlorohexadecafluorononanoic AcidSEQ ID No: 528: - Sensor for> L87M_Ll 17W A160S PROPYLPARABENSEQ ID No: 529: - Sensor for> L87M Y120G V164E TAFLUPROSTSEQ ID No: 530: - Sensor for> L87V ETHYLPARABEN PROPYLPARABENSEQ ID No: 531: - Sensor for> L87V_Y120A_N167D CYCLANDELATESEQ ID No: 532: - Sensor for> N167D OLANEXIDINESEQ ID No: 533: - Sensor for> N167K 2-HYDROXY-9-FLUORENONESEQ ID No: 534: - Sensor for> N167Q CHLOROXYLENOLSEQ ID No: 535: - Sensor for> S122E_A160V_V163W OSTHOLESEQ ID No: 536: - Sensor for> S122E_F159A_N167V PICOXYSTROBINSEQ ID No: 537: - Sensor for> S122E_F159I_N167V PICOXYSTROBINSEQ ID No: 538: - Sensor for> S122E_F159I_V164H AMIPROPHOS METHYL WHILE OLIVETOL MELITRACENAtty Docket No. 690104.0046SEQ ID No 539: - Sensor for> S122G_A160M_V163W OSTHOLESEQ ID No 540: - Sensor for> S122G_F159H lH,lH,8H,8H-Dodecafluoro-l,8-octanediolSEQ ID No 541: - Sensor for> S122G_V163W_N167D PENTOSALENSEQ ID No 542: - Sensor for> S122I_A160S_V163W HEXYLRESORCINOLSEQ ID No 543: - Sensor for> S122I_F159V_V164E MONOBENZONESEQ ID No 544: - Sensor for> S122M FLUTAMIDESEQ ID No 545: - Sensor for> S122N_A160G_V163W_N167D ImperatorinSEQ ID No 546: - Sensor for> S122N_F159I_V164F OSTHOLESEQ ID No 547: - Sensor for> S122N_V163W_N167D MethoxsalenSEQ ID No 548: - Sensor for> S122Q A160V V163W RAC-3-N-BUTYLPHTHALIDE SEQ ID No 549: - Sensor for> S 122Q E 141T F159M KHELLINSEQ ID No 550: - Sensor for> S122Q_F159M AMIPROPHOS METHYLSEQ ID No 551: - Sensor for> S122V_A160I_N167I DICLAZURILSEQ ID No 552: - Sensor for> S92A_E94L 2H,2H,3H,3H-Perfluorononanoic acidSEQ ID No 553: - Sensor for> S92L THIOCTIC ACIDSEQ ID No 554: - Sensor for> S92L_E94G_N167D TOLBUTAMIDESEQ ID No 555: - Sensor for> V163H N167Y RAC-3-N-BUTYLPHTHALIDE IBUDILAST SEQ ID No 556: - Sensor for> V163M_N167Q YANGONINSEQ ID No 557: - Sensor for> V 163 W_N167D OSTHOLESEQ ID No 558: - Sensor for> Vl 63 W V164S HEXYLRESORCINOLSEQ ID No 559: - Sensor for> V164G_N167K KHELLINSEQ ID No 560: - Sensor for> V164HNONIVAMIDE WHILE OLIVETOLSEQ ID No 561: - Sensor for> V164H_N167D OLANEXIDINESEQ ID No 562: - Sensor for> V164I_N167E OLANEXIDINESEQ ID No 563: - Sensor for> V164L_N167V EUGENOL FLUFENAMIC ACID 2- HYDROXY-9-FLUORENONE EFAVIRENZ CHLOROXYLENOL 5-BROMO-2- HYDROXYBENZOPHENONESEQ ID No: 564: - Sensor for> V164S_N167K KHELLINSEQ ID No: 565: - Sensor for> V164S_N167Q CHLOROXYLENOLSEQ ID No: 566: - Sensor for> V164T KHELLINSEQ ID No: 567: - Sensor for> V164T_N167V EFAVIRENZSEQ ID No: 568: - Sensor for> V81I TIOXOLONESEQ ID No: 569: - Sensor for> V81I_A160L METRONIDAZOLE BENZOATESEQ ID No: 570: - Sensor for> V81I_E94G_A160M DICLAZURILSEQ ID No: 571: - Sensor for> V81I_F159H PENTOSALENSEQ ID No: 572: - Sensor for> V81I_Ll 17A V164L LIOTHYRONINESEQ ID No: 573: - Sensor for> V81I_V164N ANGELICINSEQ ID No: 574: - Sensor for> V81I_V83L_F108W_S122G_F159H_V163W_V164F 7- MethoxycoumarinSEQ ID No: 575: - Sensor for> V81I_V83L_Y120M_A160G_V163W_N167D OstholeSEQ ID No: 576: - Sensor for> V81I_V83L_Y120M_S122E_A160G_V163W_N167D OstholeSEQ ID No: 577: - Sensor for> V81I_V83L_Y120M_S122G_F159H_A160I_V163W BergaptenSEQ ID No: 578: - Sensor for> V81I_V83L_Y120M_S122N_F159H_V163W_V164F 7- MethoxycoumarinSEQ ID No: 579: - Sensor for> V81I_Y120M_N167G FLUTAMIDESEQ ID No: 580: - Sensor for> V81I_Y120T_V164I DIHYDROCAPSAICINAtty Docket No. 690104.0046SEQ ID No 581: - Sensor for> V81L_A89I_N167F AMITRAZSEQ ID No 582: - Sensor for> V81L_E94D_F159H DIHYDROCAPSAICINSEQ ID No 583: - Sensor for> V81L_E94D_Y120A CINCHOPHENSEQ ID No 584: - Sensor for> V81L_E94D_Y120A_F159A_A160L FLUFENACETSEQ ID No 585: - Sensor for> V81L_F108K_Y120F BUDESONIDESEQ ID No 586: - Sensor for> V81L_F159S_Al 60V ACETOMENAPHTHONESEQ ID No 587: - Sensor for> V81L_Il 10R VALPROIC ACIDSEQ ID No 588: - Sensor for> V81L_Il 10R V164S VALPROIC ACIDSEQ ID No 589: - Sensor for> V81L_L87F_Ll 17A DIETHYLTOLUAMIDESEQ ID No 590: - Sensor for> V81L L87F S122V ETOMIDATESEQ ID No 591: - Sensor for> V81L_Nl 67V BENZYL CINNAMATESEQ ID No 592: - Sensor for> V81L_S92L_Y120G_N167G OXYTETRACYCLINESEQ ID No 593: - Sensor for> V81L_V83F_H10W_Y120M PRAZIQUANTELSEQ ID No 594: - Sensor for> V81L_V83L_F159G 2-HYDROXY-9-FLUORENONEKHELLINSEQ ID No: 595 - Sensor for> V81L_V83L_F159I_V164G PENTOSALENSEQ ID No: 596 - Sensor for> V81L Y120A V164M DIHYDROCAPSAICINSEQ ID No: 597 - Sensor for> V81L_Y120G_N167G HONOKIOL MAGNOLOLSEQ ID No: 598 - Sensor for> V81M_F1591 IBUPROFEN P1CONOLSEQ ID No: 599 - Sensor for> V81M_F159T_A160L ACETOMENAPHTHONESEQ ID No: 600 - Sensor for> V81M_Il 10R VALPROIC ACIDSEQ ID No: 601 - Sensor for> V81M_Il 10R F159I VALPROIC ACIDSEQ ID No: 602 - Sensor for> V81M_Y120G_V164L WHILE OLIVETOLSEQ ID No: 603 - Sensor for> V81M_Y120L_F159I IBUPROFEN PICONOLSEQ ID No: 604 - Sensor for> V81R_A89I_V164M LONIDAMINESEQ ID No: 605 - Sensor for> V81R_E94D_Ll 17M FLAMPROP -METHYLDEHYDRO ACETIC ACIDSEQ ID No: 606: - Sensor for> V81R_F108Y DEHYDRO ACETIC ACIDSEQ ID No: 607: - Sensor for> V81R_F159V ANTHRACENE-9-CARBOXYLIC ACIDANTHRONE 5-METHYLPHENAZIN-5-IUMSEQ ID No 608: - Sensor for> V81R_L87I_A89G MEFENAMIC ACIDSEQ ID No 609: - Sensor for> V81R_L87M DEHYDRO ACETIC ACIDSEQ ID No 610: - Sensor for> V81 R_S 122Q AMITRAZSEQ ID No 611: - Sensor for> V81R_S92L_F159I AMFONELIC ACIDSEQ ID No 612: - Sensor for> V81R_V83 A LONIDAMINESEQ ID No 613: - Sensor for> V81R V83F Y120S TOLBUTAMIDESEQ ID No 614: - Sensor for> V81R_V83H_A89G LONIDAMINESEQ ID No 615: - Sensor for> V81 R V831 DEHYDRO ACETIC ACIDSEQ ID No 616: - Sensor for> V81R_V83L LONIDAMINE ANGELICINSEQ ID No 617: - Sensor for> V81R_V83L_S122Q_F159V KETOPROFENSEQ ID No 618: - Sensor for> V81R_V83M LONIDAMINESEQ ID No 619: - Sensor for> V81R_V83M_A89I LONIDAMINESEQ ID No 620: - Sensor for> V81R_V83M_F 1591 DEXKETOPROFEN KETOPROFEN SEQ ID No 621: - Sensor for> V81R_V83M_F 159V KETOPROFENSEQ ID No 622: - Sensor for> V81T_A89G_E94Q DICLOFENAC BENZBROMARONE SEQ ID No 623: - Sensor for> V81T_A89M 3 -PHENYLPHENOLAtty Docket No. 690104.0046SEQ ID No: 624: - Sensor for> V81T_F108Y_S122E_F159I 6-BENZOYL-2-NAPHTHOLSEQ ID No: 625: - Sensor for> V81T_L87M_E94Q DICLOFENACSEQ ID No: 626: - Sensor for> V81T_S122E_F159I 6-BENZOYL-2-NAPHTHOLEVODIAMINESEQ ID No: 627 - Sensor for> V81T_Y120G_A160L CYCLANDELATESEQ ID No: 628 - Sensor for> V81Y ANGELIC INSEQ ID No: 629 - Sensor for> V81Y_A160I RAMELTEON ANGELICINSEQ ID No: 630 - Sensor for> V81Y_A160L RAC-3 -N-BUTYLPHTHALIDESEQ ID No: 631 - Sensor for> V81Y_A89F_Y120A CARPROPAMIDSEQ ID No: 632 - Sensor for> V81Y A89G FLUNIXINSEQ ID No: 633 - Sensor for> V81Y_A89G_A160I METHANDROSTENOLONECITROPTENSEQ ID No: 634: - Sensor for> V81Y_A89G_A160L METHANDROSTENOLONESEQ ID No: 635: - Sensor for> V81Y_A89G_A 160V FLUNIXINSEQ ID No: 636: - Sensor for> V81Y_A89G_F159S_A160I CITROPTENSEQ ID No: 637: - Sensor for> V81Y_E94D_F159H COMBRETASTATIN A4SEQ ID No: 638: - Sensor for> V81Y E94G Y120M AMSACRINESEQ ID No: 639: - Sensor for> V81Y_E94M_H 10A 3-AMINO-l,2,4-TRIAZOLE CARBOXYLIC ACIDSEQ ID No: 640: - Sensor for> V81Y_F108M_F159V DIHYDROCAPSAICINSEQ ID No: 641: - Sensor for> V81Y_F108Y_F159I CYCLOATE ANTHRONEACETOMENAPHTHONESEQ ID No: 642 - Sensor for> V81Y_F108Y_Y120A MEZLOCILLINSEQ ID No: 643 - Sensor for> V81Y_F159A DIETHYLTOLUAMIDESEQ ID No: 644 - Sensor for> V81Y_F159A_A160M DIETHYLTOLUAMIDESEQ ID No: 645 - Sensor for> V81 Y_F 1591 METYRAPONESEQ ID No: 646 - Sensor for> V81Y_F159I_V164N CAPSAICINSEQ ID No: 647 - Sensor for> V81Y_F159S DIHYDROCAPSAICIN NONIVAMIDESEQ ID No: 648 - Sensor for> V81Y_F159T CAPSAICIN NONIVAMIDE ZUCAPSAICINLISURIDESEQ ID No: 649: - Sensor for> V81Y_F159V ETOMIDATE CAPSAICINDIHYDROCAPSAICIN MOGUISTEINE NONIVAMIDE DIETHYLTOLUAMIDECYCLOATE ANTHRACENE-9-CARBOXYLIC ACID BENZOPHENONE DANTHRONMETYRAPONESEQ ID No: 650: - Sensor for> V81Y_F159V_V164E MELITRACENSEQ ID No: 651: - Sensor for> V81Y 1110A F159V ETOMIDATESEQ ID No: 652: - Sensor for> V81Y_L87I_Y120A CINCHOPHENSEQ ID No: 653: - Sensor for> V81Y_L87M DIETHYLTOLUAMIDE CYCLOATESEQ ID No: 654: - Sensor for> V81Y_L87M_F159L ACETOMEN APHTHONESEQ ID No: 655: - Sensor for> V81Y_L87M_Ll 17M ETHOPROPHOSSEQ ID No: 656: - Sensor for> V81Y_L87V_A160I ARTEMETHERSEQ ID No: 657: - Sensor for> V81Y_S122E LISURIDESEQ ID No: 658: - Sensor for> V81Y_S122E_F159V BENZOPHENONESEQ ID No: 659: - Sensor for> V81Y_S122Q_F159V ETOMIDATE LISURIDE METYRAPONESEQ ID No: 660: - Sensor for> V81Y_V164N RAC-3 -N-BUTYLPHTHALIDEAtty Docket No. 690104.0046SEQ ID No: 661 - Sensor for> V81Y_V83A FLUNIXINSEQ ID No: 662 - Sensor for> V81Y_V83L_A160I_V163W_N167D 4-MethylumbelliferoneSEQ ID No: 663 - Sensor for> V81Y_V83L_A160V_V163W_N167D 4-MethylumbelliferoneSEQ ID No: 664 - Sensor for> V81Y_V83L_F108W_S122G_A160I_V163W_N167D 4- MethylumbelliferoneSEQ ID No: 665: - Sensor for> V81Y_V83L_F108W_Y120M_S122E_F159H_A160I_V163WV164M CitroptenSEQ ID No: 666: - Sensor for> V81Y_V83L_S122E_A160V_V163W_N167D 4- MethylumbelliferoneSEQ ID No: 667: - Sensor for> V81Y V83L S122E F159V A160I V163W N167D CitroptenSEQ ID No: 668: - Sensor for> V81Y_V83L_S122G_A160V_V163W_N167D 4- MethylumbelliferoneSEQ ID No: 669: - Sensor for> V81Y_V83L_S122G_F159H_A160I_V163W CitroptenSEQ ID No: 670: - Sensor for> V81Y_V83L_Y 120M_A160I_V 163 W_N167D 4- MethylumbelliferoneSEQ ID No: 671: - Sensor for> V81Y_V83L_Y120M_F159H_A160I_V163W CitroptenSEQ ID No: 672: - Sensor for> V81Y V83L Y120M F159H A160I V163W V164S CitroptenSEQ ID No: 673: - Sensor for> V81Y_V83L_Y120M_S122E_A160V_V163W_V164F_N167D4-MethylumbelliferoneSEQ ID No 674: - Sensor for> V81Y_Y120G CYCLANDELATESEQ ID No 675: - Sensor for> V81Y_Y120G_V164T CYCLANDELATESEQ ID No 676: - Sensor for> V81Y_Y120S CYCLANDELATESEQ ID No 677: - Sensor for> V83 A F159L V163 W ETOMID ATESEQ ID No 678: - Sensor for> V83A_F159T_A160M PICOXYSTROBINSEQ ID No 679: - Sensor for> V83A_Y120A FLUFENACETSEQ ID No 680: - Sensor for> V83 A Y 120A S122E CARPROPAMIDSEQ ID No 681: - Sensor for> V83A_Y120G CARPROPAMIDSEQ ID No 682: - Sensor for> V83A_Y120G_V164L CARPROPAMIDSEQ ID No 683: - Sensor for> V83A_Y120S_A160I CARPROPAMIDSEQ ID No 684: - Sensor for> V83A_Y120W_F159L DIBUTYL PHTHALATESEQ ID No 685: - Sensor for> V83F_F159G S-ROLIPRAMSEQ ID No 686: - Sensor for> V83F_L117N_N167S CYCLOATESEQ ID No 687: - Sensor for> V83F_Ll 17N Y120S F159H CARPROPAMIDSEQ ID No 688: - Sensor for> V83F_L87I_A89M_S92G 2,4,6-TRIHYDROXYBENZOIC ACIDSEQ ID No: 689: - Sensor for> V83H E94G F108L LONIDAMINESEQ ID No: 690: - Sensor for> V83H_F108K_F 159V ZALTOPROFENSEQ ID No: 691: - Sensor for> V83H_Y120A CARPROPAMIDSEQ ID No: 692: - Sensor for> V83H_Y120S_F159I CARPROPAMIDSEQ ID No: 693: - Sensor for> V83H_Y120S_S122D CARPROPAMIDSEQ ID No: 694: - Sensor for> V83H_Y120T_S122T LONIDAMINESEQ ID No: 695: - Sensor for> V83I CHLOROXYLENOLSEQ ID No: 696: - Sensor for> V83I_A160M_V164M FLUTAMIDESEQ ID No: 697: - Sensor for> V83I_E94D_Y120A_S122L_F159H_A160V 1H,1H,9H,9H- Perfluoro- 1,9-nonanediolAtty Docket No. 690104.0046SEQ ID No: 698: - Sensor for> V83I_E94D_Y120M_F159H_V164W 1H,1H,9H- Hexadecafluorononan- 1 -olSEQ ID No: 699: - Sensor for> V83I_E94D_Y120M_S122W_F159H_A160V 1H,1H,1OH,1OH- Perfluoro- 1, 10-decanediolSEQ ID No: 700: - Sensor for> V83I_E94D_Y120N_S122W_F159H_A160M 1H,1H,8H,8H- Dodecafluoro- 1, 8-octanediolSEQ ID No: 701: - Sensor for> V83I_E94D_Y120S_S122L_F159H_A160I 1H,1H,1OH,1OH- Perfluoro- 1, 10-decanediolSEQ ID No: 702: - Sensor for> V83I_E94D_Y120S_S122L_F159H_A160L 1H,1H,9H,9H- Perfluoro- 1,9-nonanediolSEQ ID No: 703: - Sensor for> V83I_E94D_Y120S_S122W_F159H_A160M 1H,1H,1OH,1OH- Perfluoro- 1, 10-decanediolSEQ ID No: 704: - Sensor for> V83I_E94D_Y120T_S122W_F159H_A160L 1H,1H,9H,9H- Perfluoro-1,9-nonanediolSEQ ID No: 705: - Sensor for> V83I_E94G Perfluorooctanesulfonamide 3,5,6-trichlorooctafluorohexanoic acidSEQ ID No: 706: - Sensor for> V83I E94G Y120L A160L V164W Perfluorooctanesulfonic acidSEQ ID No: 707: - Sensor for> V831_E94G_Y120L_A160V_V164W Perfluorooctanoic acid 3,5,6-trichlorooctafluorohexanoic acid 2H-Perfluoro-2-octenoic acidSEQ ID No: 708: - Sensor for> V83I_E94G_Y120L_V164W Perfluorooctanesulfonamide 3,5,6-trichlorooctafluorohexanoic acidSEQ ID No: 709: - Sensor for> V83I_E94S_A160I_V164M Perfluoro-3, 6, 9-trioxatridecanoic acidSEQ ID No: 710: - Sensor for> V83I_E94S_Y120A 2H,2H,3H,3H-Perfluorohexanoic acidSEQ ID No: 711: - Sensor for> V83I_E94S_Y120A_E141Q_V164M 2H,2H,3H,3H- Perfluorohexanoic acidSEQ ID No: 712: - Sensor for> V83I_F108L_V164H EFAVIRENZSEQ ID No: 713: - Sensor for> V83I_L87M_N167Q PROPYLPARABEN TIOXOLONE CHLOROXYLENOLSEQ ID No: 714: - Sensor for> V83I_Y120A_V164F DIMOXYSTROBINSEQ ID No: 715: - Sensor for> V83I_Y120L_V164M FLUTAMIDESEQ ID No: 716: - Sensor for> V83I_Y120S_E141K_Fl 59L V164S PerfluorobutylsulfonamideSEQ ID No: 717: - Sensor for> V83K AMITRAZSEQ ID No: 718: - Sensor for> V83L RAC-3 -N-BUTYLPHTHALIDE EUGENOLTIOXOLONE ANGELIC IN PSORALEN SCOPOLETIN WHILE OLIVETOLSEQ ID No: 719 - Sensor for> V83L_E94M LONIDAMINE BENZBROMARONESEQ ID No: 720 - Sensor for> V83L_E94M_A160S LONIDAMINESEQ ID No: 721 - Sensor for> V83L_E94M_F159L_V164N LATHYROLSEQ ID No: 722 - Sensor for> V83L_E94Q LONIDAMINE HYDROXYZINESEQ ID No: 723 - Sensor for> V83L_E94Q_Y120H HYDROXYZINESEQ ID No: 724 - Sensor for> V83L_E94Q_Y120V OXANTELSEQ ID No: 725 - Sensor for> V83L_F108W_Y120M_S122E_F159H_A160V_V163W_V164E7 -Methoxy coumarinSEQ ID No: 726: - Sensor for> V83L_Fl 08W_Y120M_Sl 22G_F159H_A16OV_V163 W 7- MethoxycoumarinAtty Docket No. 690104.0046SEQ ID No: 727: - Sensor for> V83L_F159G_A160I DIETHYLTOLUAMIDESEQ ID No: 728: - Sensor for> V83L_F159G_A160M DIETHYLTOLUAMIDESEQ ID No: 729: - Sensor for> V83L_F159G_V164T TRICLABEND AZOLESEQ ID No: 730: - Sensor for> V83L_F159S_V164F PYRACLOSTROBINSEQ ID No: 731: - Sensor for> V83L_H 10A L117H NILVADIPINE FORMESTANESEQ ID No: 732: - Sensor for> V83L_H 10T Y120A LOXAPINESEQ ID No: 733: - Sensor for> V83L_H 10V METHOXSALENSEQ ID No: 734: - Sensor for> V83L_Ll 17D N167Q CYCLOATESEQ ID No: 735: - Sensor for> V83L_Ll 17D S122Q CYCLOATESEQ ID No: 736: - Sensor for> V83L_Ll 17G Y120F CYCLOATESEQ ID No: 737: - Sensor for> V83L_Ll 17H S122Q CYCLOATESEQ ID No: 738: - Sensor for> V83L_Ll 17M LIOTHYRONINESEQ ID No: 739: - Sensor for> V83L_Ll 17N CYCLOATESEQ ID No: 740: - Sensor for> V83L_L87M_E94M LONIDAMINESEQ ID No: 741: - Sensor for> V83L_S122D_F159G TRICLABEND AZOLESEQ ID No: 742: - Sensor for> V83L_Y120E CARPROPAMIDSEQ ID No: 743: - Sensor for> V83L Y120M S122E F159H V163W V164F 7-MethoxycoumarinSEQ ID No: 744: - Sensor for> V83L_Y120M_S122G_F159H_A160V_V163W 7-MethoxycoumarinSEQ ID No: 745: - Sensor for> V83L_Y120S CARPROPAMIDSEQ ID No: 746: - Sensor for> V83L_Y120T_V164E CARPROPAMIDSEQ ID No: 747: - Sensor for> V83L_Y120T_V164F DIMOXYSTROBIN METHOXSALEN SEQ ID No: 748: - Sensor for> V83M_Ll 17G_F159M SERATRODASTSEQ ID No: 749: - Sensor for> V83M_V163W_V164H RAC-3 -N-BUTYLPHTHALIDE SEQ ID No: 750: - Sensor for> V83M_Y120S CARPROPAMIDSEQ ID No: 751: - Sensor for> V83M_Y120S_S122E CARPROPAMIDSEQ ID No: 752: - Sensor for> V83M_Y120T CARPROPAMIDSEQ ID No: 753: - Sensor for> V83Q_S122K BUMETANIDESEQ ID No: 754: - Sensor for> V83Q_Y120A_F159I LAT ANOPROSTSEQ ID No: 755: - Sensor for> V83W_E94Q_Ll 17H A160G DEHYDRO ACETIC ACID SEQ ID No: 756: - Sensor for> V83W_F159A_A160L DIETHYLTOLUAMIDE 6-BENZOYL-2-NAPHTHOLSEQ ID No: 757: - Sensor for> V83W_F159A_V164F S-ROLIPRAMSEQ ID No: 758: - Sensor for> V83W_F159H PENTOSALENSEQ ID No: 759: - Sensor for> V83W_Ll 17K F159T FLAMPROP-METHYLSEQ ID No: 760: - Sensor for> V83Y_A89G_E94Q DICLOFENACSEQ ID No: 761: - Sensor for> V83Y_E94H TRINEXAPAC-ETHYLSEQ ID No: 762: - Sensor for> V83Y_E94Q TRINEXAPAC-ETHYLSEQ ID No: 763: - Sensor for> V83Y_F159A DIETHYLTOLUAMIDESEQ ID No: 764: - Sensor for> V83Y_F159G_N167Y IBUPROFEN PICONOLSEQ ID No: 765: - Sensor for> V83Y_Ll 17H_Y120S FLUFENACETSEQ ID No: 766: - Sensor for> V83Y_Ll 17N_N167D CYCLOATESEQ ID No: 767: - Sensor for> V83Y_Y120H_F159I PRAZIQUANTELSEQ ID No: 768: - Sensor for> V83Y_Y120L_A160G PRAZIQUANTELSEQ ID No: 769: - Sensor for> V83Y_Y120V_S122V OXANTELAtty Docket No. 690104.0046SEQ ID No: 770: - Sensor for> WT BENZYL CINNAMATESEQ ID No: 771: - Sensor for> Y120A CAPSAICIN DIHYDROCAPSAICIN NONIVAMIDE ZUCAPSAICIN DIMOXYSTROBIN LISURIDESEQ ID No: 772 - Sensor for> Y120A_A160G_V163W DIMOXYSTROBINSEQ ID No: 773 - Sensor for> Y120A_A160I_V164W MESTEROLONESEQ ID No: 774 - Sensor for> Y120A_A160V DIMOXYSTROBIN MEZLOCILLINSEQ ID No: 775 - Sensor for> Y120A_A160V_N167S CYCLANDELATESEQ ID No: 776 - Sensor for> Y120A_E141A N-MethylperfluorobutanesulfonamideSEQ ID No: 777 - Sensor for> Y120A_F159A_V164F DIMOXYSTROBINSEQ ID No: 778 - Sensor for> Y120A F159M DIMOXYSTROBINSEQ ID No: 779 - Sensor for> Y120A_F159S DIHYDROCAPSAICINSEQ ID No: 780 - Sensor for> Y120A_F159V_V164F PYRACLOSTROBIN CARB ARIL ANGELICINSEQ ID No: 781 - Sensor for> Y120A_Fl 59V V164W ESTRADIOL METHYL ETHERSEQ ID No: 782 - Sensor for> Y120A_N167H CYCLANDELATESEQ ID No: 783 - Sensor for> Y 120A_S122A Perfluoroheptanal hydrate (diol)SEQ ID No: 784 - Sensor for> Y120A S122D DIMOXYSTROBINSEQ ID No: 785 - Sensor for> Y120A_S122D_F159A ZUCAPSAICINSEQ ID No: 786 - Sensor for> Y120A_S122E DIMOXYSTROBINSEQ ID No: 787 - Sensor for> Y120A_S122G_A160V ZUCAPSAICINSEQ ID No: 788 - Sensor for> Y120A_S122M_V164T ZUCAPSAICINSEQ ID No: 789 - Sensor for> Y120A_S122N_A160M_V163W_N167D MethoxsalenSEQ ID No: 790 - Sensor for> Y120A_S122Q_A160I ZUCAPSAICINSEQ ID No: 791 - Sensor for> Y120A_S122T MEZLOCILLINSEQ ID No: 792 - Sensor for> Y120A_V164S Perfluoroheptanal hydrate (diol)SEQ ID No: 793 - Sensor for> Y120D_E141D N-MethylperfluorobutanesulfonamideSEQ ID No: 794 - Sensor for> Y120F_A160I_V164E SCLAREOLSEQ ID No: 795 - Sensor for> Y120F_F159A_N167S NONIVAMIDESEQ ID No: 796 - Sensor for> Y120F_F159G_A160G PYRACLOSTROBINSEQ ID No: 797 - Sensor for > Y120F_F159G_V164M MESTRANOLSEQ ID No: 798 - Sensor for> Y120F_F159H_V163W TRICLABEND AZOLESEQ ID No: 799 - Sensor for> Y120F_F159M 2 -HYDROXYBENZOPHENONESEQ ID No: 800 - Sensor for> Y120G DIHYDROCAPSAICINSEQ ID No: 801 - Sensor for> Y120G_A160G_V164F DIMOXYSTROBINSEQ ID No: 802 - Sensor for> Y120G_A160L CINCHOPHENSEQ ID No: 803 - Sensor for> Y120G Al 60L N 167 S CYCLANDELATESEQ ID No: 804 - Sensor for> Y 12OG_A160V FLUFEN ACETSEQ ID No: 805 - Sensor for> Y120G_F159A ZUCAPSAICINSEQ ID No: 806 - Sensor for> Y120G_F159I_A160L TAFLUPROSTSEQ ID No: 807 - Sensor for> Y120G_F159T CAPSAICIN DIHYDROCAPSAICINSEQ ID No: 808 - Sensor for> Y120G_S122Q_F159A LISURIDESEQ ID No: 809 - Sensor for> Y120G_S122T CYCLANDELATESEQ ID No: 810 - Sensor for> Y120H MAGNOLOLSEQ ID No: 811 - Sensor for > Y120H_A160G_N167H LATANOPROSTSEQ ID No: 812 - Sensor for> Y120H_E141V FLUFENAMIC ACID FLUTAMIDESEQ ID No: 813 - Sensor for> Y120H_F159I MONOBENZONEAtty Docket No. 690104.0046SEQ ID No 814: - Sensor for > Y120H_F159L MAGNOLOLSEQ ID No 815: - Sensor for > Y120H_F159V_V164E LAT ANOPROSTSEQ ID No 816: - Sensor for > Y120I_S122Q 2H,2H,3H,3H-Perfluorononanoic acidSEQ ID No 817: - Sensor for > Y120L_S122E_F159T IBUPROFEN PICONOLSEQ ID No 818: - Sensor for > Y120L_S122N CALCIPOTRIENESEQ ID No 819: - Sensor for> Y120M MAGNOLOLSEQ ID No 820: - Sensor for > Y 120M A160I N 1671 DICL AZURILSEQ ID No 821: - Sensor for> Y120M_F159A_V164M CAPSAICINSEQ ID No 822: - Sensor for> Y120M_F159G_A160I WIN-552122SEQ ID No 823: - Sensor for > Y120M F159T A160L MONOBENZONESEQ ID No 824: - Sensor for > MAGNOLOLSEQ ID No 825: - Sensor for > N-MethylperfluorobutanesulfonamideSEQ ID No 826: - Sensor for >1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID No 827: - Sensor for > PerfluorobutylsulfonamideSEQ ID No 828: - Sensor for> Y120S_E141L PerfluorohexanesulfonamideSEQ ID No 829: - Sensor for > PerfluorobutylsulfonamideSEQ ID No 830: - Sensor for > Perfluoroheptanal hydrate (diol)SEQ ID No 831: - Sensor for >lH,lH,2H,3H,3H-Perfluorononane-l,2-diolSEQ ID No 832: - Sensor for > Perfluoroheptanal hydrate (diol)SEQ ID No 833: - Sensor for > BOLDENONESEQ ID No 834: - Sensor for > CAPSAICINSEQ ID No 835: - Sensor for > LISURIDESEQ ID No 836: - Sensor for > N-Methylperfluorobutanesulfonamide MAGNOLOLSEQ ID No 837: - Sensor for > CALCIPOTRIENESEQ ID No 838: - Sensor for > PerfluorobutylsulfonamideSEQ ID No 839: - Sensor for >lH,lH,2H,3H,3H-Perfluorononane-l,2-diolSEQ ID No 840: - Sensor for>1H,1H,9H,9H-Perfluoro-1,9-nonanediolSEQ ID No 841: - Sensor for > DIHYDROCAPSAICIN ZUCAPSAICINSEQ ID No 842: - Sensor for > N0NIV AMIDE LISURIDESEQ ID No 843: - Sensor for > MAGNOLOLSEQ ID No 844: - Sensor for > MONOBENZONESEQ ID No 845: - Sensor for >lH,lH,2H,3H,3H-Perfluorononane-l,2-diolSEQ ID No 846: - Sensor for > MAGNOLOLSEQ ID No 847: - Sensor for > TETRACSEQ ID No 848: - Sensor for > PRANOPROFENSEQ ID No 849: - Sensor for > ALFATRADIOL BUTYLPARABEN PROPYLPARABEN 4- HYDROXYBENZOPHENONESEQ ID No: 850: - Sensor for > PRANOPROFENSEQ ID No: 851: - Sensor for > LYNESTRENOLSEQ ID NO: 853 -Wild-Type PYR1Atty Docket No. 690104.0046REFERENCES1. P. J. Carter, Potent antibody therapeutics by design. Nat. Rev. Immunol. 6, 343-357 (2006).2. N. D. Taylor, etal., Engineering an allosteric transcription factor to respond to new ligands.Nat. Methods 13, 177-183 (2016).3. K. K. Nishikawa, et al., Highly multiplexed design of an allosteric transcription factor to sense novel ligands. bioRxiv (2024).4. S. Dong, S. C. Rogan, B. L. Roth, Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs. Nat. Protoc. 5, 561-573 (print March 2010).5. B. Z. Stanton, E. J. Chory, G. R. Crabtree, Chemically induced proximity in biology and medicine. Science 359, eaao5902 (2018).6. S. L. Schreiber, The rise of molecular glues. Cell 184, 3-9 (2021).7. L. A. Banaszynski, L.-C. Chen, L. A. Maynard-Smith, A. G. L. Ooi, T. J. Wandless, A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126, 995-1004 (2006).8. M. Putyrski, C. Schultz, Protein translocation as a tool: The current rapamycin story. FEBS Letters 586, 2097–2105 (2012).9. A. A. Glasgow, et al., Computational design of a modular protein sense-response system.Science 366, 1024-1028 (2019).10. S. Lumba, S. Cutler, P. McCourt, Plant Nuclear Hormone Receptors: A Role for Small Molecules in Protein-Protein Interactions. Annu. Rev. Cell Dev. Biol. 26, 445-469 (2010).11. M. Y. Huang, M. J. Nalley, P. Hecht, H. D. Madhani, An auxin-inducible degron system for conditional mutation in the fungal meningitis pathogen Cryptococcus neoformans. G3 (Bethesda) (2025). https: / / doi.org / 10.1093 / g3journal / jkaf071.12. T. Miyamoto, et al., Rapid and Orthogonal Logic Gating with a Gibberellin-induced Dimerization System. Nature Chemical Biology 8, 465 (2012).13. F.-S. Liang, W. Q. Ho, G. R. Crabtree, Engineering the ABA Plant Stress Pathway for Regulation of Induced Proximity. Sci. Signal. 4, rs2 (2011).14. X. Tan, et al., Mechanism of auxin perception by the TIR1 ubiquitin ligase. Nature 446, 640-645 (2007).15. N. Shabek, et al., Structural plasticity of D3-D14 ubiquitin ligase in strigolactone signalling.Nature 563, 652-656 (2018).16. W. Wang, et al., Structural basis of salicylic acid perception by Arabidopsis NPR proteins.Nature 586, 311-316 (2020).17. J. Beltran, et al., Rapid biosensor development using plant hormone receptors asAtty Docket No. 690104.0046reprogrammable scaffolds. Nat. Biotechnol. (2022). https: / / doi.org / 10.1038 / s41587-022- 01364-5.18. S.-Y. Park, et al., Agrochemical control of plant water use using engineered abscisic acid receptors. Nature 520, 545-548 (2015).19. S.-Y. Park, et al., An orthogonalized PYRl-based CID module with reprogrammable ligandbinding specificity. Nat Chem Biol 20, 103-110 (2024).20. G. Zimran, E. Feuer, O. Pri-Tal, M. Shpilman, A. Mosquna, Directed Evolution of Herbicide Biosensors in a Fluorescence-Activated Cell-Sorting-Compatible Yeast Two-Hybrid Platform. ACS Synth Biol 11, 2880-2888 (2022).21. Y. Ma, et al., Regulators of PP2C Phosphatase Activity Function as Abscisic Acid Sensors.Science 324, 1064-1068 (2009).22. P. J. Steiner, et al., A Closed Form Model for Molecular Ratchet-Type Chemically Induced Dimerization Modules. Biochemistry acs.biochem.2c00172 (2022).23. J. Pu, J. Zinkus-Boltz, B. C. Dickinson, Evolution of a split RNA polymerase as a versatile biosensor platform. Nat. Chem. Biol. 13, 432-438 (2017).24. Y. Cao, A. Charisi, L.-C. Cheng, T. Jiang, T. Girke, ChemmineR: a compound mining framework for R. Bioinformatics 24, 1733-1734 (2008).25. T. W. H. Backman, Y. Cao, T. Girke, ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 39, W486-91 (2011).26. A. Gaulton, etal., ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100–7 (2012).27. G. R. Bickerton, G. V. Paolini, J. Besnard, S. Muresan, A. L. Hopkins, Quantifying the chemical beauty of drugs. Nat. Chem. 4, 90-98 (2012).28. S. Passaro, et al., Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction.Molecular Biology (2025).29. H. Brunn, etal., PFAS: forever chemicals — persistent, bioaccumulative and mobile.Reviewing the status and the need for their phase out and remediation of contaminated sites. Environ. Sci. Eur. 35 (2023).30. O. W. Us Epa, Per- and Polyfluoroalkyl Substances (PFAS). (2021).31. P. G. Polishchuk, T. I. Madzhidov, A. Varnek, Estimation of the size of drug-like chemical space based on GDB-17 data. J. Comput. Aided Mol. Des. 27, 675-679 (2013).32. J. S. Morris, K. M. P. Caldo, S. Liang, P. J. Facchini, PRIO / Bet vl-like proteins as novel contributors to plant biochemical diversity. Chembiochem 22, 264-287 (2021).33. C. Radauer, P. Lackner, H. Breiteneder, The Bet v 1 fold: an ancient, versatile scaffold for binding of large, hydrophobic ligands. BMC Evol. Biol. 8, 286 (2008).Atty Docket No. 690104.004634. L. M. Iyer, E. V. Koonin, L. Aravind, Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins: Struct. Funct. Bioinf. 43, 134— 144 (2001).35. L. An, etal., Binding and sensing diverse small molecules using shape-complementary pseudocycles. Science 385, 276-282 (2024).36. A. C. Leonard, etal., Computational design of dynamic biosensors for emerging synthetic opioids. bioRxivorg (2025).37. K. Melcher, et al., A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors. Nature 462, 602-608 (2009).38. L. B. Sheard, et al., Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ coreceptor. Nature 468, 400-405 (2010).39. R. Yao, et al., DWARF 14 is a non-canonical hormone receptor for strigolactone. Nature 536, 469-473 (2016).40. K. Murase, Y. Hirano, T.-P. Sun, T. Hakoshima, Gibberellin-induced DELLA recognition by the gibberellin receptor GID1. Nature 456, 459-463 (2008).41. M. Ueguchi-Tanaka, etal., GIBBERELLIN INSENSITIVE DWARF 1 encodes a soluble receptor for gibberellin. Nature 437, 693-698 (2005).42. H. Xiang, H. Okamura, Y. Kezuka, E. Katoh, Physical and thermodynamic characterization of the rice gibberellin receptor / gibberellin / DELLA protein complex. Scientific Reports 8, 1- 10 (2018).43. D. S. Wishart, et al., DrugBank 5.0: a major update to the DrugBank database for 2018.Nucleic Acids Res. 46, D1074–D1082 (2018).44. J. Hastings, etal., Structure-based classification and ontology in chemistry. J. Cheminform.4, 8 (2012).45. R. Guha, Chemical Informatics functionality in R. Stat. Softw. 18, 1-16 (2007).46. J. Speck, S. C. Stebel, K. M. Arndt, K. M. Muller, Nucleotide exchange and excision technology DNA shuffling and directed evolution. Methods Mol Biol 687, 333-344 (2011).47. M. Vidal, R. K. Brachmann, A. Fattaey, E. Harlow, J. D. Boeke, Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 93, 10315-10320 (1996).48. R. D. Gietz, R. H. Schiestl, Quick and easy yeast transformation using the LiAc / SS carrier DNA / PEG method. Nat. Protoc. 2, 35-37 (2007).49. B. J. Wittmann, K. E. Johnston, P. J. Almhjell, F. H. Arnold, evSeq: Cost-Effective Amplicon Sequencing of Every Variant in a Protein Library. ACS Synth. Biol. 11, 1313— 1324 (2022).Atty Docket No. 690104.004650. H. Tian, laoda2023 / Mutant_Library-Analysis: HaoTian / Mutant_Library-Analysis: v1.0.0 (Zenodo, 2025).51. S.-Y. Park, et al., Abscisic Acid Inhibits Type 2C Protein Phosphatases via the PYR / PYL Family of START Proteins. Science 324, 1068-1071 (2009).52. S. Cutler, cutler sr / iggypop: iggypop 1.0.0 (Zenodo, 2025).53. E. E. Wrenbeck, etal., Plasmid-based one-pot saturation mutagenesis. Nat. Methods 13, 928-930 (2016).54. A. Mosquna, et al., Potent and selective activation of abscisic acid receptors in vivo by mutational stabilization of their agonist-bound conformation. Proc. Natl. Acad. Sci. U. S. A.108, 20838-20843 (2011).55. W J. George, weslgeorge / PAIR-Design-App: v1.0.0 (Zenodo, 2025).56. P. J. Steiner, M. A. Bedewitz, A. V. Medina-Cucurella, S. R. Cutler, T. A. Whitehead, A yeast surface display platform for plant hormone receptors: Toward directed evolution of new biosensors. AIChEJ. n / a, el6767.57. N. Daffern, I. M. Francino-Urdaniz, Z. T. Baumer, T. A. Whitehead, Standardizing cassettebased deep mutagenesis by Golden Gate assembly. Biotechnol. Bioeng. 121, 281-290 (2024).58. A. V. Medina-Cucurella, T. A. Whitehead, Characterizing Protein-Protein Interactions Using Deep Sequencing Coupled to Yeast Surface Display. Methods Mol. Biol. 1764, 101-121 (2018).59. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic acids research, 40(Database issue): Dl 100-7.60. Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, lynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic acids research, 46(Dl): D1074-D1082.61. Hastings J, Magka D, Batchelor C, Duan L, Stevens R, Ennis M, Steinbeck C (2012) Structure-based classification and ontology in chemistry. Journal of cheminformatics, 4:8.62. Cao Y, Charisi A, Cheng L-C, Jiang T, Girke T (2008) ChemmineR: a compound mining framework for R. Bioinformatics (Oxford, England), 24(15): 1733-1734.63. Guha R (2007) Chemical Informatics functionality in R. Journal of statistical software, 18(8):1— 16.64. Beltran J, Steiner PJ, Bedewitz M, Wei S, Peterson FC, Li Z, Hughes BE, Hartley Z, Robertson NR, Medina-Cucurella AV, Baumer ZT, Leonard AC, Park S-Y, Volkman BF,Atty Docket No. 690104.0046Nusinow DA, Zhong W, Wheeldon I, Cutler SR, Whitehead TA (2022) Rapid biosensor development using plant hormone receptors as reprogrammable scaffolds. Nature biotechnology, https: / / doi.org / 10.1038 / s41587-022-01364-565. Speck J, Stebel SC, Arndt KM, Muller KM (2011) Nucleotide exchange and excision technology DNA shuffling and directed evolution. Methods in molecular biology (Clifton, N. J.), 687:333-344.66. Vidal M, Brachmann RK, Fattaey A, Harlow E, Boeke JD (1996) Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions.Proceedings of the National Academy of Sciences of the United States of America,93(19): 10315— 10320.67. Gietz RD, Schiestl RH (2007) Quick and easy yeast transformation using the LiAc / SS carrier DNA / PEG method. Nature protocols, 2(1):35— 37.68. Wittmann BJ, Johnston KE, Almhjell PJ, Arnold FH (2022) evSeq: Cost-Effective Amplicon Sequencing of Every Variant in a Protein Library. ACS synthetic biology, 11(3): 1313-1324.69. Tian H (2025) laoda2023 / Mutant_Library-Analysis: HaoTian / Mutant_Library-Analysis: v1.0.0. https: / / doi.org / 10.5281 / ZENODO.1532039670. Park S-Y, Fung P, Nishimura N, Jensen DR, Fujii H, Zhao Y, Lumba S, Santiago J, Rodrigues A, Chow T-FF, Alfred SE, Bonetta D, Finkelstein R, Provart NJ, Desveaux D, Rodriguez PL, McCourt P, Zhu J-K, Schroeder JI, Volkman BF, Cutler SR (2009) Abscisic Acid Inhibits Type 2C Protein Phosphatases via the PYR / PYL Family of START Proteins. Science, 324(5930): 1068-1071.71. Cutler S (2025) cutlersr / iggypop: iggypop 1.0.0. https: / / doi.org / 10.5281 / ZENODO.1535139872. Wrenbeck EE, Klesmith JR, Stapleton JA, Adeniran A, Tyo KEJ, Whitehead TA (2016) Plasmid-based one-pot saturation mutagenesis. Nature methods, 13(11):928-930.73. Mosquna A, Peterson FC, Park S-Y, Lozano-Juste J, Volkman BF, Cutler SR (2011) Potent and selective activation of abscisic acid receptors in vivo by mutational stabilization of their agonist-bound conformation. Proceedings of the National Academy of Sciences of the United States of America, 108(51):20838-20843.74. George WJ (2025) weslgeorge / PAIR-Design-App: vl.0.0.https: / / doi.org / 10.5281 / ZENODO.1531959275. Steiner PJ, Bedewitz MA, Medina-Cucurella AV, Cutler SR, Whitehead TA A yeast surface display platform for plant hormone receptors: Toward directed evolution of new biosensors. AIChE Journal, n / a(n / a):el6767.76. Daffem N, Francino-Urdaniz IM, Baumer ZT, Whitehead TA (2024) Standardizing cassettebased deep mutagenesis by Golden Gate assembly. Biotechnology and bioengineering, 121(1):281— 290.Atty Docket No. 690104.004677. Medina-Cucurella AV, Whitehead TA (2018) Characterizing Protein-Protein Interactions Using Deep Sequencing Coupled to Yeast Surface Display. Methods in molecular biology, 1764:101-121.

Claims

1. Atty Docket No. 690104.0046CLAIMS1. A library comprising a plurality of polypeptides, wherein each polypeptide contained in the plurality of polypeptides comprises a mutated PYR / PYL receptor polypeptide having amino acid substitutions, relative to the corresponding position of SEQ ID NO: 853; wherein the amino acid substitutions comprise at least three of the following mutations:L, A, V, D, N, S, R, M, Q, T, or E at position 59;M, Y, R I, T, or L at position 81;QFLMAHWIY at position 83;F, M, V, or I at position 87;G, F, I, W, L, M, or D at position 89;L at position 92;G, Q, M, od D at position 94;W, Q, K, Y, S, A, M, N, or L at position 108;R, W, T, or A at position 110;M, N, H, D, G, A, or W at position 117;W, H, A, V, T, M, S, G, F, or L at position 120;K, M, D, V, T, Q, I, E, G, or N at position 122;1, V, T, orF at position 141;S, G, H, M, L, Q, I, T, V, K, A, or N at position 159;I, V, M, L, S, G, or N at position 160;W, M, H, or Q at position 163;W, F, G, S, N, T, H, M, L, K, D, I, or E at position 164; andQ, H, F, T, S, V, Y, K, G, I, D, or N at position 167.

2. A library comprising a plurality of polypeptides, wherein each polypeptide contained in the plurality of polypeptides comprises a mutated PYR / PYL receptor polypeptide having amino acid substitutions, relative to the corresponding position of SEQ ID NO: 853; wherein the amino acid substitutions comprise at least two of the following mutations:A, D, E, F, G, H, I, L, M, N, Q, R, S, T, V, W, or Y at position 59;I, L, M, R, T, or Y at position 81;A, D, E, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 83;A, F, G, I, M, V, W, or Y at position 87;Atty Docket No. 690104.0046D, E, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 89;A, D, E, F, G, H, 1, K, L, M, N, Q, R, T, V, W, or Y at position 92;A, D, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Yat position 94;A, D, E, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 108;A, F, K, L, M, R, T, V, or W at position 110;A, D, E, F, G, H, I, K, M, N, Q, R, S, T, V, W, or Y at position 117;A, D, E, F, G, H, I, K, L, M, N, Q, R, S, T, V, or W at position 120;A, D, E, F, G, H, I, K, L, M, N, Q, R, T, V, W or Y at position 122;A, D, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 141;A, D, E, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 159;D, E, F, G, H, I, K, L, M, N, Q, R, S, T, V, W, or Y at position 160;A, D, E, F, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 163;A, D, E, F, G, H, I, K, L, M, N, Q, R, S, T, W, or Y at position 164; andA, D, E, F, G, H, I, K, L, M, Q, R, S, T, V, W, or Y at position 167;and wherein the amino acid substitutions do not comprise the mutations listed in Figure S7.

3. The library of claim 1 or claim 2, wherein each polypeptide comprises I, Y, or M at position 81, relative to the corresponding position of SEQ ID NO: 853.

4. The library of any one of claims 1-3, wherein each polypeptide comprises L or I at position 83, relative to the corresponding position of SEQ ID NO: 853.

5. The library of any one of claims 1-4, wherein each polypeptide comprises H, I, L, M, or V at position 159, relative to the corresponding position of SEQ ID NO: 853.

6. The library of any one of claims 1-5, wherein each polypeptide comprises G, M, W, or S at position 163, relative to the corresponding position of SEQ ID NO: 853.

7. The library of any one of claims 1-6, wherein each polypeptide comprises D, Q, V, or G at position 167, relative to the corresponding position of SEQ ID NO: 853.

8. The library of any one of claims 1-3, wherein at least one polypeptide of the library comprises an amino acid sequence selected from the group consisting of SEQ ID NOS: 1-852.

9. The library of any one of claims 1-8, wherein the library is a display library or a yeast two-hybrid library.

10. The library of any one of claims 1-8, wherein the library is immobilized to a solid support.Atty Docket No. 690104.00461 l. The library of any one of claims 1-8, wherein each of the PYR1 receptor polypeptides further comprises a detection reagent.

12. The library of claim 11, wherein the detection agent is a member of a binding complex or an enzymatic complementation reagent.

13. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS: 1-852 and a sequence which is at least 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% to any one of SEQ ID NOS: 1-852.

14. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises D, M, or N at position 59; M or W at position 163; and one or more mutations selected from the group consisting of I at position 81; I at position 83; I at position 87; F at position 120; E at position 122; I or T at position 141; V at position 160; L or N at position 164; and V at position 167; and wherein the polypeptide is a sensor for 2,4,6-Trinitrotoluene.

15. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises D, M, or N at position 59; and one or more mutations selected from the group consisting of I at position 81; I at position 83; F or I at position 87; W at position 117; F at position 120; E at position 122; I or T at position 141; V at position 160; W at position 163; D, K or N at position 164; and Q or V at position 167; and wherein the polypeptide is a sensor for 2,4 -Dinitrotoluene.

16. A polypeptide ot the library of any one of claims 1-12, wherein the polypeptide comprises Q or V at position 167; and three or more mutations selected from the group consisting of M, N, or T at position 59; I at position 81; I at position 83; I at position 87; G at position 92; W at position 117; F at position 120; E or G at position 122; I or T at position 141; V at position 160; M or W at position 163; and K, L or N at position 164; and wherein the polypeptide is a sensor for 2-amino-4,6 -Dinitrotoluene.

17. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises V at position 160; and three or more mutations selected from the group consisting of M, N, or R at position 59; I at position 81; I at position 83; M at position 87; V or W at position 117; F, S, or W at position 120; E at position 122; I, K, or T at position 141; M at position 159; G or W at position 163; D, K, L, or N at position 164; and Q at position 167; and wherein the polypeptide is a sensor for 4-amino-2,6 -Dinitrotoluene.Atty Docket No. 690104.004618. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of A, D, Q, and E at position 59; M at position 81; M at position 89; W at position 108; A at position 120; N or V at position 122; T at position 141; V at position 159; G or I at position 160; W at position 163; M at position 164; and D at position 167; and wherein the polypeptide is a sensor for Pentosalen.

19. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of A or Q at position 59; I, R, or Y at position 81; L at position 83; W at position 108; A at position 120; N at position 122; V at position 159; I or V at position 160; W at position 163; and F, N, or S at position 164; and wherein the polypeptide is a sensor for Angelicin.

20. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises L at position 83 and one or more mutations selected from the group consisting of A or Q at position 59; I at position 81; L at position 83; W at position 108; A or M at position 120; G or N at position 122; G, I or V at position 160; W at position 163; F or S at position 164; and D at position 167; and wherein the polypeptide is a sensor for Scopoletin.

21. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of A, L or Q at position 59; I at position 81; L at position 83; W at position 89; W at position 108; M at position 120; E, G, or N at position 122; H, I, or T at position 159; I at position 160; W at position 163; and E or S at position 164; and wherein the polypeptide is a sensor for Bergapten.

22. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises L at position 83 and one or more mutations selected from the group consisting of A or Q at position 59; I at position 81; W at position 108; M at position 120; E or N at position 122; H at position 159; I, M, or V at position 160; W at position 163; E or S at position 164; and D at position 167; and wherein the polypeptide is a sensor for Psoralen.

23. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises mutations selected from the group consisting of Y at position 81; L at position 83; H at position 159; I at position 160; W at position 163; and one or more mutation selected from the group consisting of W at position 108; M at position 120; E or G at position 122; M or S at position 164; and D at position 167; and wherein the polypeptide is a sensor for Citropten.Atty Docket No. 690104.004624. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises mutations selected from the group consisting of L at position 83; H at position 159; W at position 163; and three or more mutations selected from the group consisting of A at position 59; I at position 81; W at position 108; M at position 120; E, G, or N at position 122; I or V at position 160; and E or F at position 164; and wherein the polypeptide is a sensor for 7-Methoxy coumarin.

25. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises mutations selected from the group consisting of A at position 59; L at position 83; W at position 108; M at position 120; N at position 122; I or V at position 160; W at position 163; E at position 164; and I at position 81; and wherein thepolypeptide is a sensor for 5,7-Dihydroxy-4-methylcoumarin.

26. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises mutations selected from the group consisting of E or N at position 122; W at position 163; and one or more mutations selected from the group consisting of A at position 59; I at position 81; W at position 108; A or M at position 120; I or M at position 160; F at position 164; and D at position 167; and wherein the polypeptide is a sensor for Methoxsalen.

27. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises W at position 163; and one or more mutations selected from the group consisting of Q at position 59; I at position 81; L at position 83; W at position 108; A or M at position 120; E, G or N at position 122; G, V, or M at position 160; F or S at position 164; and D at position 167; and wherein the polypeptide is a sensor for Osthole.

28. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises mutations selected from the group consisting of I or Y at position 81; L at position 83; I or V at position 160; W at position 163; and one or more mutations selected from the group consisting of Q at position 59; W at position 108; M at position 120; E, G, or N at position 122; E or F at position 164; and D at position 167; and wherein the polypeptide is a sensor for 4-Methylumbelliferone.

29. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, L, S, or T at position 120; and three or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; F at position 89; A or G at position 94; W at position 108; W at position 122; G or Q at position 141; I at position 159; I, L, M, or V atAtty Docket No. 690104.0046position 160; and L, M, or W at position 164; and wherein the polypeptide is a sensor for Perfluorooctanoic acid.

30. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises mutations selected from the group consisting of A, D, or S at position 94; A, M, or S at position 120; and one or more mutations selected from the group consisting of N at position 59; I at position 83; L at position 122; K or Q at position 141; M at position 160; and L, M, or W at position 164; and wherein the polypeptide is a sensor for 2H,2H,3H,3H-Perfluorohexanoic acid.

31. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, S, or T at position 94; W at position 163; and one or more mutations selected from the group consisting of N at position 59; A, L, M, or S at position 120; L or W at position 122; K at position 141; I, M, or V at position 160; and G, K, M, or W at position 164; and wherein polypeptide is a sensor for 2H,2H,3H,3H-Perfluoroheptanoic acid.

32. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A or S at position 94; and one or more mutations selected from the group consisting of M orN at position 59; G, L, orM at position 120; L at position 122; G at position 141; L at position 159; I, M, or V at position 160; and K, or W at position 164; and wherein the polypeptide is a sensor for 2H,2H,3H,3H-Perfluorooctanoic acid.

33. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of M or N at position 59; A at position 92; A, L, or S at position 94; I, L, M, or T at position 120; Q at position 122; G, K, or Q at position 141; I or L at position 159; M, or N at position 160; and L, M, or W at position 164; and wherein the polypeptide is a sensor for 2H,2H,3H,3H-Perfluorononanoic acid.

34. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, D, or G at position 94; and one or more mutations selected from the group consisting of M at position 59; I at position 83; M at position 87; A, I, or L at position 120 W at position 122; G or Q at position 141; I at position 159; I, L, or V at position 160; and K, L, M, or W at position 164; and wherein the polypeptide is a sensor for Perfluorooctanesulfonic acid.

35. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises L, M, S, or T at position 120; and one or more mutations selected from the group consisting of N at position 59; I at position 83; W at position 122; H, K, or Q at position 141; LAtty Docket No. 690104.0046at position 159; L or V at position 160; and M, S, or W at position 164; and wherein the polypeptide is a sensor for Perfluorobutylsulfonamide.

36. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of M or N at position 59; A or G at position 94; L, N, S, or T at position 120; L or W at position 122; G, K, L, or Q at position 141; L at position 159; L or N at position 160; and K, L, M, or S at position 164; and wherein the polypeptide is a sensor for Perfluorohexanesulfonamide.

37. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A or G at position 94; and one or more mutations selected from the group consisting of M or N at position 59; I at position 83; L at position 120; G or Q at position 141; L at position 159; I, L, or V at position 160; and N or W at position 164; and wherein the polypeptide is a sensor for Perfluorooctanesulfonamide.

38. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of L or M at position 59; I at position 83; M at position 87; F at position 89; A, D, L, M, S or T at position 120; L or W at position 122; A, D, K, or Q at position 141; I at position 159; I, M, V, orW at position 160; and G, L, M, S, or W at position 164; and wherein the polypeptide is a sensor for N-Methylperfluorobutanesulfonamide.

39. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises M at position 59; D at position 94; H at position 159; L or M at position160; and one or more mutations selected from the group consisting of A, L, or M at position 120; W at position 122; and G or Q at position 141; and wherein the polypeptide is a sensor for 1H,1H,8H-Perfluorooctan- 1 -ol.

40. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; L or M at position 120; L, R, or W at position 122; G, K, or Q at position 141; H at position 159; L, M, or V at position 160; and K or W at position 164; and wherein the polypeptide is a sensor for lH,lH,9H-Hexadecafluorononan-l-ol.

41. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of M or N at position 59; D or N at position 94; Q at position 108; L at position 120; L at position 122; Q at position 141; HAtty Docket No. 690104.0046at position 159; I or L at position 160; and W at position 164; and wherein the polypeptide is a sensor for 1H,1H,6H,6H-Perfluoro-1,6-hexandiol.

42. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises H at position 159; and one or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; L, M, N, or T at position 120; G, L or W at position 122; G or Q at position 141; I, L, M, N, or V at position 160; and G or W at position 164; and wherein the polypeptide is a sensor for 1H,1H,8H,8H-Dodecafhioro-1,8-octanediol.

43. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of L, M, N, or R at position 59; I at position 83; T at position 89; D at position 94; M at position 110; G at position 117; A, I, L, M, S, or T at position 120; L or W at position 122; G or Q at position 141; H at position 159; and L, M, or V at position 160; and wherein the polypeptide is a sensor for 1H,1H,9H,9H-Perfluoro- 1,9-nonanediol.

44. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises G or H at position 159; and one or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; A, L, M, or S at position 120; L or W at position 122; G or Q at position 141; I, M, or V at position 160; and K or M at position 164; and wherein the polypeptide is a sensor for lH,lH,10H,10H-Perfluoro-l,10-decanediol.

45. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of L, M, or N at position 59; I at position 83; D at position 94; A, G, L, M, S, T, or V at position 120; R or W at position 122; G or Q at position 141; I, L, or M at position 159; I or W at position 160; and L, M, S, or W at position 164; and wherein the polypeptide is a sensor for 1H,1H,2H,3H,3H-Perfluorononane-1,2-diol.

46. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, E, G, or S at position 94; and one or more mutations selected from the group consisting of L or M at position 59; I at position 83; L at position 108; A, G, or L at position 120; L at position 122; G at position 141; H at position 159; A, I, L, or V at position 160; and H, K, L, or M at position 164; and wherein the polypeptide is a sensor for Perfluoro-3,6,9-trioxatridecanoic acid.Atty Docket No. 690104.004647. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A or T at position 94; L or M at position 120; and two or more mutations selected from the group consisting of M at position 59; M at position 87; G at position 141; I at position 159; and V at position 160; and wherein the polypeptide is a sensor for 9-Chlorohexadecafluorononanoic Acid.

48. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises G at position 94; and one or more mutations selected from the group consisting of M at position 59; I at position 83; L at position 120; G, K, or Q at position 141; L or V at position 160; I at position 163; and K or W at position 164; and wherein thee polypeptide is a sensor for 3, 5, 6 -tri chi orooctafluorohexanoi c aci d.

49. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of M or N at position 59; D at position 94; H at position 108; G, K, M, S, T, or V at position 120; L or W at position 122; G, K, or Q at position 141; L or T at position 159; L, M, or V at position 160; and G, L, M, S, or W at position 164; and wherein the polypeptide is a sensor for Perfluoroheptanal hydrate (diol).

50. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, G, S, or T at position 94; and one or more mutations selected from the group consisting of M or N at position 59; I at position 83; L at position 120; G, K, or Q at position 141; L at position 159; L or V at position 160; and G, M, or W at position 164; and wherein the polypeptide is a sensor for 2H-Perfluoro-2-octenoic acid.

51. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises M or N at position 59; A or G at position 94; A or L at position 120G or Q at position 141; I, M, or V at position 160; and W at position 164; and wherein the polypeptide is a sensor for Perfluorohexanesulfonic Acid.

52. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises T or V at position 159; and one or more mutations selected from the group consisting of W at position 120; W at position 163; and G at position 164; and wherein the polypeptide is a sensor for ALFATRADIOL.

53. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of S at position 59; T atAtty Docket No. 690104.0046position 81; A at position 117; S at position 120; T at position 122; I or L at position 159; V at position 160; and D at position 167; and wherein the polypeptide is a sensor for BOLDENONE.

54. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of N or S at position 59; Y at position 81; G at position 89; Q at position 122; I or L at position 160; M at position 163; and D at position 167; and wherein the polypeptide is a sensor for METHANDROSTENOLONE.

55. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises N, R, S, or T at position 59; T at position 81; and one or more mutations selected from the group consisting of I or L at position 159; L at position 160; and T at position 167; and wherein the polypeptide is a sensor for NORETHINDRONE.

56. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises R at position 81; L or M at position 83; I or V at position 159; and optionally Q at position 122; and wherein the polypeptide is a sensor for KETOPROFEN.

57. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises T or V at position 159; and one or more mutations selected from the group consisting of L at position 59; I at position 83; N or Q at position 108; W at position 120; V at position 160; W at position 163; and E or G at position 164; and wherein the polypeptide is a sensor for PRANOPROFEN.

58. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises D at position 59; and one or more mutations selected from the group consisting of L at position 81; I at position 87; I at position 89; I or V at position 160; and L at position 164; and wherein the polypeptide is a sensor for DEXMEDETOMIDINE.

59. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of A, M, or S at position 59; L, M, or Y at position 81; A at position 83; F at position 87; D at position 94; Y at position 108; A at position 110; T at position 120; Q or V at position 122; I, L, or V at position 159; L at position 160; and W at position 163; and wherein the polypeptide is a sensor for ETOMIDATE.

60. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises D or E at position 59; and one or more mutations selected from the group consisting of L at position 81; F at position 89; and V at position 160; and wherein the polypeptide is a sensor for MEDETOMIDINE.Atty Docket No. 690104.004661. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of M at position 59; L or Y at position 81; D at position 89; A at position 110; A, F, G, M, or S at position 120; I or V at position 122; A, I, T, or V at position 159; and F, M, or N at position 164; and wherein the polypeptide is a sensor for CAPSAICIN.

62. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of A, M, Q, or R at position 59; I, L, T, or Y at position 81; L at position 89; D at position 94; L or M at position 108; A, G, S, or T at position 120; I or N at position 122; A, H, S, T, or V at position 159; I, M at position 160; and H, I, or M at position 164; and wherein the polypeptide is a sensor for DIHYDROCAPSAICIN.

63. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of R at position 59; I or Y at position 81; I at position 87; A, F, or T at position 120; V at position 122; A, S, T, or V at position 159; V at position 160; H at position 167; and S at position 167; and wherein the polypeptide is a sensor for NONIVAMIDE.

64. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises D or E at position 167; and one or more mutations selected from the group consisting of L at position 159; and H or I at position 164; and wherein the polypeptide is a sensor for OLANEXIDINE.

65. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of A, M, or T at position 59; Y at position 81; A, G, S, or T at position 120; D, G, I, M, or Q at position 122; A, H, or T at position 159; I or V at position 160; and L or T at position 164; and wherein thepolypeptide is a sensor for ZUC APSAICIN.

66. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of D at position 94; I or L at position 159; M at position 160; and H at position 164; and wherein the polypeptide is a sensor for CROTAMITON.

67. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises I or M at position 159; and one or more mutations selected from the group consistingAtty Docket No. 690104.0046of E or Q at position 122; and H or L at position 164; and wherein thepolypeptide is a sensor for AMIPROPHOS METHYL.

68. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises K at position 159; and one or more mutations selected from the group consisting of D at position 94; M at position 117; and M or T at position 164; and wherein the polypeptide is a sensor for CARBIMAZOLE.

69. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of R at position 59; L or Y at position 81; L, M, W, or Y at position 83; F or M at position 87; A at position 117; W at position 120; M at position 122; A, G, H, or V at position 159; and I, L, M, or V at position 160; and wherein the polypeptide is a sensor for DIETHYLTOLUAMIDE.

70. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of A, L, N, R, or S at position 59; L or Y at position 81; F, L, or Y at position 83; M at position 87; Y at position 108; D, G, H, or N at position 117; F at position 120; N or Q at position 122; I at position 159; L at position 160; and D, Q, or S at position 167; and wherein the polypeptide is a sensor for CYCLOATE.

71. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises R at position 110; and one or more mutations selected from the group consisting of L or M at position 81; I at position 159; S at position 160; S at position 164; and H at position 167; and wherein the polypeptide is a sensor for VALPROIC ACID.

72. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of E at position 59; L or R at position 81; K at position 83; I at position 89; Q at position 122; and F at position 167; and wherein the polypeptide is a sensor for AMITRAZ.

73. A polypeptide of the library of any one of claims 1-12, wherein thepolypeptide comprises A, I, S, T, or V at position 159; and one or more mutations selected from the group consisting of T at position 59; A at position 83; Y at position 108; A at position 117; E at position 122; I, L, or M at position 160; I at position 164; and G, I, T, or V at position 167; and wherein the polypeptide is a sensor for PICOXYSTROBIN.Atty Docket No. 690104.004674. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, G, I, S, T, or V at position 159; and one or more mutations selected from the group consisting of A at position 59; L at position 83; M at position 87; G at position 89; D at position 94; A or F at position 120; G at position 160; F or S at position 164; and Q or S at position 167; and wherein the polypeptide is a sensor for PYRACLOSTROBIN.

75. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of A or S at position 108; K or Q at position 122; K at position 159; and L at position 160; and wherein the polypeptide is a sensor for VOXELOTOR.

76. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises Q at position 94; and two or more mutations selected from the group consisting of T at position 81; Y at position 83; M at position 87; and G at position 89; and wherein the polypeptide is a sensor for DICLOFENAC.

77. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of M at position 59; R at position 81; W at position 83; D at position 94; I, R at position 108; K or M at position 117; T or V at position 159; W at position 163; and G at position 164; and wherein the polypeptide is a sensor for FLAMPROP -METHYL.

78. A polypeptide of the library of any one of claims 1-12, wherein thepolypeptide comprises two or more mutations selected from the group consisting of R at position 81; H, L, or M at position 83; M at position 87; G or I at position 89; G, M, or Q at position 94; L at position 108; T at position 120; T at position 122; S at position 160; M at position 164; and wherein the polypeptide is a sensor for LONIDAMINE.

79. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of I or L at position 83; A, G or T at position 120; D or E at position 122; A, M, or V at position 159; G, N, or V at position 160; W at position 163; F at position 164; and I at position 167; and wherein the polypeptide is a sensor for DIMOXYSTROBIN.

80. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of Q at position 59; Y at position 81; A, F, H, L, or M at position 83; F at position 89; H or N at position 117; A, G, S, orAtty Docket No. 690104.0046T at position 120; D or E at position 122; H, I, or L at position 159; I at position 160; and E or L at position 164; and wherein the polypeptide is a sensor for CARPROPAMID.

81. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, G, or S at position 120; and one or more mutations selected from the group consisting of L at position 81; A or Y at position 83; D at position 94; Y at position 108; H at position 117; A at position 159; and L or V at position 160; and wherein the polypeptide is a sensor for FLUFENACET.

82. A polypeptide of the library of any one of claims 1-12, wherein thepolypeptide comprises two or more mutations selected from the group consisting of Y at position 83; H or Q at position 94; R at position 108; and H at position 164; and wherein the polypeptide is a sensor for TRINEXAPAC-ETHYL.

83. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises F, Y, or L at position 89; and one or more mutations selected from the group consisting of A, T, or W at position 110; G, H, or N at position 117; N or S at position 164; and H or S at position 167; and wherein thepolypeptide is a sensor for CHLORMADINONE ACETATE.

84. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises two or more mutations selected from the group consisting of Q at position 59; A at position 83; F, I, L, or M at position 89; A, T, or W at position 110; A, D, or N at position 117; L at position 159; and E at position 164; and wherein the polypeptide is a sensor for CYPROTERONE ACETATE.

85. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises D at position 59; L or M at position 160; and one or more mutations selected from the group consisting of A at position 110; and L at position 120; and wherein the polypeptide is a sensor for DIFLUCORTOLONE 21-V ALERATE.

86. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A at position 108; D, H, or N at position 117; and I or V at position 159; and wherein the polypeptide is a sensor for GEDUNIN.

87. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises three or more mutations selected from the group consisting of L at position 83; M atAtty Docket No. 690104.0046position 87; A at position 110; H or W at position 117; N at position 159; I at position 160; H at position 163; and N at position 164; and wherein the polypeptide is a sensor for FORMESTANE.

88. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises I or L at position 160; and one or more mutations selected from the group consisting of Q or S at position 108; A at position 120; and W at position 164; and wherein the polypeptide is a sensor for MESTEROLONE.

89. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of D, Q, or T at position 59; L or Y at position 81; L or M at position 83; M or V at position 87; D at position 94; D or Q at position 122; T at position 141; L or V at position 160; H or W at position 163; H or N at position 164; and Y at position 167; and wherein the polypeptide is a sensor for RAC-3-N-BUTYLPHTHALIDE.

90. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A, I, T, or V at position 159; and one or more mutations selected from the group consisting of V at position 59; T at position 110; W at position 120; and M or W at position 163; and wherein the polypeptide is a sensor for BUTYLPARABEN.

91. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises H or L at position 159; and one or more mutations selected from the group consisting of R at position 59; M at position 160; and H at position 167; and wherein the polypeptide is a sensor for ORSELLINIC ACID, ETHYL ESTER.

92. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of I at position 83; M or V at position 87; W at position 117; W at position 120; G, H, or T at position 159; M, S, or V at position 160; W at position 163; E or K at position 164; and H or Q at position 167; and wherein the polypeptide is a sensor for PROPYLPARABEN.

93. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of D or N at position 59; I at position 81; I or L at position 83; M at position 87; I at position 141; V at position 160; and Q at position 167; and wherein the polypeptide is a sensor for TIOXOLONE.

94. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises Y at position 81; and one or more mutations selected from the group consisting of AAtty Docket No. 690104.0046at position 83; G at position 89; and V at position 160; and wherein the polypeptide is a sensor for FLUN1X1N.

95. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises A or G at position 120; and one or more mutations selected from the group consisting of T or Y at position 81; V at position 87; A or W at position 108; M at position 117; T at position 122; L or V at position 160; T at position 164; and D, H, or S at position 167; and wherein the polypeptide is a sensor for CYCLANDELATE.

96. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises I, T, or V at position 159; and one or more mutations selected from the group consisting of Y at position 81; M at position 160; Y at position 164; and T at position 167; and wherein the polypeptide is a sensor for DANTHRON.

97. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of L at position 81; L at position 83; G, I, or M at position 159; I at position 160; I, D or L at position 164; and K, Q, or V at position 167; and wherein the polypeptide is a sensor for 2-HYDROXY-9-FLUORENONE.

98. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises L, M, or V at position 159; and one or more mutations selected from the group consisting of F at position 120; S at position 160; W at position 163; and G at position 164; and wherein the polypeptide is a sensor for 2-HYDROXYBENZOPHENONE.

99. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of D, F, or L at position 89; M at position 159; and H at position 167; and wherein the polypeptide is a sensor for BETANAPHTHOL.

100. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of M at position 87; W at position 120; I or T at position 159; N at position 160; W at position 163; and G or H at position 167; and wherein the polypeptide is a sensor for 4-HYDROXYBENZOPHENONE.

101. A polypeptide of the library of any one of claims 1-12, wherein the polypeptide comprises one or more mutations selected from the group consisting of T at position 81; W at position 83; N or Y at position 108; E at position 122; A, I, L, S, T, or V at position 159; L or NAtty Docket No. 690104.0046at position 160; Q or W at position 163; D or F at position 164; and Q at position 167; and wherein the polypeptide is a sensor for 6-BENZOYL-2-NAPHTHOL.

102. Sensors for ANTHRACENE-9-CARBOXYLIC ACID, harboring a mutation selected from F159: 1, L, M, V and 1 or more mutations selected from the following: V81: R, Y; V164: L relative to the corresponding positions in SEQ ID NO:853.

103. Sensors for ANTHRONE, harboring a mutation selected from F159: I, M, V and 1 or more mutations selected from the following: V81: R, Y; F108: M, Y relative to the corresponding positions in SEQ ID NO:853.

104. Sensors for CINCHOPHEN, harboring a mutation selected from Y120: A, G and 1 or more mutations selected from the following: V81: L, Y; L87: 1; E94: D; A160: L relative to the corresponding positions in SEQ ID NO:853.

105. Sensors for FLAVONE, harboring 2 or more mutations selected from the following: K59: D, N; L87: 1; F108: Q; E141: I; F159: 1, T, V; A160: V; V163: M, W; V164: F, G; N167: G, S, V relative to the corresponding positions in SEQ ID NO:853.

106. Sensors for KHELLIN, harboring 1 or more mutations selected from the following: V81: L; V83: L; S122: Q; E141: I, T; F159: G, M, T; V164: F, G, S, T; N167: K relative to the corresponding positions in SEQ ID NO:853.

107. Sensors for ACETOMENAPHTHONE, harboring 1 or more mutations selected from the following: V81: L, M, Y; L87: I, M; A89: F, M; F108: N, W, Y; 1110: T; S122: T; F159: A, I, L, S, T, V; A160: L, V relative to the corresponding positions in SEQ ID NO:853.

108. Sensors for HEXYLRESORCINOL, harboring 2 or more mutations selected from the following: K59: A; L117: W; S122: I; F159: T; A160: G, S; V163: W; V164: G, S relative to the corresponding positions in SEQ ID NO:853.

109. Sensors for WHILE OLIVETOL, harboring 1 or more mutations selected from the following: V81: M; V83: L; L87: I; Y120: G; S122: E; F159: I, M, T; V164: H, L, N relative to the corresponding positions in SEQ ID NO:853.

110. Sensors for DEHYDRO ACETIC ACID, harboring 2 or more mutations selected from the following: V81: R; V83: I, W; L87: M; E94: D, Q; F108: Y; LI 17: H, M; A160: G relative to the corresponding positions in SEQ ID NO:853.Atty Docket No. 690104.0046111. Sensors for LISURIDE, harboring 1 or more mutations selected from the following: V81: Y; Y120: A, G, S, T; S122: E, Q, V; F159: A, T, V relative to the corresponding positions in SEQ ID NO:853.

112. Sensors for WIN-552122, harboring a mutation selected from F159: G, S, T and 1 or more mutations selected from the following: Y120: M; A160: I, L, M, V; V164: N; N167: T relative to the corresponding positions in SEQ ID NO:853.

113. Sensors for BICALUTAMIDE, harboring a mutation selected from A160: I, V and 1 or more mutations selected from the following: K59: D; E141: I; V164: F, W relative to the corresponding positions in SEQ ID NO:853.

114. Sensors for EFAVIRENZ, harboring 2 or more mutations selected from the following: K59: S, T; V81: T; V83: I; L87: M; F108: L; F159: N, Q; A160: G; V163: M, W; V164: H, L, S, T; N167: V, Y relative to the corresponding positions in SEQ ID NO:853.

115. Sensors for FLUTAMIDE, harboring 1 or more mutations selected from the following: K59: A, D; V81: I; V83: I; Y120: H, L, M; S122: M; E141: F, I, T, V; A160: M, V; V164: M, S; N167: G, S relative to the corresponding positions in SEQ ID NO:853.

116. Sensors for RILUZOLE, harboring 2 or more mutations selected from the following: K59: E, Q, S; V81: L; V83: M; L87: I; Y120: A; S122: G; E141: I; F159: I, L; A160: M; V164: E relative to the corresponding positions in SEQ ID NO:853.

117. Sensors for CINACALCET, harboring a mutation selected from K59: D, E, M and 1 or more mutations selected from the following: 1110: T; L117: A, M; Y120: A, F, G, S; S122: M, N, V; F159: I; V164: F, I relative to the corresponding positions in SEQ ID NO:853.

118. Sensors for MONOBENZONE, harboring a mutation selected from Fl 59: A, I, T, V and 1 or more mutations selected from the following: K59: N; F108: M; LI 17: H; Y120: H, M, V; S122: I, M; E141: T; A160: G, L; V164: E, F, K; N167: F, H relative to the corresponding positions in SEQ ID NO:853.

119. Sensors for PRAZIQUANTEL, harboring a mutation selected from Y120: H, L, M and 2 or more mutations selected from the following: V81: L; V83: F, Y; F108: W; Il 10: W; F159: 1; A160: G relative to the corresponding positions in SEQ ID NO:853.

120. Sensors for DICLAZURIL, harboring 3 or more mutations selected from the following: V81: I; E94: G; Y120: M; S122: V; A160: I, M, N; V164: T; N167: H, I, Y relative to the corresponding positions in SEQ ID NO:853.Atty Docket No. 690104.0046121. Sensors for TRICLABENDAZOLE, harboring a mutation selected from F159: G, H, Q, T, V and 2 or more mutations selected from the following: K59: A, S; V83: L; Y120: F; S122: D; A160: I, L; V163: W; V164: T, W relative to the corresponding positions in SEQ ID NO:853.

122. Sensors for TOLBUTAMIDE, harboring 2 or more mutations selected from the following: V81: R; V83: F; S92: L; E94: G; Y120: S; V164: N; N167: D relative to the corresponding positions in SEQ ID NO:853.

123. Sensors for MELITRACEN, harboring a mutation selected from F159: I, T, V and 1 or more mutations selected from the following: K59: L; V81: Y; S122: E; A160: M; V164: E, F, H relative to the corresponding positions in SEQ ID NO:853.

124. Sensors for LATANOPROST, harboring a mutation selected from Y120: A, H and 2 or more mutations selected from the following: V83: Q; F159: 1, V; A160: G; V164: E; N167: H relative to the corresponding positions in SEQ ID NO:853.

125. Sensors for GUANABENZ, harboring a mutation selected from K59: A, E, Q and 1 or more mutations selected from the following: A89: D; F159: A, V; A160: I; V163: M; V164: F relative to the corresponding positions in SEQ ID NO:853.

126. Sensors for MEZLOCILLIN, harboring a mutation selected from Y120: A and 1 or more mutations selected from the following: V81: Y; F108: Y; S122: T; A160: V relative to the corresponding positions in SEQ ID NO:853.

127. Sensors for LIOTHYRONINE, harboring a mutation selected from L117: A, M and 1 or more mutations selected from the following: V81: I; V83: L; Y120: F; V164: I, L relative to the corresponding positions in SEQ ID NO:853.

128. Sensors for PHENAZOPYRIDINE, harboring mutations selected from K59: D, S; F159: T, V and 1 or more mutations selected from the following: V83: L; A89: I; S122: Q;N167: Q relative to the corresponding positions in SEQ ID NO:853.

129. Sensors for CHLOROXYLENOL, harboring 1 or more mutations selected from the following: K59: D, M, N; V81: I; V83: I; L87: M; L117: W; Y120: F; E141: I; F159: T; A160: V; V163: M; V164: K, L, S; N167: Q, V relative to the corresponding positions in SEQ ID NO:853.

130. Sensors for METYRAPONE, harboring mutations selected from V81: Y; F159: I, V and 1 or more mutations selected from the following: S122: Q relative to the corresponding positions in SEQ ID NO:853.Atty Docket No. 690104.0046131. Sensors for BENZBROMARONE, harboring a mutation selected from E94: G, M, Q and 1 or more mutations selected from the following: K59: L; V81: T; V83: L; L87: F; A89: G; S92: L; F159: H; A160: L relative to the corresponding positions in SEQ ID NO:853.

132. Sensors for IBUDILAST, harboring 2 or more mutations selected from the following: K59: R; V81: I; F159: M, S; V163: H; V164: L; N167: Y relative to the corresponding positions in SEQ ID NO:853.

133. Sensors for IBUPROFEN PICONOL, harboring a mutation selected from F159: G, I, T and 1 or more mutations selected from the following: V81: M; V83: Y; Y120: L; S122: E; N167: Y relative to the corresponding positions in SEQ ID NO:853.

134. Sensors for COMBRETASTATIN A4, harboring a mutation selected from F159: H, I, L, T and 1 or more mutations selected from the following: K59: N; V81: Y; L87: F; E94: D; A160: M; N167: G, T relative to the corresponding positions in SEQ ID NO:853.

135. Sensors for 2-AMINOPYRIMIDINE, harboring a mutation selected from F159: L, Q and 1 or more mutations selected from the following: L87: 1; F108: M; L117: W relative to the corresponding positions in SEQ ID NO:853.

136. Sensors for MAGNOLOL, harboring a mutation selected from Y120: G, H, M, T, V and 1 or more mutations selected from the following: V81: L; S122: D, T; F159: L; N167: G, Y relative to the corresponding positions in SEQ ID NO:853.

137. Sensors for BENZYL CINNAMATE, harboring 1 or more mutations selected from the following: V81: L; F108: Y; F159: H; A160: G; V164: F; N167: N, T, V relative to the corresponding positions in SEQ ID NO:853.

138. Sensors for per and poly-fluorinated substances, harboring a mutation selected from E94: A, D, G, Q and one or more mutations selected from the following: F159: I, L; A160: I, L, M, N, V; V163: S; V164: K, L, M, S, W relative to the corresponding positions in SEQ ID NO:853.

139. Sensors for non-steroidal anti-inflammatory drugs (NSAIDs) harboring a mutation selected from F159: G, I, T, V and one or more mutations selected from the following: K59: L; V81: M, R; V83: H, I, L, M, Y; F108: K, N, Q; Y120: L, W; S122: E, Q; A160: V; V163: W; V164: E, G; N167: Y relative to the corresponding positions in SEQ ID NO:853.

140. Sensors for strobilurin class fungicides, harboring a mutation selected from F159: A, G, I, S, T, V and one or more mutations selected from the following: K59: A, T; V83: A, L; L87:Atty Docket No. 690104.0046M; A89: G; E94: D; F108: Y; L117: A; Y120: A, F; S122: E; A160: G, I, L, M; V164: F, I, S; N167: G, I, Q, S, T, V relative to the corresponding positions in SEQ ID NO:853.

141. A system for detecting a substance selected from the group consisting of a drug, a natural product, a chemical compound and an agrochemical, wherein the system comprises one or more of the mutated PYR / PYL receptor polypeptides according to any one of claims 1-141 and an HAB polypeptide.

142. The system of claim 141, wherein the HAB1 polypeptide is an N-terminus deleted HAB1 polypeptide.

143. The system of claim 142, wherein the N-terminus deleted HAB1 polypeptide is thermostable.

144. The system of any one of claims 141-143, wherein the engineered PYR1 polypeptides are labeled with a first detection reagent, and the HAB1 polypeptide is labeled with a second detection reagent.

145. The system of any one of claims 141-144, wherein the first detection reagent and the second detection reagent are capable of binding to each other.

146. The system of any one of claims 141-145, wherein a signal is generated when the engineered PYR1 polypeptides bind the substance and the first detection reagent binds to the second detection reagent.

147. The system of any one of claims 141-146, wherein the first detection reagent and / or the second detection reagent are an antibody, a ligand or an aptamer.

148. The system of any one of claims 141-147, wherein the first detection reagent and the second detection reagent are first and second components of a split complement system.

149. The system of claim 148, wherein the split complement system selected from: a split GFP system; a split Vex-GFP system, a NanoBiT split ubiquitin system; a split beta-gal system; a split luciferase system; a split mCherry system; a split FRET system; and a split biotin system.

150. The system of any one of claims 141-149, wherein the first detection reagent and the second detection reagent are fluorescent moieties, or one of the first detection reagents is a fluorescent moiety and the second is a quenching moiety that quenches the fluorescent moiety.

151. The system of any one of claims 141-150, wherein the first detection reagent and the second detection reagent are oligonucleotides, wherein the oligonucleotides are proximity assay components.Atty Docket No. 690104.0046152. The system of claim 151, wherein the proximity assay is a proximity extension assay or proximity ligation assay.

153. The system of any one of claims 141-152, wherein the substance is present in a sample selected from: a biological sample, a food sample, and an environmental sample.

154. The system of any one of claims 141-153, wherein the biological sample is selected from urine, blood, plasma, hair, sweat, and saliva.

155. A method for detecting a substance of interest in a sample, wherein the method comprises contacting a sample containing, or suspected of containing the substance of interest with one or more of the engineered PYR1 polypeptides according to any one of claims 1-141, wherein the engineered PYR1 polypeptides are labeled with a first detection reagent, and a HAB1 polypeptide, wherein the HAB1 polypeptide is labeled with a second detection reagent, and wherein a signal is generated when the engineered PYR1 polypeptides bind the substance of interest and the HAB1 polypeptide and the first detection reagent binds to the second detection reagent.

156. The method of claim 155, wherein the HAB1 polypeptide is an N- terminus deleted HAB1 polypeptide.

157. The method of claim 156, wherein the N-terminus deleted HAB1 polypeptide is thermostable.

158. The method of any one of claims 155-157, wherein the sample is a biological sample, a food sample, or an environmental sample.

159. The method of any one of claims 155-158, wherein the biological sample is selected from urine, blood, plasma, hair, sweat, and saliva.

160. The isolated polypeptide of claim 13, wherein the amino acid sequence is at least 95%, 96%, 97%, 98%, 99%, or 100% identical to SEQ ID NO: 336 and retains substitutions K59M, E94G, Y120L, E141Q, A160V, and V164W relative to SEQ ID NO: 853, and wherein the polypeptide is a sensor for PFOA, PFNA, PFOS, and PFHxS.